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ABSTRACT 
To Smoke or Not to Smoke: Predictors of Smoking Behavior in People with  
Head and Neck Cancer and Chronic Obstructive Pulmonary Disease 
Kim Phillips Baron 
Christine Maguth Nezu, Ph.D. 
 
 
 
Research demonstrates that smoking is highly correlated with, and a cause of, head and 
neck cancer and Chronic Obstructive Pulmonary Disease (COPD). Although the 
prevalence of smoking has declined since 1965, a significant proportion of the population 
continue to smoke. In addition to smoking being a cause of cancer and COPD, smoking 
has also been implicated in the progression of disease-related symptoms, diminished 
treatment outcome, and recurrence of disease. Previous research demonstrates that 
approximately 70% of individuals with COPD continue to smoke as compared to 
approximately 30% of individuals with head and neck cancer. Most of the studies have 
focused on demographic, smoking, disease severity and treatment variables, with little 
attention to psychosocial variables. Whereas demographic variables are stable variables 
which cannot be reversed, psychosocial variables are important to investigate not only 
because they may serve as obstacles to smoking cessation, but also, because interventions 
exist which would allow health professionals to intervene and increase smoking cessation 
success. This study investigated psychosocial predictors of smoking cessation in the head 
and neck cancer and COPD populations. One-hundred and three participants completed a 
semi-structured interview of their smoking history and two self-report questionnaires, the 
Profile of Mood States and the Social Problem-Solving Inventory - Revised. Fifty-four 
and 49 participants were diagnosed with COPD and with head and neck cancer, 
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respectively. Approximately 31% of individuals with COPD and 26% of individuals with 
head and neck cancer were current cigarette smokers, resulting in 29% of the combined 
sample currently smoking cigarettes. A logistic regression found that marital status, 
alcohol use, and depression predicted smoking status. The smoking history, problem-
solving, and anger variables did not predict smoking status. In the final model, 
approximately 25% of the variance was accounted for. A response operating 
characteristics analysis yielded a model with 71% sensitivity, 68% specificity, and an 
overall classification rate of 70%. The results suggest that for individuals who are 
diagnosed with either head and neck cancer or COPD, and who report some distress, 
psychosocial treatment that addresses alcohol use and that is geared toward decreasing 
depression may help these individuals quit smoking.   
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CHAPTER 1: INTRODUCTION 
 
Smoking accounts for 434,000 deaths annually in the United States (Cinciripini, 
Wetter, & McClure, 1998). In 1995, 24.7% of people in the United States considered 
themselves smokers, accounting for approximately 47 million adults (Centers for Disease 
Control [CDC], 1997). In 1996, 43% of men over the age of 18 and 33% of women over 
the age of 18 smoked cigarettes. Although the prevalence of smoking has declined by 40% 
between 1965 and 1990, this decrease reached a plateau between 1990 and 1995, and 
smoking prevalence has remained unchanged (National Center for Health Statistics, 1998).  
 Smoking is considered one of the few preventable behaviors and causes of morbidity 
and mortality (American Cancer Society [ACS], 1994; U.S. Department of Health and 
Human Services [USDHHS], 1990). However, although many smokers state that they 
would like to quit, only a small percentage are successful over the long term. Epidemiologic 
studies reported that in 1995, 45.8% of smokers had made at least one quit attempt during 
the past year, but only 23.3% were considered former smokers (CDC, 1997). In other 
words, approximately one half of the individuals who attempted to quit smoking subsequently 
relapsed. Similarly, in a community-level, 4-year smoking intervention study of over 20,000 
smokers, smoking prevalence declined only 2.8% between 1988 and 1993 (Green, 1995b). 
These large scale findings show that many individuals continue to smoke cigarettes and that 
many who quit smoking have difficulty maintaining abstinence.  
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 Smoking is strongly associated with many chronic diseases including cancer and 
pulmonary disease. Cigarette smoking is related to 30% of total cancer mortality and 82% of 
deaths from chronic obstructive pulmonary disease ([COPD], CDC, 1991). According to 
the CDC, the smoking-attributable mortality (SAM) in the year 1990 was 6,475 for 
individuals with cancers of the lip, oral cavity, and pharynx, 7,284 for individuals with cancer 
of the esophagus, and 2,990 for individuals with cancer of the larynx (CDC, 1993). 
Although the research shows a high correlation between smoking and cancer and smoking 
and COPD, many individuals with these illnesses continue to smoke. Research also shows 
that people who stop smoking, regardless of the age at which they quit, live longer longer 
(Taylor, Hassellblad, Henley, Thun, & Sloan, 2002).  
The current study will investigate predictors of smoking behavior in people with 
either COPD or with head and neck cancer. The paper will begin with a brief overview of 
two illnesses that have been strongly linked to smoking behavior: head and neck cancer and 
COPD. Following this overview will be a description of current research on smoking 
behavior in three populations: the general population, head and neck cancer, and COPD. 
Several theories related to health behaviors such as smoking will be introduced. Particular 
attention will be paid to the problem-solving model. The current study will then be described, 
along with the results and a discussion.  
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CHAPTER 2: HEAD AND NECK CANCER 
 
Etiology and Epidemiology 
 
 Head and neck cancer includes cancers of the lip, the oral cavity (i.e., the tongue, the 
inside lining of the cheeks, the floor of the mouth, the gums, and the hard palate), the 
paranasal sinuses and nasal cavity, the salivary glands (i.e., the parotid glands, the 
submaxillary or submandibular glands, the sublingual glands, the salivary glands, the pharynx 
(i.e., the oropharynx, nasopharynx, and hypopharynx), the larynx (i.e., the voice box, which 
includes the supraglottic larynx, the glottis, and the subglottis), the maxillary glands, and the 
thyroid gland. Together, head and neck cancers “account for 5 to 10 percent of all 
malignancies” (Helsper & Dollinger, 1991, p. 410). There are approximately 41,000 newly 
diagnosed cases of head and neck cancer per year (Moadel, Ostroff, & Schantz, 1998, p. 
314).  Approximately one third of people diagnosed with head and neck die of the illness 
(Helsper & Dollinger, 1991). The cure rate is considered “good” if the cancer is “found 
early, evaluated adequately and treated with the best available therapy” (Helsper & 
Dollinger, p.410). Five year survival rate, which is the most common statistic used to 
measure prognosis, is approximately 52% (Moadel et al., 1998). 
Head and neck cancer has been strongly correlated to environmental pathogens. 
Tobacco use and alcohol use are considered to be the greatest risk factors for head and 
neck cancer. “Smoking contributes to 90% of all cancers occurring in organs that come in 
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direct contact with smoke, including the mouth, esophagus, lungs, and bronchus” (Hecht et 
al., 1994, p. 1658). Smoking is responsible for 87% of lung cancers as well as 30% of all 
cancer deaths. The American Cancer Society conducted two prospective studies on cancer 
prevention (Thun, Day-Lally, & Myers, 1995) and found that there has been a rise in cancer 
mortality due to smoking, and that smokers are more likely to die from cancer than non-
smokers. 
The relative risk of developing head and neck cancer is higher for current smokers 
than for former smokers. Relative Risk is defined as “the ratio of the incidence of those who 
are exposed to a risk (such as smoking two packs per day) divided by the incidence of the 
same disease in those who do not possess the characteristics (e.g., nonsmokers)” (Davis & 
Zitsch, 1999). Research has established that smoking increases the odds ratio of being 
diagnosed with cancers of the oral cavity and pharynx (Blot, McLaughlin, Winn, Austin, 
Greenberg, et al., 1988; Bungaard, Wildt, Fryenberg, Elbrand, & Nielsen, 1995; Talamini, 
La Vecchia, Levi, Conti, Farero, & Franceschi, 1998) and of the esophagus (Castellsague, 
1999; Castellsague, Munoz, De Stefani, Victoria, Castelletto, Rolon, et al., 1999). 
Furthermore, individuals who quit smoking decrease their relative risk of developing cancer 
(Castellsague et al., 1999) as well as from dying of cancer (Hinds, Yang, Stemmerman, Lee, 
& Kolonel, 1982; Johnston & Ballantyne, 1977), whereas individuals who continue to 
smoke after their diagnosis increase their chances of developing another cancer (Newcomb 
& Carbone, 1992).  
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As examples to highlight the above points, one study found that smoking increased 
the risk of acquiring head and neck cancer 5.8 times (Stevens, Gardner, Parkin, & Johnson, 
1983). A more recent study found that “male smokers have an 8.8-fold increased risk of 
developing cancer of the oral cavity” (Newcomb & Carbone, 1992), which is greater than 
never smokers, but less than current male smokers. Another study found that male smokers 
have a 22.5-fold increased risk of developing cancer of the oral cavity as compared to men 
who never smoked. In other words, men who currently smoke are approximately 22 times 
more likely to develop cancer of the oral cavity than men who never smoked. A recent study 
found tobacco and alcohol to be the strongest individual risk indicators and contributed 
significantly to the risk of developing oral cancer in 161 inpatients with intra-oral squamous 
cell carcinoma (Bundgaard et al., 1995). In a sample of 223 women with primary lung 
cancer, the risk of dying was significantly greater among ever-smokers than never-smokers 
(Hinds et al., 1982). In a sample of 351 patients with oral tongue cancer, 31% of the 
patients who had used tobacco, alcohol, or both were dead from tumors in five years, as 
compared to 14% of nonusers  (Johnston & Ballantyne, 1977). In a sample of 115 patients 
with head and neck cancer, there was a significant difference in survival rates such that “the 
two-year survival rate was 66 percent in the group that did not smoke, as compared with 39 
percent in the group that smoked” (Brownman et al., 1993, p.160).  
Unfortunately, although smoking prevalence in the cancer population has declined, a 
significant number of individuals diagnosed with cancer continue to smoke. For instance, in a 
sample of 5,998 cancer patients with mixed diagnoses, current smokers and recent smokers 
   6 
(defined as having abstained less than one year), smoking prevalence was 30% for males 
and 29% for females (Spitz, Fueger, Erikson, & Newell, 1990) and 18% of 688 males and 
females (Gritz, Kristeller & Burns, 1993). Samples consisting solely of smoking-related 
malignancies contain a larger percentage of current and former smokers. For instance, in two 
lung cancer studies, 51% of the sample were current smokers (Gail et al., 1984; Johnston-
Early et al., 1980). More recent studies, which may reflect the anti-tobacco campaigns of the 
1990s, have found smoking prevalence among head and neck cancer patients to be 62.5% 
at initial interview and quit rates to be 70.6% among males and 61.1% among females (Spitz, 
Fueguer, Chamberlain, Goepfert, & Newell, 1990). Sarna (1995) found that in a sample of 
65 newly diagnosed lung cancer patients, five (7.7 %) were smokers during the time of the 
study, 51 (78.5 %) were former smokers, and 9 (13.8%) had never smoked. Of those who 
were former smokers, 26 (39.9%) quit in response to lung cancer, 15 (23%) quit at 
diagnosis, and 11 (16.9%) quit at surgery. Among a group of 840 lung cancer patients, 
16.8% were smokers at one year follow-up and at 2 year follow-up, the cessation rate was 
at 40% (Gritz, Nisenbaum, Alashoff, & Holmes, 1991). In a sample of 144 patients with 
newly diagnosed squamous cell carcinoma of the upper aerodigestive tract, 35% of the 74 
patients who had smoked the year before diagnosis reported continuing to smoke after 
surgery (Ostroff et al., 1995). In a review of smoking cessation among hospitalized patients 
with lung and head and neck cancers, “long term unassisted cessation rates … have ranged 
from 40% - 70%,” (Orleans, Kristeller, & Gritz, 1993. p. 784) revealing both the success of 
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smoking cessation programs as well as the difficulty of many patients in maintaining 
abstinence. 
 There are a variety of pathophysiologic mechanisms through which cigarette smoke 
causes cancer. According to Carbone (1992), tobacco causes mutations in tumor 
suppresssor genes (that ordinarily control cell growth) and dominant oncogenes (that cause 
unregulated cell growth when over-expressed). In addition, smoking causes “impaired 
mucociliary clearance” in the lungs and “decreased immunologic responsiveness” (Carbone, 
1992, p. 15S) which can predispose an individual to cancer. In a group of 129 patients with 
squamous-cell carcinoma of the head and neck, “mutations of the [p53] gene correlated 
strongly with cigarette smoking” (Brennan, Boyle, Koch, Goodman, Hruban, Eby, et al., 
1995, p.715). 
As highlighted earlier, quitting smoking once diagnosed with cancer has important 
implications for survival. One possible explanation for the increased mortality among 
smokers in this population is that smoking decreases successful recovery of individuals 
already diagnosed with a chronic medical conditions by increasing complications and 
decreasing treatment efficacy. For instance, individuals who smoke during radiotherapy 
experience lower response rates and poorer survival as compared to individuals who 
discontinue smoking (Browman et al., 1993; Wynder, Dodo, Blooch, Gantt, & Moore, 
1969). Several studies have found that continued smoking increases the risk of developing a 
second primary malignancy in the oropharygeal area (Day et al., 1994; Silverman, 
Greenspan, Grosky, 1983; Wynder et al., 1969). For instance, in a sample of over 1,000 
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patients with oral and pharyngeal cancer, tobacco significantly contributed to the risk of 
developing a second cancer (Day et al., 1994). The odds ratios rose with duration and 
intensity of smoking such that current smokers had a higher risk of developing a second 
cancer than former smokers (Day et al., 1994). This risk decreased for those who quit 
smoking at the time of diagnosis. Specifically, individuals who smoked 40 or more cigarettes 
per day had more than a threefold increased risk of developing a second cancer (Day et al., 
1994). In a sample of over 2,000 men, the risk of esophageal cancer was found to decrease 
“rapidly, strongly and significantly with longer periods of abstention” (Castellsague et al., 
2000). Likewise, Moore (1971) found that among 203 smokers considered cured of 
cancers of the oral cavity, larynx or pharynx, 40% of those who continued to smoke 
developed second cancers in “tobacco-contact tissues” versus only 6% of the nonsmokers 
(p.553). Stevens et al. (1983) found, in 269 patients with head and neck neoplasms, that 
those who continued to smoke after a diagnosis of cancer had a fourfold increase in the risk 
of recurrence over those who did not smoke, and twice the risk of recurrence over those 
who quit smoking. Moreover, smoking cessation and quitting alcohol reduces the risk of 
esophageal cancer after ten or more years (Bosetti et al., 2000).  
 
 
 
 
Diagnosis 
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 There is no routine screening for head and neck cancer. Often times, a dentist 
identifies a suspicious lesion and refers the patient to an otolaryngologist (a head and neck 
specialist). Symptoms of head and neck cancer vary according to the site of the cancer. 
Common signs include, but are not limited to, a “swelling or ulcer that does not heal ….sinus 
trouble that does not respond to antibiotics …. painless swelling and later paralysis of one 
side of the face …. difficulty or pain on swallowing …. enlarged lymph nodes in the neck …. 
and persistent hoarseness” (Helsper & Dollinger, 1991, p. 412). A diagnosis  will include 
inspection of the oral and nasal cavities using mirrors and scopes, palpation of suspicious 
lesions, testing for the Epstein-barr antibody, x-rays of the sinus and skull, CT and MRI 
scans, and biopsies of suspicious lesions.  
 Cancers, including head and neck cancers, are typically codified for curability 
according to the TNM system whereby T represent tumors, N represents nodal involvement 
and M represents metastasis. Pathological staging is utilized to characterize not only the 
existence of a malignancy, but the extent to which tissues have been invaded by cancerous 
cells (Holland, 1998). This information is then combined, resulting in a severity rating ranging 
from Stage I (least invasive) to Stage IV (most invasive, includes metastasis to other areas of 
the body). (see Table 1). “Accuracy of staging is especially critical, since a slight difference in 
the location and size of the tumor has a significant effect on the therapy chosen, the extent of 
surgery and the prognosis (Helsper & Dollinger, p. 413).  
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Table 1. TNM stage groupings for cancers of the head and neck  
Tumor Nodal Involvement 
 N0 N1 N2 N3 
     
T1 I III IV IV 
     
T2 II III IV IV 
     
T3 III III IV IV 
     
T4 IV IV IV IV 
     
Note. In addition, any tumor that has metastasized is classified Stage IV. 
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Treatment 
 
Treatment for head and neck cancer depends upon the severity of the illness, and 
most frequently includes surgery, radiotherapy, chemotherapy, or a combination of these 
treatments. Therefore, individuals who are diagnosed at a later stage of illness are more likely 
to receive more invasive surgery, and are more likely to have post-operative radiation 
treatment. In addition to patients having surgery to remove the tumor, a majority of the 
patients require orthopedic reconstruction of the face and jaw.  
 
Psychosocial Adjustment  
 
 Treatment for head and neck cancer often involves the aerodigestive tract as well as 
deconstruction of the face and jaw. Therefore, many patients experience not only facial 
disfigurement, but also exhibit difficulty swallowing, poor saliva production, and pain. In 
addition, other senses such as sight, hearing, taste, and smell are affected (Helsper & 
Dollinger, 1991). Patients may experience dry mouth, sensitivity to heat and cold, 
hoarseness, nasal discharge, and persistent drooling. Those with more disfigurement are at 
greater risk for psychological and interpersonal difficulties. Someone who experiences major 
disfigurement is also more likely to experience low self body-image and low self-esteem. 
Individuals can experience a range of psychological and emotional responses to their 
diagnosis and treatment including, but not limited to, shock, depression, anxiety, anger, and 
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fear. These can all lead to social withdrawal (e.g., from activities such as dining with friends 
or attending events). Although an instrument called a Servox now allows individuals whose 
voice box has been removed to verbally communicate, many patients are self conscious and 
hesitant to use the Servox in public.  
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CHAPTER 3: CHRONIC OBSTRUCTIVE PULMONARY DISEASE 
 
Etiology and Epidemiology 
 
Fourteen million persons in the United States suffer from Chronic Obstructive 
Pulmonary Disease (COPD, American Thoracic Society [ATS], 1995). In 1991 there were 
85,544 deaths due to COPD (ATS, 1995). An estimated 16.0 million Americans suffered 
from COPD in 1994, and this represented an increase in 60% since 1982 (National Center 
for Health Statistics, 1998).  In 1995, COPD “ranked fourth among leading causes of death” 
(National Center for Health Statistics, 1998). There was a 40% increase in mortality due to 
chronic bronchitis and emphysema between 1979 and 1995 (National Center for Health 
Statistics, 1998).  
Chronic obstructive pulmonary disease is “a disease of the airways characterized by 
airflow obstruction due to chronic bronchitis or emphysema” (ATS, 1995, p. S78). The 
purpose of the respiratory system is “to supply oxygen to the cells and to remove carbon 
dioxide” (Labott, 1998, p. 102). COPD has an insidious onset, is progressive in nature, and 
is primarily irreversible. Both  emphysema and chronic bronchitis are associated with heavy 
cigarette consumption. Symptoms of COPD include dyspnea (shortness of breath), cough, 
sputum production, airflow limitation, impaired gas exchange, and frequent respiratory 
infections (Labott, 1998). Since there is no cure for COPD, treatment is both palliative and 
to reduce the risk of infection. While the clinical manifestations of chronic bronchitis and 
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emphysema are similar (i.e., both share the common symptoms of difficulty exhaling air from 
the lungs), and while the two share some of the same etiology (i.e., smoking and genetic risk 
factors), there are also some pathological differences. Chronic bronchitis is defined by its 
clinical manifestation, and is diagnosed with “the presence of chronic productive cough for 3 
months in each of two consecutive years in a patient in whom other causes … have been 
excluded” (ATS, 1995, S78). Emphysema is defined according to anatomical pathology 
when there is “abnormal permanent enlargement of the air spaces distal to the terminal 
bronchioles, accompanied by destruction of their walls and without obvious fibrosis” (ATS, 
1995, p. S78).  
 Tobacco smoke is, without doubt, a major risk factor for COPD. According to the 
ATS, the “primary cause of COPD is without question exposure to tobacco smoke” (ATS, 
1995, S78). “Tobacco smoking accounts for an estimated 80 to 90% of the risk of 
developing COPD (U.S. D.H.H.S., 1984). Several studies conducted by Pederson and 
colleagues have found long-term cessation rates to average approximately 20% (Pederson, 
Baskerville, & Wanklin, 1982; Pederson Wanklin, & Lefcoe, 1991). The most recent large 
scale study of smoking cessation among individuals with chronic obstructive pulmonary 
disease followed 5,887 adult smokers with early COPD for 5 years (Murray et al., 1998). 
At baseline, 818 (20.1%) were sustained quitters, 1146 (20.1%) intermittent quitters, and 
3711 (65.3%) continued smokers.  
In a review of the pathophysiologic damage due to cigarette smoking, McKusker 
(1992) and colleagues cited a variety of ways in which the respiratory system is damaged. 
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More specifically, “smoke-induced damage to the lower respiratory tract may occur directly 
by oxidants carried within smoke particles …. By secretion or reactive oxygen species or 
degradative proteases …. By rendering inhibitors of enzyme activators inactive, or by 
changing the responsiveness of inflammatory cells to stimulatory events (See Sethi & 
Rochester, 2000, for review). Individuals who smoke show a greater annual decline in 
Forced Expiratory Volume (FEV1), a primary measurement of pulmonary function. (ATS, 
1995).  
Smoking cessation is considered the most important treatment for COPD (Labott, 
1998), and improves prognosis regardless of age (Postma & Sluiter, 1989). Although 
quitting smoking neither reverses disease nor helps to regain significant lung function, 
individuals who quit may show an increased bronchodilator response (i.e., can breath more 
easily with the aid of inhalers), and in addition, a decreased rate of decline of lung function, 
becoming commensurate with individuals of the same age who never smoked (Anthonisen et 
al., 1994). In other words, research shows that quitting smoking after a diagnosis of COPD 
“has a beneficial effect on the course of COPD (Wise, 1997). For instance, among 
individuals with COPD, the decline in FEV1 (a measurement of expired air) is steeper for 
smokers than nonsmokers, and the heavier the smoker, the steeper the rate (ATS, 1995; 
Xu, Dochery, Ware, Speizer, & Ferris, 1992). COPD patients who continue to smoke 
show a decline in FEV1 that is twice the decline of those who quit smoking (Anthonisen et 
al., 1994). Unfortunately, continuous abstinence is low among COPD. Cessation rates 
during follow up periods ranging from 6 months to 7 years have been as low as 27% 
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(Pederson, Williams, & Lefcoe, 1980). Cigarette smokers have higher death rates from 
chronic bronchitis and emphysema and a higher rate of long term abnormalities (CDC, 
1993). These differences increase in proportion to the quantity of smoking such that age of 
starting smoking, total pack-years and current smoking status are all “predictive of COPD 
mortality.” (ATS, 1995, S79). Mortality rates for COPD are higher in smokers than in 
nonsmokers (ATS, 1995).  
  Interestingly, research has shown an “increase in COPD mortality even when the 
analysis was confined to active smokers (Wise, Szklo, Matanoski, & Neugut, 1997). 
Anthonisen (1994) and colleagues investigated the efficacy of a smoking cessation program 
plus inhaled bronchodilator therapy with individuals with mild obstructive pulmonary disease. 
Although the authors state that “the rates of 5-year sustained smoking cessation in these 
groups were among the highest ever reported for a major study” (p.1502), their 5-year 
cessation rate was only approximately 22%. Although the percentage of sustained 
nonsmokers was significantly greater than smokers in the usual care group (5%), this 
cessation rate is quit low. Smoking did not decrease significantly in either the intervention or 
control group of the Community Intervention Trial for Smoking Cessation ([COMMIT]; 
Green, 1995b), a prospective program which provided community intervention to reduce 
smoking.  
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Diagnosis 
 
 A diagnosis of COPD includes a detailed medical history, a smoking history, a 
physical exam, chest x-rays, blood tests and arterial blood gases, sputum culture and 
pulmonary function tests (PFTs; ATS, 1995). The most objective measurement available to 
make a differential diagnosis of COPD and to determine severity of illness is by administering 
a PFT. During spirometry (a component of the PFT), the patient is asked to breath in as 
much air as possible (in order to maximally fill the lungs) and then to exhale the air into a tube 
as quickly and as forcefully as possible, until he or she can no longer blow out any air. This 
procedure is often repeated three times for reliability. The instruments and methods for 
performing these tests are standardized by the American Thoracic Society. Measurements of 
spirometry include measurements of Forced Vital Capacity (FVC), which measures the total 
volume of air the patient expires after full inspiration, Forced Expiratory Volume in the first 
second (FEV1), which measures the volume of air the patient forcefully expires in the first 
second of exhalation, and the ratio of FEV1 to FVC. The “most useful indicator of disease 
severity, across all stages of disease, is spirometry, with FEV1 being the best indicator of 
abnormality” (Petty, 1993, p. 88). Forced expiratory volume is also “considered to be the 
best predictor of remaining life expectancy for [COPD] patients (Kaplan, Reis, Prewitt, & 
Eakin, 1994) and is the “best, most easily followed indicator of airway resistance in COPD” 
(Sethi & Rochester, 2000, p. 76). Among individuals with COPD, FEV1 is reduced as 
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compared to individuals with normal lung function. Disease severity measured by FEV1% 
takes into account individual differences such as size, gender, and age (Leidy & Traver, 
1995, p.539). Outcome measures include the patient’s actual flow rates as well as the flow 
rate as a percentage predicted for the patient based on normative data. In addition, FEV1 is 
considered a valid measure of airways obstruction due to its correlation with pathologic 
scores of airway diameter” (Enright, Lebowitz, & Cockroft, 1994, p. S10). Individuals with 
COPD display decreased flow rates as evidenced by a decrease in FEV1 and a decrease in 
the FEV1/FVC ratio. Airway obstruction has been defined as a ratio of FEV1 to FVC of 
70% or less (Anthonisen et al., 1994). A diagnosis of COPD must include an FEV1/FVC 
less than 70% and a post-bronchodilator response of less than 80%. Although there is no 
current staging system, the ATS recommends a standardized categorization in order to 
“facilitate [the] approach to COPD ….[for] epidemiologic and clinical studies, health 
resource planning, prognostication, and the application of clinical recommendations” (ATS, 
1995). They propose the following stages: FEV1% predicted >= 50% (and less than 70% 
predicted) stage I; 35-49%, stage II, <35% stage III.  
 
Treatment 
 
There is no cure for COPD. It is a chronic disease whereby treatment is designed to 
slow the progression of symptoms and severity. There are a variety of treatment options 
available to help patients manage their illness, slow down disease progression, reduce 
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symptoms, increase daily functioning, and improve quality of life. Such medical management 
may include smoking cessation; pharmacological interventions  such as nicotine gum, the 
nicotine patch, or bupropion (e.g., Zyban®), to reduce the withdrawal symptoms of smoking 
cessation; bronchodilator therapy to “induce bronchodilation, decrease the inflammatory 
response, and facilitate expectoration” (ATS, 1995, p. S85); anti-inflammatory therapy  
(e.g., steroidal medications); psychotropic medications to treat depression, anxiety, insomnia 
or pain; oxygen therapy to reduce the risk of cellular hypoxia in individuals with hypoxemia; 
and pulmonary rehabilitation in order to “decrease respiratory symptoms and improve quality 
of life” (ATS, 1995, p. S93) by increasing exercise tolerance and thereby allowing patients 
to better engage in activities of daily living. Pulmonary rehabilitation includes education, 
exercise training, psychosocial intervention and support, and breathing retraining. Smoking 
cessation is an integral component to the treatment of COPD. Unfortunately, many 
individuals with COPD continue to smoke. For instance, “[c]ontinuous abstinence … may be 
as low as 27% in follow up periods ranging from 6 months to 7 years” (ATS, 1995, p. S84). 
Individuals with COPD who quit smoking may halt the decline, or loss, of lung function (See 
ATS, 1995, for review; Murray et al., 1998). However, over the long term, there is not a 
significant improvement in lung function (Anthonisen et al., 1994; Wise, 1997), such that the 
damage to the lung up to the point of quitting is relatively irreversible.  
 
 
Psychosocial Adjustment 
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 There are a variety of psychosocial sequelae including depression, anxiety, difficulty 
with relationships, sexual problems, and losses due to illness (Labott, 1998). Individuals with 
COPD experience a multitude of losses and health consequences such as “fatigue, dyspnea, 
and reduced exercise tolerance” (Dudley & Sitzman, 1988, p. 196). They suffer from a 
decrease and change in recreational activities, become increasingly dependent on others to 
assist in everyday activities, leading to changes in social roles. They often report a loss in 
positive body image subsequent to weight gain and use of home oxygen. Depression is 
common in the chronically ill, including individuals with COPD. Subsequent to changes in 
social roles and body image, relationships, including sexual relationships, often suffer. Many 
individuals with COPD report symptoms of depression. They also report fears, such as fear 
of breathlessness and fears of behaviors that can induce dyspnea (Greenerg, Ryan, & 
Bourlier, 1985). These fears subsequently lead to social avoidance and withdrawal, further 
intensifying feels of depression.  
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CHAPTER 4: VARIABLES ASSOCIATED WITH SMOKING BEHAVIOR 
IN THE GENERAL POPULATION 
 
Introduction 
 
There is a large amount of research correlating smoking cigarettes with head and 
neck cancer and with COPD, as well as research which attempts to predict smoking 
cessation. A majority of the smoking cessation literature has focused on demographic, 
smoking history, disease severity and disease treatment variables as predictors of smoking 
behavior. Although demographic, smoking history variables, and disease-related  variables 
have been found to predict smoking cessation, these variables are static and cannot be 
modified. For instance, we cannot change individuals’ smoking histories. However, 
psychosocial variables such as depression, anger and problem-solving skills, if found to be 
predictors of smoking behavior, are variables in which health care professionals may 
intervene and increase the success rate of smoking cessation within these two populations. 
As highlighted earlier, decreasing the prevalence of smoking in the general amd medical 
populations is particularly important because continued tobacco use has been shown to not 
only increase the risk of developing an illness, but also to increase number and severity of 
symptoms of disease, to reduce treatment success, and to reduce prognostic outcome. 
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Demographic Variables 
 
 Demographics related to smoking behavior and smoking cessation are inconclusive. 
The demographic variables that have been primarily studied in the smoking research include 
age, gender, education, and income. 
 
Age. 
 
Several large-scale studies have found age-related differences (Kviz, Clark, 
Crittenden, Freels, & Warnecke, 1994; Green, 1995b; Salive et al., 1992) in smoking 
behavior, whereas others have found no age-related differences (Duncan, Cummings, 
Hudes, Xahnd, & Coates, 1992; Matheny & Weatherman, 1998; Spitz, Fueger, Erikson, & 
Newell, 1990). In a cross-sectional study of 2,353 smokers, Kviz (1994) and colleagues 
investigated intentions to quit smoking within the next three months. Overall, less than one 
quarter of the sample planned to quit within the next three months, with younger smokers 
more likely to be “ready to quit,” more concerned about the negative health effects of 
smoking, and more confident about their ability to quit. However, these variables 
discriminated between plans to quit rather than actual quitting behavior. In a community-
based sample of over 10,000 adults, Salive (1992) and colleagues found that the “oldest 
were more likely to quit smoking and less likely to relapse” (Salive, 1992, p. 1269). 
Likewise, Green (1995b) found age to predict smoking cessation, with the greatest actual 
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decrease in smoking among individuals over 44 years of age, and the smallest decrease in 
cessation among individuals between 18-24 years of age. In the Framingham Heart Study, 
which investigated smoking behavior of adults over four decades beginning in the 1950s, 
older subjects, both male and female, were more likely to quit than younger subjects 
(Freund, D’Agostino, Belanger, Kannel, & Stokes, 1992).  
Alternatively, Matheny and Weatherman (1998) conducted a clinical trial smoking 
cessation program with 263 individuals, and found that after completing a smoking cessation 
program, age did not discriminate between current smokers and former smokers. Likewise, 
in a large-scale study of over 5,000 respondents, there was “no clear-cut pattern between 
age and the prevalence of current smoking” (Spitz et al., 1990, p. 75).  
 
Gender. 
 
Studies on the relationship between gender and smoking behavior are inconclusive 
and yield mixed results. One review of the literature reported that while not all studies show 
gender differences, in those that do, men have been more successful at quitting (Ward, 
Klesges, Zbikowski, Blis, & Garbey, 1997). Garfinkel (1997) reported that since 1965, the 
prevalence of smoking has decreased among both men and women, with a more rapid 
decrease among men. Although there are several studies investigating gender differences in 
readiness to change (Tessaro et al., 1997), studies investigating actual smoking behavior 
have found no gender differences in relapse rates (Brown, 1995; Matheny & Weatherman, 
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1998; O’Connor, Carboni, & DiClemente, 1996). In the Framingham Heart Study, women 
and men were equally likely to quit smoking, with 42% of women smokers and 41% of male 
smokers having quit after 32 years of follow-up (Freund et al., 1992). Furthermore, amount 
of cigarettes smoked predicted cessation in women, but not in men, such that for every half 
pack fewer cigarettes smoked, women were 2.1 times more likely to quit. Finally, heavy 
female smokers (greater than 2 packs per day) were found to be less likely to quit than male 
smokers (Freund et al., 1992). In a sample of 135 smokers, gender predicted long-term 
(e.g., through 12 months) relapse but not short-term (15 days post cessation) such that 
women were more likely to relapse after controlling for other demographic and smoking 
history variables (Ward et al., 1997).  
Alternatively, in a sample of 19,960 adults, men were more likely to quit smoking 
than women, and this gender difference became more evident after controlling for age, 
education and amount smoked (Osler, Prescott, Gidtfredsen, Hein, & Schnohr, 1999). The 
higher quit rate among men has been found in several other studies (Lichtenstein, Lando, & 
Nothwehr, 1994; McWhorter, Boyd, & Mattson, 1990; Pirie, Murray, & Luepker, 1991; 
Royce, Corbett, Sorensen, & Ockene, 1997; Ward et al., 1997).  
Several studies have found no gender differences in either direction. Freund et al. 
(1992) found no difference in quit rates among men and women, except among heavy 
smokers (as highlighted above). Finally, gender did not predict smoking cessation at one-
year follow-up in a group of medical patients (Duncan et al., 1992). 
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Education.  
  
The correlation between education and smoking has yielded diverse results. In a 
sample of medical patients, Duncan et al. (1992) found that those with a higher education 
(e.g. with some college education) were more likely to quit smoking that those without a 
college education. Wise et al. (1997), in their workshop discussion of smoking in the United 
States, characterized smokers as having lower socioeconomic status and a lower educational 
status. In a sample of 2,462 adults, the risk of being a current smoker, as opposed to a 
former smoker or never smoker, was higher among lower educational groups (Stronks, Van 
de Mheen, Looman, & Mackenback, 1997). Garfinkel (1997) found a greater smoking 
prevalence among those with a less formal education. Finally, “current smoking prevalence 
was highest among persons with 9 to 11 years of education … and lowest among persons > 
16 years of education” (CDC, 1997, p. 1217). 
Alternatively, some studies demonstrate that education does not discriminate 
between smokers and former smokers (Matheny & Weatherman, 1998) and does not 
predict smoking cessation (Freund et al., 1992). Furthermore, Green (1995a) found 
education to impact smoking behavior in the opposite direction such that individuals who 
were less-educated were “more responsive to the intervention than college-educated 
smokers” (p.189). 
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Income. 
 
There is very little research investigating the relationship between income and 
smoking behavior. Spitz (1990) and colleagues found that “high-income (>$43,000) 
respondents were significantly more likely to be heavy smokers than respondents with the 
lowest incomes (<$23,000 annually)” (p.77).   
 
Knowledge and Risk-Perception 
 
Research results on the impact of knowledge on smoking behavior are mixed. Some 
studies have found that smoking status is a function of awareness of the risks from smoking. 
In other words, knowledge of the negative health effects of smoking has been found to be 
lower among smokers as compared to nonsmokers (Brownson et al., 1992; Lee, 1989). 
For instance, Brownson and colleagues surveyed over 2,000 adults about their beliefs about 
smoking. Eighty-eight percent believed smoking to be harmful to their health; with 74% 
reporting the knowledge that smoking causes emphysema. However, “current smokers were 
significantly less likely than never smokers to acknowledge the health effects of smoking” 
(Brownson et al., 1992, p. 100). In addition, 83% reported to believe quitting smoking has 
health benefits. Overall, knowledge was lower for those who were older, female, less 
educated or current smokers.  Other studies have found that smokers and non-smokers are 
similarly and well aware of the health risks of smoking, yet smokers tend to underestimate 
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their own personal health risk when they compare themselves to other smokers (McCoy et 
al., 1992; Strecher, Kreuter, & Kobrin, 1995). A more recent study found that knowledge 
about the causes of oral cancer among current smokers, quitters and never smokers was not 
significantly different (Fabian, Irish, Brown, Liu, & Gullane, 1996). The researchers 
compared 22 patients diagnosed with oral cancer to 112 patients without head and neck 
cancer. Only 20 out of the 124 participants (14.9% of the total group) were aware of the 
causes of oral cancer (3 of the 22 cancer patients and 17 of the 112 controls) (Fabian et al., 
1996). There was no statistical difference in knowledge between the groups. Furthermore, 
knowledge about the causes of mouth cancer between smokers, those who had quit 
smoking, and non-smokers was not significant” (Fabian et al., 1996, p. 90). However, 
approximately 86% were aware of the association between smoking and the development of 
lung cancer. Results did not indicate whether there was a difference in this knowledge among 
smokers, former smokers and non-smokers.  
 Tessaro (1997) and colleagues found that smokers who perceived that lung cancer 
would result from smoking were more likely to be thinking about quitting smoking. However, 
actual smoking quits was not investigated in this study.  
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Smoking History Variables  
 
 Overall, smoking variables have been found to predict smoking cessation and 
relapse. Several of the more popular ways of measuring smoking variables have included 
nicotine dependence, pack years, number of cigarettes per day, number of years smoked, 
and finally, number and/or duration of prior quit attempts.  
Shiffman, Hickcox, Paty, Gnys, Kassel, & Richards (1996) found that, in a sample 
of 133 ex-smokers, more nicotine-dependent (defined by self-reported baseline smoking 
rate and a modified version of the Fagerstrom Tolerance Questionnaire) participants 
progressed more rapidly toward relapse. Likewise, Duncan  et al. (1992) found that in a 
sample of medical patients, those who were nicotine-dependent (e.g. those who smoked 
within 15  minutes of awakening) were less likely to have quit at one year follow-up. Another 
study found that “heavy smoking was significantly more prevalent among current smokers 
than former smokers” (Spitz, Fueger, Erikson, et al., 1990, p.77). Alternatively, in a sample 
of 215 smokers, self-reported nicotine dependence did not predict urges to smoke 
(Doherty, Kinnunen, Militello, & Garvey, 1995). Relapse was greatest immediately after 
quitting, and relapse was highly correlated with dysphoric emotions. 
A majority of studies suggest that the number of cigarettes smoked per day is a good 
predictor of smoking cessation success. In a summary of 10 longitudinal smoking cessation 
studies, light smokers (defined as smoking less than 21 cigarettes) were 2.2 times more likely 
to quit for 12 continuous months than heavy smokers (defined as smoking at least 21 
   29 
cigarettes per day) (Cohen, Lichtenstein, Prochaska, Rossi, Gritz, et al., 1989). In a sample 
of 10,300 participants over 65 years of age, Salive (1992) and colleagues found that 
individuals who smoked fewer cigarettes or who had smoked for fewer years were 
significantly more likely  to quit smoking at the end of three years, and moreover, a heavier 
smoking history was predictive of relapse within the three year period. In a treatment 
outcome study, Green (1995a) also found a significant decrease in prevalence of smokers in 
the intervention group among light- and moderate-smoker cohorts as compared to the heavy 
smokers. Heavy smoking also was found to predict smoking cessation in a large population 
sample (Osler et al., 1999). 
Alternatively, Matheny and Weatherman (1998) found smoking variables, 
specifically tar content and number of cigarettes per day, to be predictive of maintenance of 
abstinence, but in the opposite direction. Surprisingly, those who had smoked cigarettes with 
a higher tar content, and those who had smoked a greater number of cigarettes per day, 
were more likely to be abstainers. Number of cigarettes per day correctly classified 85% of 
relapsers and 42% of abstainers. This finding that greater number of cigarettes smoker per 
day predicted abstention goes against previous research findings reporting that the greater 
number of cigarettes smoked per day predicts unsuccessful cessation outcomes (Gunn, 
1983; Mothersill, McDowell, & Rosser, 1988; Ockene, Benfari, Nuttall, Hurwitz, & 
Ockene, 1982). 
 Another smoking variable found to predict future smoking cessation is number and 
duration of previous quit attempts. Mothersill (1988) and colleagues found that among 333 
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adult smokers, longer duration of previous quit attempts predicted continued abstinence. 
Alternatively, Cohen et al. (1989) found that the number of previous quit attempts was 
unrelated to successful smoking cessation. 
 
Social Support 
 
Several studies have investigated the role of social support in the efficacy of smoking 
cessation programs. Such studies have primarily focused on the effect of living with other 
smokers. Results of these studies concur that the existence of other smokers in the household 
(Matheny & Weatherman, 1986; McIntyre-Kingsolver, Lichtenstein, & Mermelstein, 1986) 
and exposure to other smokers (Horowitz, Hindi-Alexander, & Wagner, 1985; Wewers, 
1988) affects continued abstinence. For instance, McIntyre-Kingsolver and colleagues 
(1986) compared smoking intervention with smokers and an intervention with smokers and 
their spouses. They found that the smoking status of the two groups did not differ significantly 
at 12 month follow-up. However, the spouses’ smoking status was significantly related to the 
subject’s smoking status such that those with nonsmoking spouses were more likely to 
maintain abstinence at 6-month follow-up, regardless of whether the intervention included 
spouses. Similarly, Matheny and Weatherman (1998) found that relapsers had a significantly 
greater number of other smokers in the household than did continued abstainers. 
 
Depression 
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 Depression has been associated with smoking in adolescent (Anda et al., 1990; 
Coogan et al., 1998; Wang, Fitzhugh, Westerfield, & Eddy, 1994; Wang, Fitzhugh, Eddy, 
& Westerfield, 1998), adult general, and adult medical populations (see Glassman et al., 
1993 for review; Kick and Cooley, 1997; Parchman, 1991). Smoking has been found to be 
correlated with a lifetime history of Major Depression (Glassman et al., 1990) and a history 
of major depressive disorder among smokers has been found to be as high as 44% 
(Ginseberg, Hall, Reus, & Munoz, 1995), higher than the prevalence rate of MDD in the 
general population. Wang (1994) and colleagues found that in a sample of 6,900 adolescents 
(885 regular smokers and 6,015 never smokers), smokers were more likely to report 
symptoms of depression (through a telephone interview) such as feeling unhappy and feeling 
hopeless about the future. Likewise, Coogan (1998) and colleagues found that in a sample of  
31, 861 adolescents in grades 4-6, 15 % (n=4,884) were smokers, with smokers more 
likely than nonsmokers to report stress and depression (on a survey developed by the 
researchers of the study). In a sample of over 1,000 young adults, Breslau, Kilby, and 
Andreski (1993) found that “nicotine dependence … was positively associated with … 
negative affect, hopelessness, and general psychological distress (p.945). Swan, Ward, and 
Jack (1996) found, in a sample of 64 ex-smokers, that depressed mood (as measured by 
the depression/dejection subscale of the Profile of Mood States) was associated with a 
higher rate of relapse. Likewise, Shiffman et al. (1997) found that more nicotine dependent 
smokers tended to lapse when experiencing negative affect (as reported by participants in an 
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electronic diary), and less nicotine dependent smokers tend to lapse when consuming 
alcohol. Other studies have also found greater negative emotion to predict stronger urges to 
smoke (Doherty et al., 1995; Shiffman, 1986). Overall, these studies suggest a strong 
association between depressive symptoms and smoking behavior.  
 In addition to depression being highly correlated with smoking behavior, smokers 
with a history of depression have been shown to be less successful at smoking cessation than 
nondepressed smokers (Anda et al., 1990; Ginsberg et al., 1995; Glassman, 1993; Hall, 
Munoz, Reuss, & Sees, 1993; Rabois & Haaga, 1997). One study found that smokers 
attribute their lapses to negative mood (Shiffman, Gnys, et al., 1996). Furthermore, in a 
sample of almost 3,000 individuals, depressed smokers (as measured by the Center for 
Epidemiologic Studies Depression Scale[CESD]) were 40% less likely to have quit at 
follow-up than nondepressed smokers (Anda et al., 1990). Research investigating adult 
populations have also found the prevalence of depression and depressive symptoms to be 
higher among smokers than nonsmokers (see Glassman, 1993 for review). In a sample of 
internal medicine patients, depression (measured using the Structured Clinical Interview for 
DSM-III-R) was highly correlated with smoking (Kick and Cooley, 1997).  
Alternatively, Rabois and Haaga (1997) compared smokers and nonsmokers with 
and without a history of depression (according to DSM-III-R criteria) and found a main 
effect for depression history. In other words, participants who had a history of depression 
reported more negative ways of coping than did participants without a history of depression. 
Furthermore, there is evidence that smokers with a history of depression are less successful 
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at cessation than nondepressed smokers (Glassman, 1993; Hall et al., 1993). In a sample of 
151 former smokers, 116 relapsed within 23 days of abstinence and 35 maintained 
abstinence (Shiffman, Gnys, et al., 1996). All smokers experienced temptations to quit and 
cravings; however, relapsers experienced greater negative affect and more cues. Likewise, in 
a group of 250 smokers, dysphoric emotions (as measured by the CESD) “were among the 
most consistent correlates of urges to smoke” (Doherty et al., 1995, p. 176). Therefore, 
while all faced challenges to quitting smoking, affect predicted cessation success.  
Alternatively, in a sample of 613 women attending a 13-week smoking cessation 
program, only 18.5% met the criteria for a history of depression (Ginsberg et al., 1995) as 
measured by the MDD scale of the Diagnostic Interview Scale. Women who reported a 
history of depression were heavy smokers and had a longer smoking history. However, 
depression history was not associated with adherence to the smoking cessation program. 
Likewise, Ginsberg et al. (1997) found that “adherence to a multisession, multicomponent 
smoking cessation program was not found to be associated with a history of depression in 
women smokers who did not report any current depression (p.786).  
 
 
 
Anger 
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Anger has been minimally investigated in the smoking research, and the studies which 
do exist demonstrate mixed findings. In some studies, anger neither classifies smokers from 
nonsmokers, nor distinguishes  among light, moderate and heavy smokers (Muller, 1992; 
Witt, Kaelin, & Stoner, 1988). Muller suggests that the concept of a “smokers personality” 
does not exist. However, some studies show that smokers report more anger (as measured 
by Spielberger’s State-Trait Personality Inventory and the Anger EXpression Scale) than 
nonsmokers (Speilberger, Foreyt, Reheiser, & Poston, 1998), and in the short term, 
abstinence among smokers results in increased depressive and anger symptoms (Doherty et 
al., 1995; Gilbert et al., 1997; Ginsberg et al., 1995; Tate, Stanton, Green, & Schmitz, 
1996; Tsuda, Steptoe, West, Fieldman, & Kirschbaum, 1996). For instance, anger (as 
measured by the Profile of Mood States [POMS]) has been  associated with a higher rate of 
relapse (Doherty et al., 1995). In a sample of 149 people receiving cognitive-behavioral 
intervention of nicotine gum, individuals with higher anger according to the Profile of Mood 
States “were more likely to fail to attain continuos abstinence than those with lower scores at 
baseline” (Hall, Munoz, & Reus, 1994, p.144). Similarly, smokers who had a history of 
depression reported more symptoms of anger and depression, according to the POMS, at 
the time of quitting than did smokers without a history of depression (Ginsberg et al., 1995). 
A study investigating the effects of smoking abstinence on mood in 50 male smokers, found 
that overall, depression and anger (according to the POMS) increased in the group of 
smokers who quit, and this negative affect did not return to pre-cessation levels at one month 
follow-up (Gilbert et al., 1997). 
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Coping and Problem Solving  
 
Horowitz (1985) and colleagues found that ex-smokers “actively coped with 
smokers in their environment [and] avoided other smokers in public places,” whereas 
recidivists did not engage in such coping behaviors and placed less responsibility on  
themselves for their health. The authors recommended coping skills training as part of 
smoking cessation programs. Coping style assessment revealed that smokers were less 
inclined to display avoidance behavior and less inclined to seek social support or to show 
their emotions. Wewers (1988) found that abstainers used more problem-focused coping 
strategies (as measured by the Ways of Coping Checklist) as compared with relapsed 
participants. Problem focused coping strategies included approaching a nearby smoker and 
asking the person to extinguish the cigarette, or leaving a stressful situation to reduce the 
temptation to smoke. Likewise, Matheny and Weatherman (1998) found that both stress 
coping resources (defined in their study as perceived confidence, physical health, physical 
fitness, problem solving, self-directness, and tension control and measured by the Coping 
Resources Inventory for Stress) and smoking history variables to be more predictive of 
maintenance than perceived locus of control or demographic variables. 
Studies investigating relapse have suggested a multitude of background and 
precipitating factors such as environmental cues, biological factors such as withdrawal 
symptoms, personal factors such as coping ability, mood, and health status, and smoking 
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characteristics (see Shiffman et al., 1986 for review). Many of the studies investigating 
relapse rates in smoking have been guided by either a biobehavioral model, focusing on the 
combined psycho-biological influences on relapse, or stress-coping models, explaining 
smoking as a means of coping with stress. In the latter model, “high levels of stress are 
thought to predispose ex-smokers to relapse, but ex-smokers can be buffered from this 
effect if they have adequate skills other than smoking … for coping with stress” (Shiffman, 
Shumaker, Abrams, Cohen, Garvey, Grunberg, et al., 1986, p.21), such that coping 
resources may help an individual to overcome temptations to smoke during situations of high 
stress.  
 
Self-Efficacy 
 
Matheny and Weatherman (1998) found that high confidence (e.g., belief in one’s 
coping abilities and expectations to succeed), and belief in one’s self as capable and 
competent, predicted abstinence. In a sample of 42 smokers, followed over a one year 
period, Colletti and Kopel (1979) found that self-attribution (e.g. those who believed that the 
results of the program were due to changes in their own attitudes) was correlated with 
maintenance of smoking cessation. The authors suggested that this study supported the “role 
of cognition as predictors of maintenance of behavior change” (Colletti & Kopel, 1979, 
p.167). In a later study of 29 people participating in a smoking reduction clinic, Colletti, 
Supnick, and Payne (1985) found that “individuals who relapsed before 1-month follow-up 
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had lower [self-efficacy] scores that those who relapsed after 3-month follow-up” (p. 255). 
In a 6-month prospective study of 146 adults who attended a smoking cessation program, 
Baer, Holt and Lichtenstein (1986) found that self-efficacy predicted smoking rates but not 
smoking status. In other words, self-efficacy was not correlated with abstinence, but was 
related to reductions in smoking rates. Furthermore, they found self-efficacy to be a good 
predictor of relapse. The role of self-efficacy on improving smoking cessation success has 
also been found in other studies (DiClemente, Prochaska, & Gilbertini, 1985; Grove, 1993; 
Kowalski, 1997; Lawrence & Rubinson, 1986; Mothersill et al., 1988; Strecher et al., 
1995).  
 
Locus of Control 
 
Bennett, Norman, Moore, and Murphy (1997) found smokers to hold stronger 
internal, chance and powerful others beliefs than never smokers. They also found that the 
interaction between health locus of control (LOC) and value for health is a significant 
predictor of smoking status. In other words, one’s value for health moderates the relationship 
between health LOC and health-related behaviors (e.g., smoking tobacco). Another study 
found that former smokers (i.e., quitters) were significantly more internal than either current 
or never smokers (Molloy et al., 1997). Locus of control has been found to account for 
30% of the socioeconomic gradient (Stronks et al., 1997). In other words, although there 
was a significant difference in smoking behavior as a function of educational level, this risk 
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was associated with the fact that individuals in lower SES more frequently had an external 
locus of control. Bunch and Schneider (1991) found that “addicted smokers scored more 
externally [on a measure of LOC] than nonaddicted smokers” in a group of 70 smokers. 
Matheny and Weatherman (1998) found that current smokers more frequently had an 
external locus of control as compared to never and former smokers (though the difference 
was not statistically significant). In a population survey, Owen and Brown (1991) found that 
those individuals who had made more cessation attempts in the past or who had abstained 
for less than a week were more likely to attribute their current smoking status to 
uncontrollable factors such as addiction. 
 
Summary of Variables Related to Smoking Behavior in the General Population 
 
 Research investigating predictors of smoking behavior in the general population 
indicate the following: demographic variables predict smoking behavior in some, but not all, 
studies; knowledge and risk-perception predict smoking behavior in some, but not all, 
studies; social support, and in particular, exposure to other smokers, predicts smoking 
behavior in some, but not all, studies; smoking history variables predict smoking behavior, 
and depression and coping skills predict smoking behavior. There is also some evidence that 
anger predicts smoking behavior, but research in this area is limited.  
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CHAPTER 5: VARIABLES ASSOCIATED WITH SMOKING BEHAVIOR  
IN THE CANCER POPULATION 
 
Introduction 
 
This section will review the current research related to smoking in the cancer 
population. When possible, attention will be given to studies investigating head and neck 
cancer.  
 
Demographic Variables  
 
Age. 
 
Studies investigating age-related smoking differences have yielded varied results. For 
instance, in a group of 65 women diagnosed with lung cancer, Sarna (1995) found that 
current smokers are more likely to be younger. Alternatively, Gritz et al. (1993) found that 
younger smokers quit at higher rates. Several studies have found no age-related differences. 
Moore (1971) found no age-related differences in smoking cessation in a sample of 203 
patients with cancer of the mouth, pharynx, and larynx, or in smoking cessation. Likewise, 
several other studies found no age-related differences in a group of patients with head and 
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neck cancer (Ostroff et al., 1995; Schnoll et al., 2002; Spitz, 1995; Vander Ark, DiNardo, 
& Oliver, 1997).  
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Gender. 
  
Studies investigating gender-related differences in smoking in the cancer population 
reveal mixed results. Moore (1971) found no gender-related differences in smoking 
cessation. In a sample of 160 patients with head and neck carcinoma, “more than half the 
patients  continued to smoke, with the women patients being slightly more reluctant to give 
up their habit” (Silverman et al., 1983, p.34) at one-year follow-up. A recent study of 75 
patients with head and neck cancer and lung cancer also found no age-related differences 
(Schnoll et al., 2002). Alternatively, Vander Ark (1997) and colleagues found that men were 
less likely to quit (61%) than women (82%), although the authors of this study did not report 
whether this difference was statistically significant given the variability of the distribution (70 
males and 17 females).  
 
Education. 
  
Ostroff (1995) and colleagues found that those who were less educated were more 
likely to abstain as compared to individuals with higher education, who were more likely to 
relapse. Alternatively, Vander Ark (1997) and colleagues identified a trend such that “those 
with a high school education or greater were more likely to achieve smoking cessation” (p. 
890). Schnoll et al. (2002) found no education-related differences.  
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Income. 
 
 Vander Ark (1997) and colleagues found that those who earned less than $10,000 
per year were more likely to quit than those who earned $10,000 or more. However, the 
author did not report if the difference between these two groups was significant. Schnoll 
(2002) and colleagues found no differences between smokers and abstainers on income. 
 
Ethnicity. 
  
One study found that minority smokers quit at higher rates than nonminority smokers 
(Gritz, Carr, et al., 1993). Other studies did not report on ethnicity differences (Ostroff et al., 
1995; Vander Ark et al., 1997).  
 
Disease Severity and Treatment Variables 
 
 Overall, disease severity and treatment severity have been associated with cessation 
success.  
Gritz, Carr, et al. (1992) conducted a smoking cessation intervention study with 186 
current and recent smokers with first primary squamous cell carcinoma of the upper 
aerodigestive tract. They found that 88 percent of the patients were current smokers and at 
12 month follow-up of a smoking cessation program, 70.2% of the participants were 
   43 
complete abstainers (Gritz, Carr, et al., 1993). One month follow up revealed a majority of 
the participants quit smoking prior to or at initial advice. One of the predictors of continuous 
abstinence was medical treatment. More specifically, patients receiving primary radiation 
therapy achieved a low 36% abstinence as compared to patients who had undergone a total 
laryngectomy, who achieved an 87% abstinence rate.  
 Ostroff (1995) and colleagues investigated prevalence and predictors of continued 
tobacco use after treatment of patients with head and neck cancer. Specifically, these 
authors were interested in the role of disease and treatment characteristics in continued 
tobacco use. One hundred forty-four patients who had undergone surgical treatment for 
newly diagnosed head and neck cancers at Memorial Sloane-Kettering Cancer Center 
between January of 1991 and June of 1992 completed a tobacco-use survey. Smoking 
status was based on even a single puff during the time period specified. Thirty-five percent 
(26 out of 74) of those who had smoked the year before diagnosis (or 18% of the total 
sample) reported continued tobacco use after surgery. Of these 26 patients, 88% believed 
quitting smoking would be beneficial, 92% had thought about quitting, and 84% had made at 
least one attempt to quit. Those more likely to abstain from smoking had undergone 
postoperative radiotherapy, had cancers of the larynx or pharynx as opposed to cancer of 
the oral cavity, and had more severe disease. For instance 83% of patients who underwent 
postoperative radiation treatment remained abstinent versus 53% of the patients who did not 
receive post-operative radiation treatment. Also, “72% of patients with Stage II-IV disease 
were likely to have remained abstinent, compared to 24% of patients with in situ or Stage I 
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disease” (p.573). Moreover, in this study, of those who relapsed, resumption typically 
occurred one month after surgery and of those who returned, 58% were daily users. 
Continued use of tobacco was associated with less severe disease and less extensive 
treatment. Furthermore, although state of disease and post-operative radiotherapy were the 
best predictors of continued smoking, these disease variables did not account for a significant 
additional variability in smoking status after disease site.  
 Likewise, Vander Ark (1997) and colleagues found disease and treatment severity 
to be predictive of smoking cessation in a group of 87 patients with squamous cell carcinoma 
of the head and neck. Overall, 69% of the participants quit smoking. Seventy-five percent of 
those who did quit did so because of a diagnosis of cancer. Forty percent quit at the time of 
diagnosis, 19% at time of treatment, and 16% after therapy. Combined therapy (e.g., 
surgery and post-operative radiation) was a positive predictor of smoking cessation as was a 
total laryngectomy. For instance, 95% of patients who underwent a total laryngectomy and 
post-operative radiation therapy quit smoking as compared to 47% of the patients who 
received radiation therapy alone or 63% of the patients who had undergone the surgery 
without postoperative radiation therapy. Ostroff et al. (1995) reported similar findings such 
that abstainers were those who had more extensive disease. More specifically, “72% of 
patient with stage II-IV disease were likely to have remained abstinent, compared with 24% 
of patients with in situ or Stage I disease” (p.573). Furthermore, “patients with less extensive 
disease were two times more likely than patients with more extensive disease to resume 
tobacco” (p. 574). In a recent study of 75 patients with either head and neck cancer  
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(n = 23) or lung cancer (n = 51), when time since diagnosis was partialled out, “patients who 
were not undergoing treatment were more likely to be smokers (Schnoll et al., 2002, p. 
140). 
 
Smoking and Alcohol Variables 
 
 Smoking behaviors and risk factors were examined in a sample of 5,998 cancer 
patients between February 1986 and February 1988 (Spitz, Fueger, Eriksen, et  al., 1990). 
Smoking history was defined as “smoking cigarettes on a daily basis for at least 6 months” 
(p. 74). Approximately 30% of the participants were current smokers. There was no clear-
cut pattern between age and the prevalence of current smoking. However, heavy smoking 
was significantly more prevalent among current smokers of both genders than among former 
smokers, suggesting that heavy smokers may have more difficulty quitting.  
 Vander Ark (1997) and colleagues found prior alcohol use to be a predictor of 
smoking cessation, as did Duffy et al. (2002) in a sample of 81 head and neck cancer 
patients. It has also been found that heavy smokers have a more difficult time quitting than 
light or moderate smokers (Gritz, Carr, et al., 1993). This study also found that nicotine-
dependent smokers, defined as “time to first cigarette” (p. 268), have more difficulty with 
cessation than non-nicotine dependent smokers. Recent studies have similarly found that 
smokers tend to be more dependent on nicotine than abstainers (Duffy et al., 2002; Schnoll 
et al., 2002). 
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 The role of tobacco, in combination with alcohol use, has also been investigated. 
Ostroff (1995) and colleagues found that the number of years a person smoked and daily 
consumption of alcohol was not associated with continued tobacco use. A study of 545 
cases and 641 controls (referents) investigating the use of tobacco, oral snuff and alcohol in 
the etiology of squamous cell carcinoma of the head and neck found that there was a fourfold 
increased risk for cancer for ever-users (Lewin et al., 1998). This risk increased with 
duration of smoking, not intensity. Of the cancer cases, 44 (8%) had never smoked and 501 
(91.9%) had a smoking history, 385 (76.8% of ever smokers) were currently smoking, and 
116 (23.1%) were ex-smokers. They found that alcohol had increased the relative risk of 
head and neck cancer for smokers but not for nonsmokers. In fact, the combination of 
alcohol and tobacco produced a multiplicative effect on the relative risk, which has also been 
found in other studies (Bundgaard, et al., 1995).  
Several studies have shown that alcohol interacts with smoking, contributing 
significantly to the development of oral cancer (Blot et al., 1998; Bundgaard et al., 1995), 
pharyngeal cancer (Blot et al., 1998), an increased risk of second cancers (Day et al., 
1994), and an increased risk of death (Deleyiannis, Thomas, Vaughan, & Davis, 1996). 
Deleyiannis et al. (1996) investigated smoking behavior in 649 patients diagnosed with 
cancer of the oral cavity, oropharynx, hypopharynx, and larynx, and found that alcoholism 
“was associated with increased risk of death …. independent of age, site of cancer, 
anatomical stage, histopathology, grade, smoking and type of antineoplastic treatment” 
(p.542). For instance, after adjusting for smoking variables, the 5-year survival estimate for 
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abstinent alcoholics and for alcoholics currently drinking was 57.1% and 40.9%, respectively 
(Deleyiannis et al., 1996), and the authors suggested that quitting alcohol use may prolong 
life. Furthermore, there was an association between decreased alcohol use and decreased 
smoking such that 55.3% of abstinent alcoholics versus 73.7% of nonabstinent alcoholics 
were currently smoking 20 or more cigarettes per day (Deleyiannis et al., 1996).   
Likewise, prior heavy alcohol use was found to be a negative predictor of smoking 
cessation (Vander Ark et al., 1997). “The risk of esophageal cancer decreased rapidly, 
strongly, and significantly with longer periods of abstention” of both tobacco and alcohol use 
(Castellsague et al., 2000, p. 814). The authors reported that that decreased use of both 
tobacco and alcohol decreased the risk of developing esophageal cancer, “regardless of 
amount, duration, or type of tobacco and alcoholic drink consumed” (Castellsague et al., 
2000, p.817).  
  
Psychosocial Variables 
 
 Many studies have indicated that depression is prevalent among individuals with 
cancer (Derogatis et al., 1983; see Massie and Popkin, 1998 for review). Research 
suggesting a high correlation between depression and smoking behavior in the general 
population was highlighted earlier. In a sample of over 1,100 patients with cancer, 
approximately 35% reported mild to severe depression according to the Zung Self-Rating 
Depression Scale (Passik et al., 1998). According to Massie and Popkin’s (1998) review, 
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depression among cancer patients ranges from 1% - 53%, depending on the study. 
Furthermore, among individuals with cancer, advanced stages of disease correlated with a 
higher prevalence of depression. These high prevalence rates are important to consider, since 
in the general population, smokers with depression are less successful at cessation. Given the 
data in the general population, depressive symptoms may predict smoking behavior in the 
cancer population as well. To date, however, depression in the context of smoking cessation 
among cancer patients has bee examined in only one study (Schnoll et al., 2002), in  which 
smokers displayed higher levels of emotional distress as measured by a revised impact of 
events scale ([RIES]).   
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CHAPTER 6: VARIABLES ASSOCIATED WITH SMOKING BEHAVIOR  
IN THE COPD POPULATION 
 
Introduction 
 
This section will review the current research related to smoking in the COPD  
population.  
 
Demographic Variables 
 
Age. 
  
Overall, studies conducted by Pederson and colleagues have found that successful 
quitters tended to be older than those who continued to smoke, although this difference was 
not significant (Pederson, Wanklin & Lefcoe, 1991). Another study also found that older 
patients were more likely to quit than younger patients (Bjornson et al., 1995). Wise (1997) 
found that “there have been substantial reductions in smoking behavior in young adults” (p. 
420), whereas “older groups have shown little or no reduction in smoking prevalence” 
(Wise, 1997).  
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Gender. 
 
The predictive role of gender and smoking behavior in the COPD population has 
yielded mixed results. Some studies have demonstrated that gender is associated with 
smoking cessation (Pederson, Baskerville, & Wanklin, 1982; Pederson, Williams, & Lefcoe, 
1980) whereas a more recent study did not demonstrate a relationship (Pederson et al., 
1991).  
In the Lung Health Study, 27% (n=1069) of all participants in the Special 
Intervention Group were sustained nonsmokers at 12 months (Bjornson et al., 1995). 
Results showed that men had a higher sustained quit rate at 12 and 36 month follow-ups. 
Variables that were related to men’s longer abstention rate were education, length of longest 
quit attempt, having another smoker in the household, consuming more than 7 drinks per 
week, smoking more than 30 cigarettes per day at baseline and finding the first cigarette for 
the day the hardest to give up. Overall, women had greater difficulty quitting smoking than 
men. However, gender alone explained only some of the difference in smoking cessation 
rates. Within each gender group, those who were “better educated, married, older, had 
made longer quit attempts in the past, had not used Nicorette before, … and had a lower 
cotinine level were more likely to be sustained nonsmokers” (Bjornson et al., 1995, p.228).  
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Education. 
 
Some studies have found a relationship between educational level and smoking 
behavior (Bjornson et al., 1995; Pederson et al., 1982; Pederson et al., 1980), while others 
have not found an association (Pederson et al., 1991). For instance, in the Lung Health 
Study, those who were more educated were more likely to be sustained nonsmokers 
(Bjornson et al., 1995). Pederson et al. (1980) found that the older and younger COPD 
patients were more likely to quit smoking than the middle-aged patients.   
 
Income. 
 
 Socio-economic status has been associated with smoking cessation in some studies 
(Pederson et al., 1982; Pederson, Wanklin, & Baskerville, 1984; Pederson et al., 1980; 
Pederson et al., 1988) but not in others (Pederson et al., 1991). For instance, Pederson et 
al. (1980) found that individuals in the upper and middle social status were more likely to quit 
smoking as compared to individuals in the lower social status. Alternatively, future smoking 
status was not related to socioeconomic status (Pederson et al., 1991).  
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Ethnicity. 
 
Although there has been a “greater proportional decline in smoking prevalence 
among African-Americans than among whites,” there is still a greater prevalence of smoking 
among African-American men” (Wise, 1997, p. 420).  
 
Disease Severity Variables 
 
 In a sample of 45 patients with COPD, severity of disease (defined by FEV1) was 
not related to initial or follow-up smoking status (Devins & Edwards, 1988). Other studies 
have found a higher smoking cessation rate with increased severity (Pederson et al., 1980). 
However, given the chronicity of the COPD, many patients may have tried repeatedly to quit 
smoking over the course of their disease (Orleans et al., 1993). 
 
Smoking and Alcohol Variables 
 
 Murray, Istvan, Voelker, Rigdon, and Wallace (1995) reported on the association 
between alcohol consumption and smoking cessation as part of a large scale study, the Lung 
Health Study. The Lung Health Study was a randomized multi-center clinical trial sponsored 
by the Division of Lung Disease of the National Heart, Lung, and Blood Institute. The goal of 
this study was to determine whether an intensive smoking cessation program in combination 
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with an inhaled bronchodilator could reduce the rate of decline of pulmonary function and 
thereby reduce respiratory morbidity in middle-aged smokers with mild airflow obstruction 
over a 5-year period. Participants included smokers ages 35 to 60 who were at the early 
stages of COPD. Murray (1995) and colleagues found that, in a sample of 3,997 men and 
women in the Lung Health Study, nearly half of all participants quit smoking. Only baseline 
binge drinking predicted smoking behavior at one year follow-up. Neither amount of drinking 
nor drinking status were predictive of smoking status after one year for the intervention 
group. However, in the  control group, baseline nondrinkers smoked more heavily than 
drinkers after one year. Measures of smoking status were assessed via self-report, carbon 
monoxide in expired air and salivary cotinine. In the intervention group, those who had quit 
smoking were heavier drinkers than those who did not quit smoking. According to these 
authors, this finding suggested that individuals with two habits will quit drinking alcohol before 
quitting smoking cigarettes. The authors did not find consistent results regarding the 
relationship between alcohol and relapse.  
 Crowley, MacDonald, and Waller (1995) implemented a smoking cessation 
program with 49 smoking COPD patients. Individuals in the experimental group were 
reinforced for smoking cessation with lottery tickets whereas individuals in the control group 
received non-contingent lottery tickets (i.e., received lottery tickets that were not contingent 
upon co-validated smoking status). At 6 month follow up, 31/36 (90%) patients were still 
smoking and 3 individuals (10%) were no longer smoking. Overall, few patients quit 
smoking, and quit rates between the experimental and control groups did not differ 
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significantly. Advice and reinforcement, including money, were not enough of a reinforcement 
to quit smoking. Patients pretreatment reports of desire to quit did not predict outcome, nor 
did scores on “dependence.” 
 
Depression  
 
 Several studies have demonstrated a correlation between depression and COPD 
(Agle, Baum, Chester, & Wendt, 1973, Light, Merrill, Despars, Gordon, & Mutalipassi, 
1985; Weaver & Narsavage, 1992). In a sample of patients with moderate to severe 
COPD, 42% had significant depression (Light et al., 1985). Weaver and Narsavage (1992) 
found that approximately half of their participants attending an outpatient clinic for COPD 
had a mean depressive mood score (as measured by the Multiple Affect Adjective Check 
List Revised [MAACL-R) greater than norm, and this was significantly correlated with 
functional status. Unfortunately, no studies were found which specifically examined the 
relationship between depression and smoking in the COPD population.  
 
Self-Efficacy 
 
 Research on smoking cessation within the COPD population shows that overall, 
COPD patients do not quit smoking. An early study investigating the role of self-efficacy in 
smoking cessation among 45 COPD patients found only 11.1% quit at 3 month follow-up 
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(Devins & Edward, 1988). However, 68 % significantly reduced their number of cigarettes 
per day. Perceived self-efficacy was a significant predictor of smoking behavior change.  
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CHAPTER 7: MEASUREMENT OF SMOKING VARIABLES 
 
Velicer, Prochaska, Rossi, and Snow (1992) reviewed various self-report and 
biochemical measures of smoking status, as well as issues to consider in choosing a smoking 
measure for research, including type of study, type of population, and demand 
characteristics. Three ways to measure self-reported smoking status include point-
prevalence, continuous abstinence and prolonged abstinence. Overall, all of these measures 
are “ad hoc measures” (i.e., “do not reflect the complex variety of changes that are involved 
in smoking cessation” (Velicer et al., 1992, p.35). 
Point prevalence, which will be utilized in this study, is defined as the “percentage of 
smokers who are not smoking at the particular point in time” (Velicer et al., 1992, p. 23). 
Point prevalence self reports have the advantage of including individuals who were “delayed 
quitters.” Point prevalence rates “also allow lapses or relapses to occur following treatment 
without making it necessary to categorize the smoker as a permanent failure” (Velicer et al., 
1992, p.26). It thereby recognizes the dynamic nature of the smoking/not smoking process. 
However, such self reports may overestimate cessation by including short-term quitters who 
have not yet “had time” to relapse. Furthermore, because of high relapse rates within the first 
three months following quitting … many individuals who are counted as former smokers at 
one point in time will be current smokers at the next point in time” and “abstinent rates are 
not stable” (Velicer et al., 1992).  
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Three ways to obtain smoking status are through self-report, report by significant 
others, or use of biochemical markers, such as measures of carbon monoxide, thiocyanate, 
and cotinine. The general advantage to self reports is the greater ease and lower cost in 
collecting data. However, biochemical verification reduces misreporting (Velicer et al., 1992) 
among populations which may feel high demand characteristics to underreport. Several 
studies have shown a higher rate of false negatives for medical populations (Sillett, Wilson, 
Malcolm, & Bal, 1978; see Velicer et al., 1992, for review; Vogt, Selvin, Widdowson, & 
Hulley, 1977) than in other populations. The use of biochemical markers, however, is not a 
cure-all to the underreporting problem. The half lives of CO, thiocyanate, and cotinine are 5 
hours, 10-14 days and 15-40 hours, respectively. Therefore, biochemical markers can only 
assess for recent smoking, going as far back as up to one month prior to the assessment. 
Furthermore, a disagreement between a self-report and a biochemical marker may not only 
reflect underreporting, but may also reflect environmental conditions (e.g., individuals who 
work with certain chemicals). In addition to disadvantages of measurement, the use of 
biochemical markers may increase refusal rate of participation in the studies.    
In addition to biochemical validation, another method sometimes used to decrease 
underreporting or false negative rates is to introduce the “bogus pipeline” (Evans, Hansen, & 
Mittelmakr, 1977; Jones & Sigall, 1971). As part of this procedure, subjects are told that 
biochemical assessments will be used to assess smoking status, when they will actually be 
collected, but not evaluated (Velicer et al., 1992, p.32). Murray, O’Connell, Schmid, and 
Perry (1987) provided an extensive review of this procedure and found that half of the 
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studies investigating the bogus pipeline effect found no difference in self-reported smoking 
rates between those assessed under the pipeline versus no pipeline procedures, while half of 
the studies did find significant differences in reporting. Most of these studies were conducted 
with adolescent students, which represent a very different population from adult medical 
populations. In addition, several of these studies showed that the students, unlike medical 
patients, did not experience pressure to underreport. Finally, the studies did not test whether 
the participants actually believed in the bogus pipeline. Murray and Perry (1987) found that 
among a group of 770 adolescents, simply ensuring anonymity reduces underreporting and 
therefore reduces the need for the bogus pipeline procedure. Among a group of 149 
volunteers in a smoking cessation study, Baer et al. (1986) found that CO measures 
contradicted self-reported smoking status in only 3 instances.   
There is some controversy over the measurement of smoking variables. Some 
research shows that self-reports tend to underestimate smoking habits (see Velicer et al., 
1992, for review) and that people often underreport the amount they currently smoke 
(Murray & Perry, 1987; Stookey, Katz, Olson, Drook, & Cohen, 1987; see Velicer et al., 
1992, for review), while others do not show this to be the case (Duncan et al., 1992; Glynn, 
Gruder, & Jegerski, 1986; Hall, Tunstall, Rugg, Jones, & Benowitz, 1985; Murray, Connett, 
Lauger, Voelker, 1993). For instance, in a sample of over 2,000 medical patients, 245 out 
of 334 (75%) self-reported quitters passed biochemical validation (Duncan et al., 1992). In 
a study of 127 adult smokers participating in a smoking cessation program, “[o]nly 16% of 
self reports of abstinence were not verified by CO measurement (Glynn et al., 1986, p.125). 
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Furthermore, there was no significant difference in misreporting between the groups who 
were educated about CO validation and informed that they would be tested, and the control 
group (who was not educated and informed about CO validation techniques). Thus, the 
authors suggest that a biochemical index “is not indicated to validate self-reports” (p. 134). 
In a group of 120 individuals undergoing a smoking cessation program, “biochemical 
measures failed to verify self report in only 3 instances (Hall et al., 1985, p. 256). Among 
those participating in the Lung Health Study, 1% of individuals in the usual care group 
reported not smoking but had positive cotinine, and 6% of those in the intervention group 
underreported based on a cotinine assay (Murray et al., 1993). While these differences were 
found to be significant, the effect size was small and the authors suggest that the size of the 
difference would not mislead the findings. Overall, research on false reporting of abstinence 
is variable (see Glynn et al., 1986 for review). In addition, several researchers have found 
significant inaccuracy of biochemical validation techniques (Abrams, Follick, Biener, Carye, 
& Hitti, 1987; Petitti, Friedman, & Kahn, 1981; see Velicer et al., 1992, for review), 
suggesting that the cost of such techniques does not outweigh the gains and does not provide 
significant additional, nor necessarily more accurate, information. For instance, saliva has a 
false positive rate “in periods less than seven days of abstinence” (Abrams et al., 1987). 
Overall, point prevalence measures are the most popular in survey research studies 
investigating the relationship between smoking and disease (Velicer et al., 1992). However, 
research has not been consistent on how to measure point prevalence rates. Common 
minimum periods of abstinence are 24 hours, 7 days and 30 days. According to Velicer et 
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al. (1992), the National Interagency Council for Smoking and Health has recommended 
using a minimum of 7 days of abstinence for defining cessation, which has also been 
recommended by several other authors (Lichtenstein & Glasgow, 1992; Velicer et al., 
1992). Several studies have defined current smokers as anyone who has smoked in the past 
7 days (Duncan et al., 1992; Ostroff et al., 1995). Classification rates of smokers, quitters, 
and relapsers will depend on how liberal the criterion is. According to the U.S. Department 
of Health and Human Services, using a 1-day quit criteria, 18% will quit and 70 to 80% will 
relapse, whereas using a 7-day criteria, only 12% will have attempted to quit, and only a 
minority will relapse (Velicer et al., 1992).  
In addition to biochemical validations of self-report, a less expensive validation 
technique to verify self reports is with an informant who lives with the participant or has 
regular contact with the participant (Ossip-Klein et al., 1991). Measures that have been 
developed to assess nicotine dependence (e.g., Fagerstrom Test for Nicotine Dependence) 
have yielded mixed findings with respect to it psychometric properties. However, “time to 
first cigarette” has been found to be a valid measure of nicotine dependence because in the 
morning, blood nicotine levels have decreased, and presumably, dependent smokers will 
experience withdrawal upon waking and smoke as soon as possible to relieve these 
withdrawal symptoms. Correlations between self-report measure of dependence and 
biochemical measures have been shown to be high (Hall et al., 1985). Overall, Velicer et al. 
(1992) concluded that “false reporting does not support the regular use of biochemical 
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markers,” mostly because underreporting is relatively low, and biochemical markers are 
costly and difficult to obtain.  
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CHAPTER 8: SUMMARY OF SMOKING RESEARCH 
 
Overall, research investigating predictors of smoking behavior has yielded disparate 
results. The most common variables that have been measured include demographic variables 
(e.g., age, gender, educational attainment, income, and ethnicity), smoking history, alcohol 
history, and social support. Most studies have found smoking history to be associated with 
smoking behavior, and most studies have found that social support is associated with 
smoking behavior when the measurement of social support is one which accounts for the 
number of other smokers in the household. Research has also examined the role of 
depression, anger and coping skills with respect to smoking behavior. Many of the studies 
have demonstrated a strong association between depression and smoking behavior (e.g., 
initiation of smoking cigarettes, smoking cessation, relapse) in the general population, but this 
relationship has been minimally investigated in the head and neck cancer and COPD 
populations. Approximately 70% of individuals with COPD continue to smoke as compared 
to approximately 30% of individuals with head and neck cancer. Continued smoking has 
important implications for treatment outcome, morbidity, and mortality. Much of the research 
in these two medical populations has focused on demographic variables, smoking history, 
disease severity and treatment variables, with little attention paid to psychosocial variables. In 
studies that do examine psychosocial variables, the variables are not examined in the context 
of smoking behavior, thus leaving several potential and fruitful areas for research.  
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CHAPTER 9: RELEVANT THEORIES 
 
Introduction 
 
 Many theories exist which explain health behavior and which guide research 
attempting to understand and explain human health behavior. Several theories which have 
guided research on smoking behavior include the Health Belief Model (HBM), the 
Transtheoretical model (a.k.a. Stages of Change), and the Theory of Self-Efficacy. Although 
the present study will not test these theoretical constructs, the following section will describe 
these theories and discuss their relevance to smoking research. Finally, the Social Problem-
Solving Model will be introduced, and the relevance of this model to smoking research, and 
this study, will be discussed.  
 
The Health Belief Model 
 
The Health Belief Model (HBM) is a widely used model explaining a person’s health 
behaviors, including both behavior change and health. The HBM was initially proposed to 
help explain why individuals do not participate in health prevention programs (See Strecher 
& Rosenstock, 1997 for review). More recently, with more people living longer and in the 
face of chronic illness, the HBM has also been utilized to explain people’s response to a 
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diagnosed illness (Strecher & Rosenstock, 1997).  Therefore, although initially developed to 
help explain screening behaviors, the HBM  
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also explains preventive behaviors, illness behaviors and sick-role behaviors (Janz & Becker, 
1984).  
Simply stated, the HBM represents a value expectancy theory positing that  
one’s behavior is not simply the result of  learning, but rather, “a function of the subjective 
value of an outcome and of the subjective probability, or expectation, that a particular action 
will achieve that outcome” (Strecher & Rosenstock, 1997). Within the context of health 
behaviors, value can be defined as “the desire to avoid illness or to feel well” and expectancy 
can be defined as “the belief that a specific health action available to a person would prevent 
(or ameliorate) illness” (p.43).  
There are four original components to the HBM: perceived susceptibility and 
perceived severity (which, together, comprise perceived threat); perceived benefits, and 
perceived barriers. Perceived susceptibility is one’s perception of his or her risk of 
contracting an illness or, in the case of individuals already diagnosed with an illness, 
“acceptance of the diagnosis, personal estimates of resusceptibility, and susceptibility to 
illness in general” (Strecher & Rosenstock, 1997, p.44). Perceived severity measures one’s 
perception of the seriousness of contracting an illness, or leaving it untreated, including 
perceptions of the medical and social consequences. Perceived benefits represents one’s 
perceptions of the effectiveness of one’s available actions to reduce susceptibility or severity. 
Finally, perceived barriers represent a cost-benefit analysis of the expected benefits from a 
health action to the expected barriers. Taken together, an individual will perform a health 
behavior if he or she believes the personal risk to developing an illness is high, that such an 
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illness will have severe consequences (e.g., pain, death, decrease in quality of life), that an 
available course of action will be effective in reducing susceptibility and finally, that the 
benefits to performing the action outweigh the barriers.  
The HBM may be useful in explaining an individual’s decision to continue to smoke 
or to quit smoking as a result of being diagnosed with cancer or COPD. This model would 
propose that quitters are more likely to believe that they are susceptible to worsening of 
symptoms, to future hospitalizations for respiratory failure or complications, to treatment 
failure or to recurrence. According to this model, quitters would be more likely to believe 
that quitting smoking will reduce their chances of disability, improve their quality of life, and 
reduce their chances of death. Quitters would  believe that quitting smoking will, in fact, be 
effective in reducing their own personal susceptibility to the above negative consequences, 
and that the benefits of stopping smoking (e.g., reducing the risk of recurrence; reduced cost 
of buying cigarettes, reinforcement from family) outweighs the barriers to stopping smoking 
(e.g., withdrawal symptoms, weight gain, fear of increased stress). Fourth, quitters would be 
more likely to hold the view that the benefits to quitting outweigh the barriers. According to 
Strecher and Rosenstock (1997), a cost-benefit analysis of the pros and cons of smoking 
are “predictive of movement through stage of behavioral change readiness.” Overall, the 
theory suggests that individuals’ perceptions of personal health risk motivate health 
behaviors.  
A summary of research on the HBM suggests some empirical support for the  
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model (Janz & Becker, 1984). Overall, these authors found perceived barriers to be the 
most powerful predictor and perceived severity to be the least powerful predictor, across 
various studies and behaviors (Strecher & Rosenstock, 1997). One of the main challenges to 
studying the application of the HBM to behaviors is that no reliable or valid measure of the 
HBM concepts exists (Strecher & Rosenstock, 1997).  
According to Strecher and Rosenstock, the HBM is not widely used in the  
smoking research because “of consistent findings that the majority of cigarette smokers 
already perceived a general health threat from smoking” (Strecher & Rosenstock, 1997, 
p.50). However, although few studies in the smoking literature have tested the HBM, several 
studies do exist investigating the role of the HBM in explaining smoking behavior. Overall, 
smokers do perceive a greater threat to their health than nonsmokers (Brownson et al., 
1992). In this survey of over 2,000 adult smokers, 83% of the current smokers believed 
smoking was harmful to their health. The fact that smokers already perceived their health as 
threatened makes this particular construct of the HBM irrelevant. Furthermore, this 
perceived threat, in essence, had no effect on their smoking behavior, suggesting that there 
be another underlying construct at work. It has been suggested, particularly in the smoking 
literature, that self-efficacy is a barrier component in the HBM (Rosenstock, Strecher, & 
Becker, 1988), and that this construct will be predictive of smoking behavior change among 
individuals with a strong perceived threat.  
Some research on perceived benefits and barriers to cigarette smoking indicates that 
smokers and nonsmokers do differ in their beliefs that quitting smoking would result in a 
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health benefit (Brownson et al., 1992). In a sample of over 2,000 adult current smokers, 
former smokers and never smokers, they found that 8% of current smokers believed 
smoking was harmful to their health versus 91% of never smokers and 92% of former 
smokers who believed smoking to be harmful (Brownson et al., 1992). Alternatively, in a 
study of 308 patients recently diagnosed with pulmonary disease, Pederson et al. (1984) 
found that health beliefs were not associated with smoking cessation.  
 However, research has also shown that although smokers accurately assess the 
threat of smoking, they often underestimate their own personal susceptibility (Strecher et al., 
1995; Weinberger, Greene, Mamlin & Jerin, 1981). Weinberger (1981) and colleagues 
found that both ex-smokers and current smokers viewed smoking as a threat to health, yet 
only ex-smokers perceived themselves to be more personally susceptible to the negative 
consequences of smoking than smokers. The authors concluded that in addition to believing 
smoking to be a serious health problem, individuals must see themselves as personally 
susceptible to adverse affects in order to quit (Weinberger et al., 1981).” Likewise, in a 
sample of 2,785 adults, smokers were more likely than nonsmokers to perceive a higher 
personal risk of heart attack, cancer and stroke, yet tended to underestimate their actual risk 
of these conditions (Strecher et al.,1995). The theory helps to explain perceived health risks 
in the general population.  
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Transtheoretical Model (Stages of Change) 
 
 The Transtheoretical Model (TM; Prochaska and DiClemente, 1983) posits that 
behavior change occurs through a series of linear stages. Initial studies of the TM focused on 
smoking behavior, and more recently, on alcohol and substance use, anxiety and panic 
disorder, eating disorder, HIV/AIDS prevention, mammograms, and compliance with 
medical regimen. The six temporal dimensions of the model include precontemplation, 
contemplation, preparation, action, maintenance, and termination. In the precontemplation 
stage, individuals are not considering taking action in the foreseeable future, typically 
measured as the next 6 months. The contemplation stage characterizes people who intend to 
change within the next six months. These individuals are often in the midst of weighing the 
pros and cons of behavior change. Individuals in the preparation stage intend to take 
immediate action, typically measured in the next month, and already have a plan of action. 
Finally, people in the action stage have made behavior changes in the past 6 months. In the 
TM, however, only total abstinence from smoking counts as a behavior change (Prochaska, 
Redding & Evers, 1997). The  fifth component of the model is Maintenance, or the attempt 
to prevent relapse. The sixth and final stage is termination, characterized by individuals who 
have no temptation and 100% self-efficacy (Prochaska et al., 1997).  
 Additional constructs deemed important in the process of change are decisional 
balance, defined as an “individual’s relative weighing of the pros and cons of changing” and 
self-efficacy, defined as “the situation-specific confidence people have that they can cope 
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with high-risk situations without relapsing to their unhealthy or high-risk habits” (Prochaska et 
al., 1997, p.65).  
 There is a tremendous amount of literature on the use of the TM with smoking and 
more specifically, with smoking cessation. Supporters of the TM assumes that cessation 
programs have not been effective because they do not take into account individual 
differences regarding stages of change. For instance, “people with precontemplation should 
not be treated as if they were ready for action interventions” (Prochaska et al., 1997). One 
study found that smokers in the precontemplation stage abstined the least over 18 months as 
compared to smokers in the preparation stage, who proressed the most (Prochaska, 
DiClemente, & Norcross, 1992), suggesting that knowing what stage an individual is in will 
allow cessation programs to be tailored more toward the individual, thereby improving 
success rates. Several variables, such as self-efficacy, have been shown to mediate the stage 
of change. For instance, self-efficacy increases as one progresses through the stages of 
change (Orleans et al., 1993).  
 A second variable important to consider is the perceived severity of the health 
hazard. Becker (1977) proposed that motivation to change one’s health behavior depends 
on both the person’s feelings of personal vulnerability as well as his or her beliefs about the 
seriousness of the health hazard. This difference in perceived hazard may explain the 
difference in smoking cessation rates between head and neck cancer and COPD 
populations. Even with the many advances in treatment for cancer, individuals with cancer 
may still perceive their illness to be life-threatening, whereas individuals with COPD may 
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experience a range of respiratory symptoms, even to the extent of a decrease in physical 
functioning, yet not perceive their lives to be in danger.  
Although the TM may be helpful in explaining why some individuals are successful in 
a smoking cessation program and others are not, the TM, although important in theory, is not 
necessarily relevant to this study, and will not be measured specifically in this study. More 
specifically, a proportion of individuals participating in this study have already quit smoking. 
Therefore, according to the TM theory, these individuals are already in the action phase.  
 
Theory of Self-Efficacy 
 
Bandura (1977), in his seminal article on the impact of self-efficacy on behavior, 
found that behavior change is a function of one’s expectation of personal efficacy. In other 
words, cognitive processes mediate change. Bandura’s theory of self-efficacy posits that an 
individuals’ expectations of his or her efficacy, “the conviction that one can successfully 
execute the behavior required to produce the [desired] outcome” (Bandura, 1977, p.193) 
will predict whether “coping behavior is initiated, how much effort will be expended, and 
how long it will be sustained in the face of obstacles and aversive experiences” (Bandura, 
1977, p. 191). For instance, a person may believe that smoking is poor for his or her health. 
But someone who is diagnosed with a chronic condition  may not believe that quitting 
smoking can improve an already bad situation. Another component of self-efficacy, 
therefore, is not only whether a particular behavior will produce the desired outcome, but 
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whether one can perform such behaviors (e.g., whether one can or cannot quit smoking). 
One might think that previous quit attempts would influence one’s self efficacy to quit (e.g., “I 
tried to quit before and failed, so I won’t be able to quit this time”). However, “expectation 
alone will not produce desired performance if the component capabilities are lacking” 
(Bandura, 1977, p.194). In other words, in addition to having a high self-efficacy, one must 
also have the actual coping skills to perform the desired behavior. Furthermore, one must 
have “incentive” to perform the behavior. Individuals diagnosed with head and neck cancer 
may have higher incentive because cancer is still considered a life-threatening illness whereas 
individuals with COPD may live many years, and experience a more gradual increase in 
symptoms, therefore not having incentive to quit smoking.  
According to Bandura, self-efficacy is based on “four major sources of information: 
performance accomplishments, vicarious experience, verbal persuasion, and psychological 
states” (Bandura, 1977, p.195). For instance, prior success (e.g., quit attempts) increases 
feelings of self-efficacy whereas prior failures reduces such feelings. As another example, 
high emotional arousal may affect one’s self-efficacy such that “diminishing emotional arousal 
can reduce avoidance behavior” (Bandura, 1977, p.199). 
More recently , Bandura’s theory of self-efficacy has been applied in research with 
people with cancer (see Lev, 1997, for review). More specifically, several studies have 
investigated the role of self-efficacy in smoking cessation. Yates and Thain (1985) found that 
self-efficacy successfully classified smokers into abstainers and relapsers. In a prospective 
study by the same authors, self-efficacy accounted for approximately 13% of the total 
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variance on relapse/nonrelapse (Yates & Thain, 1985). More specifically, participants’ self-
reported self-efficacy predicted smoking status at 8-month follow-up, suggesting that self-
efficacy may serve to identify individuals at risk for relapse, and that “enhancing self-efficacy 
when it is low decreases the risk of relapse” (O’Leary, 1985). Finally, Utz, Shuster, Merwin, 
and Williams (1994) and colleagues, in a community intervention program, found that 
effective programs were ones which enhanced self-efficacy.  
 The cross-sectional design of this study does not lend itself to an examination of the 
influence of self-efficacy on smoking behavior. It is important to recognize that not only does 
an increased self-efficacy increase the likelihood of attempting to quit smoking, but a 
successful quit attempt may increase one’s self-efficacy.  
 
Social Problem Solving  
 
Problem solving is “the self-directed cognitive-behavioral process by which an 
individual, couple, or group attempts to identify or discover effective solutions for specific 
problems encountered in everyday living” (D’Zurilla, Nezu, & Maydeu-Olivares, in press). It 
is the process by which individuals make conscious efforts to change the problematic 
situations themselves, their reactions to them, or both (Nezu, 1987; Nezu, Nezu, & Perri, 
1989). In this model, problems are defined as “specific existing or anticipated situations that 
demand responses for adaptive functioning, but are not met by effective coping responses 
from the person confronted by them due to the presence of certain obstacles … [which] may 
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include ambiguity, uncertainty, conflicting demands, [or] lack of resources” (Nezu & 
D’Zurilla, 1989, p. 289). This definition of a problem includes impersonal problems … 
personal/intrapersonal problems … interpersonal problems, …. as well as broader 
community and societal problems (D’Zurilla et al., in press). A problem may be a single 
event, a series of related events, or a chronic situation. A solution, on the other hand, is a 
“situation-specific coping response or response pattern (cognitive and/or behavioral) that is 
the product or outcome of the problem-solving process when it is applied to a specific 
problematic situation (D’Zurilla et al., in press, p.3). An effective solution is one in which the 
coping response improves the nature of the problematic situation or reduces the emotional 
distress that is caused by the problematic situation (Nezu, 1987; Nezu et al., 1989). The 
problem-solving model proposed by Nezu and colleagues asserts that problems are variable 
across persons even if they experience the same type of distress because all problems 
represent an interaction of the individual and his or her own stressful situations (Nezu & 
D’Zurilla, 1989).  
The social problem-solving model “was introduced by D’Zurilla and Goldfried 
(1971) and later expanded and refined” (D’Zurilla et al., in press). Most recently, social 
problem solving has been defined as consisting of “two general, partially independent 
processes: (1) problem orientation and (2) problem-solving style” (D’Zurilla et al., in press). 
Problem orientation refers to the “metacognitive process that serves an important 
motivational function in problem solving” whereas problem-solving style “refers to the 
   75 
cognitive and behavioral activities that are aimed at finding ‘solutions’ or ways of coping with 
specific problems encountered during the course of daily living” (D’Zurilla et al., in press).  
More specifically, problem orientation is “a set of beliefs, assumptions, appraisals, 
and expectations concerning life’s problems and one’s own general problem-solving ability” 
(Nezu et al., 1989, p.408). Problem-orientation consists of two dimensions, positive 
problem orientation and negative problem orientation. Positive problem orientation “is a 
constructive, problem-solving cognitive set that involves the general disposition to (a) 
appraise a problem as a ‘challenge’ … (b) believe that problems are solvable …, (c) believe 
in one’s personal ability to solve problems successfully, … (d) believe that successful 
problem solving takes time, effort, and persistence, and (e) commit oneself to solving 
problems with dispatch rather than avoiding them” (D’Zurilla et al., in press). For instance, 
an individual with a positive problem-solving orientation believes that it is possible to quit 
smoking cigarettes, that he or she is capable of quitting smoking cigarettes, and is committed 
to taking the necessary steps toward trying to quit smoking cigarettes. “In contrast, negative 
problem orientation is a dysfunctional or inhibitive cognitive-emotional set that involves the 
general tendency to (a) view a problem as a significant threat to well-being …(b) doubt 
one’s personal ability to solve problems successfully …, and (c) easily become frustrated 
and upset when confronted with problems in living” (D’Zurilla et al., in press). Thus, and 
individual with a negative problem orientation might report being to stressed to quit smoking, 
and easily give up any attempts to quit when faced with obstacles to quitting.  
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Problem-solving styles contain three dimensions: rational problem-solving, 
impulsivity/carelessness style, and avoidance style. Rational problem solving is “a 
constructive problem-solving style that is defined as the rational, deliberate, and systematic 
application of effective problem-solving skills” (D’Zurilla et al., in press). These skills include: 
(1) problem definition and formulation, (2) generation of alternatives, (3) decision making, 
and (4) solution implementation and verification (D’Zurilla et al., in press). Problem definition 
is defined as the “ability to understand the nature of a problem, identify obstacles to goals, 
delineate realistic objectives, and perceive cause-effect relationships.” More specifically, a 
well-defined problem is one in which the individual has defined the problem, has obtained all 
the relevant information regarding the problem, has described the problem in clear, 
unambiguous language, has  demonstrated minimal use of cognitive distortions about the 
problem or about themselves, has identified why the problem is a problem, and has set 
realistic goals. Generation of alternatives involves thinking “of a wide range of possible 
alternative ideas to solve the problem in order to maximize the likelihood that the best or 
most effective solution will be eventually identified” (Nezu, Nezu, Friedman, Faddis, & 
Houts, 1998, p.44). Decision Making involves “evaluation of each possibility and selecting 
the most effective” solution from the alternatives generated in the previous step, and involves 
a cost-benefit analysis (e.g., weighing the positive and negative short-term and long-term 
consequences, as well as the positive and negative consequences to the self and others). 
Finally solution implementation and verification involves carrying out the solution and 
identifying whether the solution has met the individual’s goals.  
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According to the social problem-solving model, impulsivity/carelessness style and 
avoidance style are two “dysfunctional problem-solving patterns” (D’Zurilla et al., in press). 
Impulsivity/carelessness style is characterized by active attempts to apply problem-solving 
strategies and techniques, but these attempts are narrow, impulsive, careless, hurried, and 
incomplete” (D’Zurilla et al., in press). An individual with this style “typically considers only a 
few solution alternatives, often impulsively going with the first idea that comes to mind …. 
scans alternative solutions and consequences quickly, carelessly, and unsystematically, and 
monitors solution outcomes carelessly and inadequately” (D’Zurilla et al., in press). 
Avoidance style is “characterized by procrastination, passivity or inaction, and dependency” 
(D’Zurilla et al., in press). An individual characterized by this style “prefers to avoid 
problems rather than confronting them ‘head on,’ and puts off problem solving for as long as 
possible, waits for problems to resolve themselves, and attempts to shift the responsibility for 
solving his or her problems to other people” (D’Zurilla et al., in press).  
Based on this model, “good social problem solvers would be characterized by high 
scores on measures of positive problem orientation and rational problem solving and low 
scores on measures of negative problem orientation, impulsivity/carelessness style, and 
avoidance style, whereas “poor” social problem solvers would be characterized by low 
scores on positive problem orientation and rational problem solving and high scores on 
negative problem orientation, impulsivity/carelessness style, and avoidance style” (D’Zurilla 
et al., in press).  
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The theory of social problem solving is best understood in the context of the stress 
model because problem solving is, essentially, a coping strategy by which individuals cope 
with stress (Nezu, 1987). Stress has been defined as “the reciprocal relationships among 
four components: 1) major negative life events, 2) daily problems, 3) negative emotional 
states and 4) problem-solving coping” (Nezu et al., 1998). The problem-solving model helps 
to explain the relationship between stressful life events, including both major negative life 
events as well as daily hassles, and distress, such as depression and anxiety. According to 
the model, “negative life events can influence depression directly as well as indirectly through 
their impact on the frequency of current problems, and the level of problem-solving ability” 
(Nezu & Ronan, 1985). Second, current problems directly and indirectly affect depression. 
The more effective one is at solving problems, the less distress they will experience. The 
more effective one is at solving problems, the fewer problems they will have. Thus,  
individuals who have difficulty coping with their stress will experience greater distress.  
There has been extensive research evaluating the role of problem solving in 
explaining depression, reactions to stress, and how individuals cope with a diagnosis of 
cancer. Several studies have demonstrated the link between problem solving ability and 
depression. Specifically, problem solving has been found to serve as both a mediator and 
moderator for stress-related depression and anxiety (Nezu, 1985, 1986a, 1986b, 1987; 
Nezu, Kalmar, Ronan, & Clavijo, 1986; Nezu & Ronan, 1985). Individuals who appraise 
their problem-solving abilities as ineffective appeared more psychologically distressed as 
compared to those who appraised themselves as effective problem-solvers (Heppner, 
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Kampa, & Brunning, 1987). Conversely, the effective self-appraisers experience significantly 
less depression and anxiety. As discussed earlier, depression has been shown to correlate 
with smoking behavior as well as to predict relapse. Thus, an individual’s ability to quit 
smoking may be a function of both distress as well as coping efforts to manage distress.  
Over the past 15 years Nezu and colleagues have repeatedly demonstrated the 
stress moderating effects of problem-solving coping. In a group of 310 university students, 
Nezu (1986a) found that negative life stress leads to state anxiety, and problem solving 
moderated the effect of this stress on anxiety. Nezu (1986) and colleagues found that 
“individuals who have effective problem-solving skills are able to better cope with the 
problems and difficulties inherent in negative life stress, and, as a result, become less prone to 
depressive symptoms under circumstances of high stress” (Nezu et al., 1986, p. 495). A 
prospective study conducted by Nezu and Ronan (1988) not only supported previous 
findings (Nezu et al., 1986), but also found that, when prior depression was accounted for 
(e.g., to rule out the effects of premorbid levels of depression), problem-solving ability 
moderated the effects of stress on depressive symptomatology. The authors concluded that 
teaching clients to cope more effectively with problematic situations might serve to prevent 
depression when they encounter circumstances of high stress.  
Actual clinical outcome studies which provide problem-solving therapy have been 
shown to decrease depression among people diagnosed with unipolar depression (Nezu & 
Perri, 1989). Recent studies have investigated the moderating role of problem solving ability 
and distress in people diagnosed with cancer. The Genesis Cancer Coping Project, a large-
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scale, prospective outcome investigation on the effectiveness of problem-solving training for 
cancer patients, demonstrated problem-solving therapy to be effective in helping people with 
cancer improve their quality of life (Nezu, Nezu, Friedman, Houts, & Faddis, 1999). 
Specifically, patients who participated in problem solving therapy reported significantly lower 
levels of distress, had more effective problem-solving and decision-making skills, and 
reported significantly fewer cancer related problems as compared to individuals who 
received only standard medical treatment without problem-solving therapy (Nezu et al., 
1999). Moreover, individuals with poorer problem-solving skills reported higher levels of 
depression (Nezu et al., 1999). To summarize, findings from a variety of studies support the 
validity of the problem solving model of stress in general (Nezu et al., 1999), as well as its 
applicability to persons with chronic illness, such as cancer (Nezu et al., 1999).  
The present study will investigate the predictive role of problem-solving skills in 
smoking behavior. Why do some individuals quit smoking cigarettes upon a diagnosis, while 
others continue to smoke? The answer may lie in one’s problem-solving skills. The problem-
solving model may help explain smoking behavior among people diagnosed with either head 
and neck cancer or COPD. As highlighted earlier, the problem-solving model explains how 
individuals cope with stress, which can include major life events, daily hassles, and negative 
emotional states. For an individual diagnosed with head and neck cancer, the diagnosis of 
cancer is often, in and of itself, a major life event. Along with this diagnosis arrive a host of 
additional minor life events, or daily hassles, such as pain, physical disfigurement, difficulty 
swallowing, and speech impairment. Negative emotional states in response to a diagnosis or 
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treatment include depression and anger. In the case of COPD, individuals may too 
experience the diagnosis itself as significant. Individuals with COPD experience daily hassles 
such as decreased lung function, decreased sexual dysfunction due to dyspnea, and 
therefore, a decrease in ability to participate in hobbies, recreational activities, and other 
every day activities. These physical limitations often results in poorer work performance, a 
decrease in the quality and quantity of interpersonal relationships, and distress such as 
depression.  
In addition to the increased number of daily hassles and the distress subsequent to a 
diagnosis, individuals with COPD and cancer also face the stress of quitting smoking. 
Ironically, the act of smoking cigarettes may be serving as their stress reducer, and such 
individuals may not have alternative coping resources. If, in fact, current smokers are found 
to have fewer problem-solving skills as compared to former smokers, then problem-solving 
training could provide these individuals with new coping skills. These new skills may help 
them to cope with their current stressors (both the major life events as well as daily hassles), 
thereby reducing their distress. Subsequently, the need to smoke in order to decrease their 
distress may decrease as well. Moreover, these new skills may help current smokers to cope 
with the stress of quitting. For instance, individuals may learn to more clearly identify, or 
define, situations in which they are likely to smoke a cigarette, or they may better generate an 
exhaustive list of possible solutions of how to reduce the obstacles to quitting. Ultimately, 
rather than being advised to quit smoking, or prescribed a medication, the individual could 
become an active participant in his or her care.   
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CHAPTER 10: THE PRESENT STUDY 
 
Rationale 
 
Despite the fact that a majority of individuals diagnosed with either head and neck 
cancer or COPD have knowledge about the negative health consequences of smoking, many 
continue to smoke. Although many variables have been correlated with smoking behavior 
and smoking cessation, few variables are unequivocally correlated, and predictors of 
smoking cessation are inconclusive. Research suggests a strong relationship between 
depression and smoking behavior such that individuals who are experiencing increased 
depressive symptoms under stress are more likely to be smokers. We also know that 
problem solving ability serves to moderate and mediate distress among individuals with a 
range of distress symptoms, including depression in cancer patients.   
A significant amount of research in smoking behavior has been based on the Health 
Belief Model. The HBM has, in the past, explained underlying motivations for engaging in 
particular health behaviors, such as screening behaviors. An integral aspect of the model is 
the declaration that, among other things, an individual must perceive him- or herself to be at 
risk for an illness in order to perform a particular pro-health behavior. An underlying 
mechanism of this model is the belief in one’s self-efficacy. In other words, an individual must 
not only believe himself to be at risk of disease, but also believe he or she can implement 
change (e.g., change in behavior) in order to reduce the risk. The question is: how do 
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individuals who are already diagnosed with cancer or COPD fit into the model? The HBM 
still applies to these populations. For instance, perceived susceptibility may represent 
susceptibility for increased symptoms or recurrence of disease in a non-primary site. 
Research to date has indicated self-efficacy and perceived risk to be predictors of smoking 
cessation in the general population.   
The Transtheoretical Model, like HBM, is useful in understanding why some 
smokers quit successfully and others do not. While the TM is relevant to predicting which 
individuals successfully abstain from smoking, and in targeting and individualizing treatment 
for individuals characterized by earlier stages of change, like the HBM, it does not provide 
us with knowledge of possible interventions. Also like the HBM, the TM takes into account 
self-efficacy. Specifically, self-efficacy increases as one progresses through the stages of 
change. Utilizing these stages of change does not fit into this current study, as individuals 
classified as ex-smokers are, according to the TM, already past the action stage.  
Although the HBM and TM explain why some smokers are successful quitters while 
others are not, they do not offer clinicians with solutions with which to intervene. For 
instance, Bandura’s theory of self-efficacy, while providing an explanation for the underlying 
mechanisms of behavior, can only explain part of the quitting process. In addition to belief 
that the outcome of smoking cessation is positive, and the belief in oneself to be able to 
successfully quit smoking in order to reach the desired outcome, this model lacks the 
behavioral component of change. In other words, individuals are more likely to quit smoking 
if they are able to successfully cope with stressful life events such as stopping smoking.  
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The problem-solving model may not only offer insight into smoking behavior, but 
may also may provide possible solutions to the smoking cessation problem. Preliminary 
findings in the general, adult, nonmedical population already suggest an association between 
coping skills and smoking behavior such that individuals with better coping skills are more 
likely quit and less likely to relapse (Horowitz, 1985; Matheny & Weatherman, 1998; 
Shiffman et al., 1986; Wewers, 1988). If problem-solving skills predict whether an individual 
continues to smoke or quits smoking upon a diagnosis of either head and neck cancer or 
COPD, then individuals with poor problem-solving skills can be targeted for smoking 
cessation treatment, and furthermore, treatment exists which can help to improve an 
individual’s problem-solving skills. Individuals with good problem-solving skills may be 
better able to cope with and resolve problems in life, such as daily hassles, and overall, to 
cope better with stress. Individuals with good problem-solving skills may better cope with 
the specific problems and stress inherent in attempting to quit smoking, such as coping with 
withdrawal symptoms, increased distress, and exposure to smoking triggers and cues.  
The present study will examine, among other variables, the predictive value of 
problem solving on smoking behavior. This will be the first time problem solving will be 
examined in its relation to actual smoking behavior change. The purpose of studying two 
distinct, chronically ill populations is two-fold. First, the study will investigate predictors of 
smoking cessation in each population to better understand how clinicians might identify 
patients who require additional skills or therapy in order to quit successfully. However, the 
smoking cessation rates between these two populations are significantly different, with 
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continued abstinence significantly greater among individuals with head and neck cancer. 
Therefore, if these different rates occur in this sample, we may compare the two populations, 
investigate differences, and apply the information gleaned to help all individuals in both 
groups to reduce smoking and improve health.  
 
Original Research Questions and Hypotheses 
 
Question 1: Are the cessation rates for cancer and for COPD significantly different? 
 
Hypothesis 1: Based on previous literature, cessation rates will be significantly different 
between the two populations.  
 
Question 2: Does medical severity predict smoking status above and beyond demographic 
variables? 
 
Hypothesis 2: After controlling for demographic variables, medical severity will predict 
whether a participant is a current smoker or former smoker. 
 
Question 3: Do smoking history variables predict smoking status above and beyond 
demographic variables and medical severity? 
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Hypothesis 3: After controlling for demographic variables and medical severity, smoking 
history variables (e.g., pack years and nicotine dependence) will predict smoking status. 
 
Question 4: Does alcohol use predict smoking status above and beyond demographic, 
medical severity, and smoking history variables? 
 
Hypothesis 4: Alcohol use (e.g., number of alcoholic beverages per week) will predict 
smoking status above and beyond demographic, medical severity, and smoking history 
variables. 
 
Question 5: Does mood predict whether a participant is a smoker or former smoker?  
 
Hypothesis 5: After controlling for demographic variables, medical severity, smoking history 
variables, and alcohol variables, depressive and anger symptoms will predict the probability 
of being a current smoker or former smoker. 
 
Question 6: Does problem solving predict whether a participant is a current smoker or 
former smoker?  
Hypothesis 6: After controlling for demographic variables, medical severity, smoking history 
variables, alcohol variables, and mood variables, problem-solving ability will predict the 
probability of being a current smoker or former smoker. 
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Rationale for Revising Research Questions and Hypotheses 
 
 Due to the small sample size of each group, there was not enough power to conduct 
two separate logistic regressions. Therefore, the two medical populations were combined in 
order to increase the sample size, and therefore the power, of the logistic regression analysis. 
The prognostic indicator (i.e., severity ratings) for the two populations differ, and cannot be 
collapsed into one measure of severity for both COPD and head and neck cancer. 
Therefore, medical severity was eliminated as a predictor variable. Limitations regarding this 
elimination will be discussed in the Limitations section. However, diagnosis as a dichotomous 
variable was added as a predictor into the logistic regression analysis so as to account for 
any differences between current smokers and former smokers due to medical diagnosis.  
 
 
 
 
 
 
Revised Research Questions and Hypotheses  
 
Research questions # 1 remains the same. 
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Question 1: Are the cessation rates for cancer and for COPD significantly different? 
 
Hypothesis 1: Based on previous literature, cessation rates will be significantly different 
between the two populations.  
 
Research question #2 changes from medical severity to medical diagnosis.  
 
Question 2: Does medical diagnosis predict smoking status above and beyond demographic 
variables? 
 
Hypothesis 2: After controlling for demographic variables, medical severity will predict 
whether a participant is a current smoker or former smoker. 
 
Research questions #3 through #6 are essentially the same except that we are controlling for 
medical diagnosis rather than medical severity.  
 
Question 3: Do smoking history variables predict smoking status above and beyond 
demographic variables and diagnosis?  
Hypothesis 3: After controlling for demographic variables and diagnosis, smoking history 
variables (e.g., pack years and nicotine dependence) will predict smoking status. 
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Question 4: Does alcohol use predict smoking status above and beyond demographic, 
diagnostic, and smoking history variables? 
 
Hypothesis 4: Alcohol use (e.g., number of alcoholic beverages per week) will predict 
smoking status above and beyond demographic, diagnosis, and smoking history variables. 
 
Question 5: Does mood predict whether a participant is a smoker or former smoker?  
 
Hypothesis 5: After controlling for demographic variables, diagnosis, smoking history 
variables, and alcohol variables, depressive and anger symptoms will predict the probability 
of being a current smoker or former smoker. 
 
Question 6: Does problem solving predict whether a participant is a current smoker or 
former smoker? 
 
Hypothesis 6: After controlling for demographic variables, diagnosis, smoking history 
variables, alcohol variables, and mood variables, problem-solving ability will predict the 
probability of being a current smoker or former smoker. 
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CHAPTER 11: MATERIALS AND METHODS 
 
Participants 
 
 Participants with COPD were recruited from two urban, outpatient clinics, at  MCP 
Hahnemann University and Temple University Hospital Lung Center. Participants with head 
and neck cancer were recruited from two, urban, outpatient physician’s offices, also at MCP 
Hahnemann University and Temple University Hospital.  Inclusion criteria included: 1) a 
diagnosis of either COPD or head and neck cancer, 2) existence of a smoking history, past 
or present, and 3) between the ages of 25 to 80. This age range was chosen based on ages 
accepted in prior studies investigating head and neck cancer and COPD. Furthermore, 
although the average age in prior studies has been approximately 50 years of age, the range 
has varied. Cancer studies show up to 25% of the population being greater than or equal to 
70 years of age. COPD studies have accepted individuals up to 80 years of age. Exclusion 
criteria included any known history of mental illness including bipolar disorder, psychosis 
and/or mental retardation. 
  One-hundred and three out of the 624 patients approached participated in this study. 
Reasons for not participating in the study are listed in Table 2.  
One-hundred and three participants completed and returned all questionnaires. 
Three follow-up attempts were made for each participant. The 76 participants who 
completed the follow-up were classified into the same smoking category as they were 
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classified at initial participation. Twenty-seven of the 103 participants could not be reached 
for the 3-month follow-up, and were therefore classified into the same smoking status in 
which they had been classified upon their initial participation. More specifically, 8 had 
telephone numbers which were disconnected, 14 did not answer their telephone, 4 were 
deceased, and 1 refused to participate in the follow-up assessment. Ten of these individuals 
were classified as current smokers at initial participation. Their smoking rate ranged from 1 
cigarette per week to 10 cigarettes per day. Seventeen of the individuals were classified as 
former smokers at initial participation, and the amount of time since quit date ranged from 1 
month to 22 years. Furthermore, 4 of these individuals had quit within the past year. 
Ultimately, because not every participant was reached for their 3-month follow-up, reliability 
of classification is diminished. It is possible that the individuals who were not reached might 
have changed their smoking habits (i.e., current smokers at initial participation might have 
quit smoking and former smokers at initial participation might have picked up smoking).  
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Table 2. Reasons for not participating 
Reason Head and Neck 
Cancer 
COPD Combined 
Declined 43 3 46 
Never smoked 60 1 61 
Quit before diagnosis 70 13 83 
Younger than 25 y.o. 7 4 11 
Older than 80 y.o. 35 4 39 
Not diagnosed with cancer 207 N/A 207 
Not diagnosed with COPD N/A 58 58 
Non-English speaking 5 1 6 
Non-smoking-related malignancy 9 N/A 9 
Post lung transplant N/A 1 1 
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Materials 
  
Demographic and smoking history information. 
 
 The demographic questionnaire (See Appendix A) was developed and based on a 
demographic questionnaire used in the Genesis Cancer Coping Project. Demographic 
information was obtained using a semi-structured interview. 
Smoking history variables are found in the Demographic Questionnaire, and were 
also obtained using a semi-structured interview. The smoking history variables include 
measures that have been found, at least in some studies, to predict smoking cessation in the 
past. Smoking variables that were examined and entered into the logistic regression include 
1) pack years and 2) a measure of nicotine dependence (“how soon after you wake up do 
you smoke your first cigarette”). Additional information regarding the participants’ smoking 
habits was explored for informational purposes only, and not for inclusion in the regression 
equation. Some of the smoking habit questions were adapted from the Mayo Foundation 
Nicotine Dependence Center Patient Questionnaire (Mayo Foundation, 1993), while others 
were adapted from previous research. For instance, nicotine, which is contained in all 
tobacco products, is considered an addictive substance, and therefore, common withdrawal 
symptoms which have been well documented, were assessed, including craving, difficulty 
concentrating, increased appetite, insomnia, irritability, restlessness, and decreased heart rate 
(Greden & Pomerlau, 1995; Lillington, Leonard, & Sachs, 2000). While degree of nicotine 
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is not being assessed per se, one variable which is assessed here, and which has been shown 
to correlate with nicotine dependency, is time to first cigarette after awakening in the morning 
(Gritz et al., 1993; Lillington et al., 2000,  
p. 202).  
 A measure of alcohol use was assessed based on a study conducted by Murray et 
al. (1995), which asked the following two questions: 1) how many days per week, on 
average, do you drink alcoholic beverages, and 2) on the days you drink alcohol, how many 
drinks, on average, do you have? Number of drinks per day multiplied by number of days 
per week was computed to provide the average number of drinks consumed per week.  
 Risk perception was measured by the question “Do you believe quitting smoking 
would be beneficial to your health” (for current smokers) and “Do you think quitting smoking 
was beneficial to your health” (for former smokers). Previous studies investigating knowledge 
of risk have also used single items to assess this variable (Brownson et al., 1992; Lee, 1989; 
Strecher et al., 1995).  
 
Social problem solving information. 
 
Problem solving was measured using the Social Problem-Solving Inventory - 
Revised (SPSI-R; D’Zurilla, Nezu & Maydeu-Olivares, 2002). The SPSI-R is a 52-item 
self-report measuring social problem-solving ability based on several problem-solving 
components: problem orientation, problem definition and formulation, generation of 
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alternatives, decision-making, and solution implementation and verification (see Appendix B). 
The five scales which reflect these components are Negative Problem Orientation, Positive 
Problem Orientation, Rational Problem Solving, Impulsivity/Carelessness Style and 
Avoidance Style. Each item on the scale depicts a positive or negative cognitive, affective, or 
behavioral response to a problem situation and is rated by the patient from 0 (not at all true 
of me) to 4 (extremely true of me). Negative Problem Orientation is “a general set that 
influences a person to view problems as threats, expect problems to be unsolvable, [and to] 
doubt one’s own ability to solve problems successfully” (Nezu, Nezu, Houts, Friedman, & 
Faddis, 1999, p. 16). Positive Problem Orientation is “a general set that leads a person to 
appraise problems as challenges, have the optimistic belief that problems are solvable [and] 
perceive one’s own ability to solve problems as high” (Nezu, Nezu, Houts, Friedman, & 
Faddis, 1999, p. 16). Rational Problem-Solving is a “rational, systematic, and skillful 
application of various effective problem-solving strategies”(Nezu, Nezu, Houts, Friedman, & 
Faddis, 1999, p. 16) such as components of problem definition, generation of alternatives 
and decision making. Impulsivity/Carelessness Style is “a generalized problem-solving style 
characterized by impulsive, hurried, and careless attempts to solve problems” (Nezu, Nezu, 
Houts, Friedman, & Faddis, 1999, p. 16). Avoidance Style is “a second maladaptive 
problem-solving style characterized by procrastination, passivity, and dependency” (Nezu, 
Nezu, Houts, Friedman, & Faddis, 1999, p.16). The measure is found to have good test-
retest reliability for all five scales and the total scale, with Cronbach’s alpha ranging from .72 
to .91, good internal consistency, with Cronbach’s alpha ranging from .69 - .95, and good 
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concurrent validity as compared with the Means-Ends Problem-Solving Procedure 
(D’Zurilla & Nezu, 1990). 
 
Mood information. 
 
Depression and anger were measured using the Profile of Mood States (POMS; 
McNair, Lorr, & Droppleman, 1992). The POMS (See Appendix C) is a 65-item self-
report in which individuals are asked to indicate how various feelings describe them over the 
past week, ranging from 0 (not at all) to 4 (extremely). The POMS is comprised of six 
categories of mood states, including Anger-Hostility, Confusion-Bewilderment, Depression-
Dejection, Fatigue-Inertia, Tension-Anxiety, and Vigor-Activity. The two scales which were 
analyzed in the present study were the Depression-Dejection and Anger-Hostility subscales, 
which contain 15 and 12 items, respectively. The POMS has an internal consistency of .95 in 
two separate studies, and has been used in a wide variety of research studies (Nezu, Nezu, 
McClure, & Zwick, 2002). The POMS is a widely used measure of negative affect in 
smoking cessation studies (Gilbert et al., 1997).  
 
 
 
 
Patient diagnostic information. 
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 Medical information such as diagnosis, disease severity, and treatment, were 
obtained from each patient’s medical chart and recorded in the Patient Diagnostic Form (see 
Appendix D).  
 
Procedure 
 
 Participants were recruited from the physician’s waiting room by either the author of 
this study or by a doctoral candidate in clinical psychology. The doctoral candidate worked 
in the same research lab that the author had worked in, was familiar with the SPSI-R, and 
had collected data for other studies, including clinical outcome studies. In addition, the author 
trained the doctoral candidate in data collection procedures particular to this study and 
reviewed all measures, including all questions on the Demographic Form, in order to increase 
reliability and to reduce stylistic differences. First, the doctoral candidate observed the author 
accrue participants and collect data. Second, the author observed the doctoral candidate 
accrue participants and collect data. An administrator at each site provided the data collector 
with a list of individuals who met medical diagnostic criteria. The data collector approached 
potential participants, described the study, and asked the person to volunteer. Persons 
interested in volunteering read and signed the Informed Consent (see Appendix E and 
Appendix F). Individuals who signed the Informed Consent then participated in a semi-
structured interview (the Demographic Form) and completed two self-reports (the SPSI-R 
   99 
and the POMS). The semi-structured interview and completion of the self-reports took 
place in a private room at the physician’s office. Participants were encouraged to complete 
the interview and self-report measures while waiting for their appointment. In order to ensure 
anonymity and confidentiality, all participants were assigned a number, known only to the PI, 
and only this number appeared on the questionnaires. In addition, confidentiality of responses 
was verbally emphasized immediately prior to the interview. Medical information such as 
diagnosis, disease severity, and treatment, were obtained from the participants’ medical 
charts and recorded in the Patient Diagnostic Form.  Finally, a three-month follow-up was 
conducted. Participants were contacted by telephone three months after their initial 
participation and asked about their smoking status and habits. This information was recorded 
on the Three-Month Follow-Up Form (see Appendix F).  
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CHAPTER 12: ANALYTIC APPROACH 
  
The overall goal of this research was to investigate predictors of smoking behavior in 
people with head and neck cancer or COPD. Research to date suggests that demographic, 
smoking, and alcohol variables predict smoking behavior (e.g., smoking cessation) in the 
general population. This study looks at 1) whether these variables predict smoking behavior 
upon a diagnosis of either head and neck cancer or COPD, 2) whether mood (e.g., 
depression, anger) can predict smoking behavior above and beyond demographic, smoking 
and alcohol variables in these two populations, and 3) whether problem-solving skills can 
predict smoking behavior above and beyond the aforementioned variables in these two 
populations. 
 To address these research questions, a logistic regression model was developed to 
investigate potential demographic, diagnostic, smoking history, alcohol use, and psychosocial 
predictors of continued smoking in patients with head and neck cancer and COPD. First, 
bivariate relationships were tested between all independent (predictor) variables and 
measures of smoking status. The bivariate correlations are presented in Table 3. Next, the 
set of predictors were included in a hierarchical logistic regression, with stepwise method of 
variable entry within the demographic variables block, which contained multiple variables. 
Each block represented a group of related variables. The blocks were entered in the 
following order: demographic variables, diagnostic variable, smoking variables, alcohol 
variable, mood variables, and problem-solving variable. Any variable which had too much 
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missing data or lacked variability in distribution was  dropped from the analysis. A list of 
variables investigated is presented in Table 4.   
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Table 3. Pearson correlations between predictor variables and outcome variable 
Pearson Correlations Smoking Status 
Gender -.003 
Age  .002 
Educational attainment -.015 
Employment status -.004 
Married or living with a significant other -.009 
Single  .248* 
Separated, divorce, or widowed  .233* 
Employed  .065 
Retired -.110 
Disability  .056 
Ethnicity (white/non-white)  .078 
Diagnosis -.072 
Pack years  .082 
Nicotine dependence  .138 
Age smoked first cigarette  .030 
Has tried to cut down smoking -.208* 
Longest time ever stopped smoking -.573** 
Alcohol use . 235* 
POMS Depression -.071 
POMS Anger  .037 
SPSI Total  -.014 
* Correlation is significant at the 0.05 level (2-tailed). ** Correlation is significant at the 0.01 
level.  
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Table 4. List of predictor variables examined 
Category Variable 
Demographic  Age 
 Gender 
 Ethnicity 
 Employment status 
 Marital status 
 Years of education 
 Income a 
  
Diagnostic COPD or head and neck cancer 
  
Smoking variables  Pack years b 
 Nicotine dependence c 
  
Alcohol use Number of alcoholic beverages consumed per 
week 
  
Mood POMS depression/dejection scale 
 POMS anger/hostility scale 
  
Problem solving SPSI-R total score 
  
a excluded from logistic regression analysis due to missing data. b pack years equals number 
of packs smoked per day times number of years smoked. c nicotine dependence was 
measured by the question “how soon after you wake up do you smoke your first cigarette?” 
This variable was entered as a dichotomous variable (e.g., < 30 min and 30 min or greater.  
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CHAPTER 13: RESULTS 
 
Descriptive Data According to Medical Diagnosis 
 
Demographics. 
 
 Fifty-four patients with COPD and 49 patients with head and neck cancer 
participated in the study, resulting in a total of 103 participants. The sample was evenly 
divided between males and females. 58.3% were Caucasian, 39.8% were African 
American, and 1.9% were Hispanic. Over one half of the participants were either married or 
living with a significant other. Seventy-four percent of the sample were either retired or on 
disability. Overall, the COPD and head and neck cancer groups did not significantly differ on 
highest degree attained, gender, or marital status.  There was a significant difference between 
the COPD and head and neck cancer groups on age (t(101) = 2.239; p=.027), ethnicity (c2 
(1) = 11.446; p=.001) and income (c2 (4) = 13.902, p=.008). Individuals with COPD 
tended to be older. A majority of the head and neck cancer population tended to be 
Caucasian, whereas the COPD population was more evenly distributed between Caucasians 
and African-Americans. Data on these demographic variables is presented in Tables 5 and 
6.  
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Table 5. Means, standard deviations and medians for demographic data according to 
diagnosis 
 
Variable COPD  Head and Neck Cancer 
 M (SD) Mdn  M (SD) Mdn 
      
Age a 54 (9.52) 64.0  49 (9.11) 58.0 
      
Average number of  
years of education 
12.19 (2.79) 12.0  12.94 (2.61) 12.0 
      
a significant difference between groups 
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Table 6. Frequencies and percents for demographic data according to diagnosis 
 
Variable COPD  HNC 
 Frequency Percent  Frequency Percent 
      
Ethnicity a      
     African-American 30 55.6  11 22.4 
     Caucasian 23 42.6  37 78.5 
     Hispanic 1 1.9  1 2.0 
      
Gender      
     Female 30 63  14 28.6 
     Male 24 44.4  29 59.2 
      
Income a      
     $0 - $24,000 34 63  14 28.6 
     $25,000 - $49,999 13 24.1  9 18.4 
     $50,000 - $74,000 2 3.7  8 16.3 
     $75,000 - $99,000 0 0  3 6.1 
     $100,000 and up 5 9.3  2 4.1 
     Refused to disclose 1 1.9  13 26.5 
      
Living status      
     Single 6 11.1  5 10.2 
     Living with sig. Other 1 1.9  3 6.1 
     Married 22 40.7  28 57.1 
     Separated 2 3.7  2 4.1 
     Divorced 10 18.5  8 16.3 
     Widowed 13 24.1  3 6.1 
      
Employment status      
     Employed 11 20.4  17 34.7 
     Retired 24 44.4  20 40.8 
     Disability 19 44.2  12 24.5 
      
a significant difference between groups 
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Medical variables. 
 
A majority of the participants with head and neck cancer had cancer of the oral 
cavity, pharynx, or larynx (see Table 7). The severity of illness at which people with head 
and neck cancer were diagnosed was approximately equal  across TNM stages (see Table 
8). Over 90% of patients had undergone surgery and over 70% had received radiation 
treatment. 
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Table 7. Participants with head and neck cancer broken down by primary site 
Cancer Diagnosis N Percent 
Oral Cavity 17 34.7 
   
Pharynx 15 30.6 
   
Larynx 9 18.4 
   
Maxillary Sinus 2 4.1 
   
Salivary Glands 3 6.1 
   
Larynx and Pharynx 2 4.1 
   
Unknown Primary 1 2.0 
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Table 8. Participants with head and neck cancer broken down by TNM stage at diagnosis 
 
TNM Stage N Percent 
Stage I 11 22.4 
   
Stage II 10 20.4 
   
Stage III 12 24.5 
   
Stage IV 13 26.5 
   
Not in medical chart 3   6.1 
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Among the participants with COPD, severity of illness was evenly distributed (see 
Table 9). Individuals with COPD took an average of 4 medications per day to specifically 
treat their pulmonary disease.  
 
 
 
Table 9. Participants with COPD broken down by FEV1% predicted 
FEV1% Predicted N Percent 
50 – 70 18 33.0 
   
35-49 20 37.0 
   
< 35 16 29.9 
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Smoking variables. 
 
The majority of participants in each diagnostic group had stopped smoking. In this 
sample, 31.5% of COPD participants and 26.5% of participants with head and neck cancer 
continue to smoke cigarettes, with the remaining in each group consisting of former smokers 
(see Table 10). 
 
 
 
Table 10. Smoking status according to diagnosis 
Smoking Status  COPD Head and Neck 
Cancer 
Total 
  Frequency 
(Percent) 
Frequency 
(Percent) 
Frequency 
(Percent) 
     
Current 
Smoker 
 17 (31.5) 13 (26.5) 30 (29.1) 
      
Former 
Smoker 
 37 (68.5) 36 (73.5) 73 (70.9) 
     
Total  54 (100.0) 49 (100.0) 103 (100.0) 
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While there were no significant differences between the COPD and head and neck 
cancer groups along a majority of smoking variables, several variables did yield significant 
differences. Individuals with COPD were more likely than individuals with head and neck 
cancer to smoke in the presence of their children (c2 (1) = 4.255, df=1; p=.039). 
Significantly more individuals with COPD than head and neck cancer reported experiencing 
withdrawal symptoms such as craving (c2 (2) 6.348; p=.042) and increased eating (c2 (4) 
12.384; p=.015). More individuals with COPD than head and neck cancer reported having 
tried to cut down their cigarette consumption in the past (c2 (1) 4.669; p=.031), or had 
attempted to stop smoking (c2 (2) 5.616; p=.060). In addition, significantly more individuals 
in the COPD group had tried various quit methods such as support groups (c2 (1)= 3.376; 
p=.066), nicotine gum (c2 (1) 3.073; p=.080), and bupropion (c2 (1) 10.619; p=.001). 
Means, standard deviations, and medians for smoking variables are presented in Table 11. 
Frequencies and percents for smoking variables are presented in Table 12. 
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Table 11. Means, standard deviations, and medians for smoking variables by diagnosis 
Variable COPD HNC 
 M (SD) Mdn M (SD) Mdn 
Age of first cigarette 14.3 (3.7) 14.5 14.6 (4.3) 14.0 
     
Age of regular daily 
cigarette smoking 
17.0 (3.8) 16.0 18.2 (5.5) 18.0 
     
Average number of cpd 
at diagnosis 
26.1 (14.2) 20.0 24.7 (13.6) 20.0 
     
Average number of cpd, 
current 
4.09 (8.9) .00 2.6 (7.4) .00 
     
Average number of cpd, 
past 6 months 
4.24 (8.82) .00 2.84 (7.59) .00 
     
Average cpd when 
smoking was the heaviest 
34.3 (15.4) 30.0 34.0 (14.7) 30.0 
     
Average cpd over 
lifetime 
25.2 (11.5) 20.0 23.7 (11.1) 20.0 
     
Average cpd at time of 
quit 
20.6 (13.3)  21.1 (12.5)  
     
Pack years 53.1 (27.6) 46.5 46.6 (31.0) 37.0 
     
Number times stopped 
smoking for at least 1 
day 
8.9 (16.5) 3.0 5.2 (7.9) 2.5 
     
Number of alcoholic 
beverages/week 
1.70 (3.56) .00 4.80 (9.15) .00 
     
Number of other 
smokers in the household 
.5 (.6) .00 .8 (2.9) .00 
     
Note. cpd = cigarettes per day. 
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Table 12. Frequencies and percents of smoking variables according to diagnosis 
 
Variable COPD HNC 
 Frequency Percent Frequency Percent 
     
Participants that have 
attempted to cut down 
smoking 
52 96.3 41 83.7 
     
Participants that have 
attempted to stop 
smoking 
53 98.1 43 87.8 
     
Participants who 
experienced withdrawal 
symptoms 
    
     
     Anxiety 25 46.3 21 42.9 
     
     Craving*  37 68.5 25 51.0 
     
     Restlessness 24 44.4 21 42.9 
     
     Increased eating 35 64.8 19 38.8 
     
     Difficulty    
     concentrating 
10 18.5 11 22.4 
     
     Increased  
     irritability 
25 46.3 21 42.9 
     
Participants who have 
used other tobacco 
products 
    
     
     Snuff 0 0 0 0 
     
     Chewing tobacco 0 0 1 2.0 
     
     Cigars 8 14.8 12 24.5 
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     Pipe 9 16.7 11 22.4 
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Table 12 (continued) 
 
Variable COPD HNC 
 Frequency Percent Frequency Percent 
Participants who used 
the following quit 
methods 
    
     “Cold turkey” 43 79.6 44 89.8 
     
     Support group*  8 14.8 2 4.1 
     
     Nicotine gum* 14 25.9 6 12.2 
     
     Bupropion* 13 24.1 1 2.0 
     
     Nicotine patch 20 37.0 8 16.3 
     
Cigarette participants 
found most difficult to 
give up: 
    
     
     First cigarette of  
     the Morning 
20 37.0 12 24.5 
     
     After meals 14 25.9 13 26.5 
     
     During or after  
     stressful situations 
11 20.4 12 24.5 
     
     During social  
     occasions   
8 14.8 9 18.4 
     
     Could not choose 1 1.9 3 6.1 
     
How soon participants 
smoke upon awakening: 
    
     
     Within 30 minutes 41 75.9 35 71.4 
     
     Greater than 30  
     Minutes  
13 24.1 14 26.6 
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* p < .05 
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Psychosocial variables. 
 
 There were no significant differences between the COPD and head and neck cancer 
groups on measures of anger or problem-solving skills. There was also no significant 
difference between the groups along the subscale measures of problem solving. However, 
individuals in the COPD group reported more symptoms of depression according to the 
POMS as compared to individuals in the head and neck cancer group 
(t (101) = 3.099; p=.002). Means, standard deviations, and medians for these variables are 
reported in Table 13. 
 
 
 
Table 13. Means, standard deviations, and medians for psychosocial variables by diagnosis 
 
Variable COPD HNC 
 
 M (SD) Mdn M (SD) Mdn 
POMS Anger 8.3 (1.2) 5.5 6.2 (6.3) 5.0 
     
POMS 
Depression 
13.0 (11.9) 11.0 8.7 (9.0) 5.0 
     
POMS Total 40.6 (39.6) 35.0 19.1 (29.3) 16.0 
     
SPSI Total 13.7 (3.2) 14.0 13.9 (3.2) 14.4 
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Descriptive Data According to Smoking Status 
 
Demographic variables. 
 
 There was a total of 30 current smokers and 73 former smokers across both 
medical populations. There were no significant differences between the groups on age, 
ethnicity, gender, income or occupation. The difference between groups on educational 
attainment approached significance (c2 (5) = 9.654; p=.086). There was a significant 
differences between groups on marital status (c2 = 7.109; p=.029). Former smokers tended 
to be married whereas current smokers tended to be separated, divorced or widowed. 
Moreover, individuals who were separated, divorced, or widowed were approximately 5 
times as likely to be a current smoker as compared to individuals who were married or living 
with a significant other.  
 
Medical variables. 
 
 As noted earlier, 31.5% of COPD and 26.5% of head and neck cancer continue to 
smoke cigarettes, with the remaining in each group consisting of former smokers. No other 
medical variables, such as medical severity, could be utilized to directly compare groups 
because disease severity and types of treatment are different in these two populations.   
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Smoking variables. 
 
 As expected, there was a significant difference between groups on current smoking 
status (t(29) = 5.372; p=.000). Means, Standard deviations, and medians for smoking 
variables are presented in Table 14. Frequency and percents are presented in Table 15. 
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Table 14. Means, standard deviations, and medians for smoking history variables according 
to smoking status 
 
Variable Current Smoker Former Smoker 
 M (SD) Mdn M (SD) Mdn 
Age of first 
cigarette 
14.57 (3.47) 15.00 14.40 (4.13) 14.00 
     
Age of regular 
daily cigarette 
smoking 
17.60 (4.34) 16.00 17.58 (4.89) 17.00 
     
Average 
number of cpd 
at diagnosis 
26.80 (13.55) 25.00 24.88 (13.99) 20.00 
     
Average 
number of cpd, 
current 
11.57 (11.79) 8.00 --- --- 
     
Average 
number of cpd, 
past 6 months 
12.27 (11.36) 10.00 --- --- 
     
Average cpd 
when smoking 
was the 
heaviest 
36.00 (14.35) 35.00 33.38 (15.31) 30.00 
     
Average cpd 
over lifetime 
24.90 (10.17) 20.00 24.34 (11.81) 20.00 
     
Average cpd at 
time of quit 
--- --- 20.88 (12.86) 20.00 
     
Pack years 54.11 (25.49) 46.00 48.27 (30.73) 43.00 
     
Number times 
stopped 
smoking for at 
least 1 day 
9.28 (19.77) 4.00 6.24 (9.27) 2.00 
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Table 14 (continued)   
 
Variable Current Smoker Former Smoker 
 M (SD) Mdn M (SD) Mdn 
Number of 
alcoholic 
beverages/week 
5.60 (10.75) .00 2.18 .00 
Number of other 
smokers in the 
household 
1.03 (3.62) .00 .48 (.69) .00 
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Table 15. Frequencies and percents for smoking history variables according to smoking 
status 
 
Variable Current Smoker Former Smoker 
 Frequency Percent Frequency Percent 
     
Participants that have 
attempted to cut down 
smoking in the past 
30 100 63 93.2 
     
Participants that have 
attempted to stop 
smoking in the past 
28 93.3 68 93.2 
     
Participants who 
experienced withdrawal 
symptoms 
    
     
     Anxiety 14 46.7 32 43.8 
     
     Craving* 16 53.3 46 63.0 
     
     Restlessness 15 50.0 30 41.1 
     
     Increased eating 13 43.3 41 56.2 
     
     Difficulty  
     concentrating 
5 16.7 6 8.2 
     
     Increased    
     irritability 
17 56.7 29 39.7 
     
Participants who have 
used other tobacco 
products 
    
     
     Snuff 0 0 0 0 
     
     Chewing tobacco 0 0 1 1.4 
     
     Cigars 10 33.3 11 15.1 
   126 
     
     Pipe 8 26.7 12 16.4 
Table 15 (continued)   
 
Variable Current Smoker Former Smoker 
 Frequency Percent Frequency Percent 
Participants who used 
the following quit 
methods 
    
     
     “Cold turkey” 21 70 66 90.4 
     
     Support group* 4 13.3 6 8.2 
     
     Nicotine gum* 8 26.7 12 16.4 
     
     Bupropion* 6 20.0 8 11.0 
     
     Nicotine patch 9 30.0 19 26.0 
     
Cigarette participants 
found most difficult to 
give up: 
    
     
     First cigarette of  
     the morning 
7 23.3 25 34.2 
     
     After meals 8 26.7 19 26.0 
     
     During or after  
     stressful situations 
9 30.0 14 19.2 
     
     During social  
     occasions   
6 20.0 11 15.1 
     
     Could not choose 0 .00 4 5.5 
     
How soon participants 
smoke upon 
awakening: 
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     Within 30 minutes 20 66.7 56 76.7 
     
     Greater than 30  
     Minutes 
10 33.3 17 23.3 
Table 15 (continued)   
 
Variable Current Smoker Former Smoker 
 Frequency Percent Frequency Percent 
When do you/did you 
smoke the heaviest 
    
     Mornings 10 33.3 8 11.0 
     
     Afternoons 2 6.7 13 17.8 
     
     Evenings 14 46.7 37 50.7 
     
     Throughout the  
     day 
4 5.5 15 20.5 
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Significantly more former smokers than current smokers had tried to cut down or 
limit their smoking in the past (c2(1) = 4.551; p=.033). Significantly more former smokers 
reported smoking in their car when non-smokers were with them (c2(1) = 8.320; p=.004) 
and were more likely to smoke in other peoples’ cars (c2(1) = 3.959; p=.047). Significantly 
more former smokers had smoked in the presence of their children than current smokers 
(c2(1) = 5.652; p=.017). In terms of quitting techniques, significantly more former smokers 
had attempted to quit “cold turkey” (c2(1) = 6.751; p=.009). Otherwise, there were no 
significant differences between these groups on quitting variables. There were no significant 
differences with respect to withdrawal symptoms. There was a significant difference between 
groups in terms of when former smokers and current smokers smoked the heaviest (c2(3) = 
8.572; p=.036). More specifically, former smokers tended to have smoked the heaviest in 
the evenings. There was a significant difference between the two groups based on the longest 
ever stopped smoking (c2(4) = 34.796; p=.000) whereby a majority of former smokers had 
a quit attempt greater than one year. Former smokers were more likely to have smoked in 
other people’s homes (c2(1) = 5.988; p=.014) as well as in public (c2(1) = 8.842; 
p=.003), in restaurants (c2(1) = 23.499; p=.000), and at work (c2(1) = 5.411; p=.020). 
Most former smokers had smoked in public and in restaurants, whereas approximately half 
of current smokers smoke in restaurants.  
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Psychosocial variables. 
 
 There were no significant differences between former smokers and current smokers 
on measures of depression, anger, and problem solving skills. Means, standard deviations, 
and medians for psychosocial variables according to smoking status are presented in Table 
16. 
 
 
 
Table 16. Means, standard deviations, and medians for psychosocial variables according to 
smoking status 
 
Variable Current Smoker Former Smoker 
 
 M (SD) Mdn M (SD) Mdn 
POMS Anger 7.83 (8.09) 9.50 7.10 (7.57) 5.00 
     
POMS 
Depression 
10.63 (10.92) 9.20 11.10 (10.81) 9.00 
     
POMS Total 30.80 (38.35) 18.50 30.22 (36.03) 24.00 
     
SPSI Total 13.43 (2.78) 14.02 13.76 (3.00) 14.42 
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Logistic Regression 
 
The results of the logistic regression are presented in Table 17. In the first step, 
demographic variables were entered. Using a stepwise method of entry, only marital status 
was significant and entered into the equation. Marital status significantly contributed to the 
equation, and accounted for 9.9% of the variance in smoking status. Demographic variables, 
as a whole, predicted smoking status.  
In the second step, diagnosis was the only variable entered. Diagnosis did not 
significantly add to the prediction of smoking status above and beyond demographic 
variables, and the overall model remained nonsignificant. Diagnosis did not raise the amount 
of variance accounted for in smoking status.  
In the third step, smoking variables were entered. Pack years and time to first 
cigarette in the morning (a measure of nicotine dependence) were entered into the equation. 
These variables did not significantly add to the prediction of smoking status, and the overall 
model remained nonsignificant. The smoking history variables raised the amount of variance 
accounted for to 12.3%. 
In the fourth step, the alcohol variable (number of alcoholic beverages consumed per 
week) was entered. Alcohol significantly contributed to the equation and increased the 
variance accounted for to 19.5%. 
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In the fifth step, both mood variables were entered. Neither depression nor anger 
were significant. The overall model remained significant, with 22.9% of the variance 
accounted for.  
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In the sixth and final step, problem solving was entered. This variable was not 
significant. The overall model remained significant. However, total variance accounted for did 
not increase, and remained at 22.9%.   
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Table 17. Variables entered in the stepwise logistic regression analysis for smoking status 
 
Variable Step 
c2   
Df Sig. Model c2 Df Sig. Nagelkerke 
R2 
Demographics 7.38 2 .03* 7.38 2 .03* .099 
        
Diagnosis .001 1 .97 7.38 3 .06 .099 
        
Smoking 
history 
1.92 2 .38 9.30 5 .10 .123 
        
Alcohol 5.86 1 .02* 15.16 6 .02* .195 
        
Mood 2.85 2 .24 18.01 8 .02* .229 
        
Problem 
solving 
.019 1 .89 18.03 9 .03* .229 
        
* p < .05 
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Next, independent variables that were specifically predictive of smoking status were 
examined. A list of variables included in the equation are presented in Table 18. In the final 
equation, only marital status and alcohol use were significant.  
 
 
 
Table 18. Variables in the equation 
a  married or living with significant other. b  single. c  separated, divorced, or widowed 
p < .05 
Variable B S.E. Wald df Sig. R Exp(B) 95.0% C.I. for Exp(B) 
 
        Lower Upper 
Marital Status 
a 
  8.466 2 .015 .205    
  Marital b -.004 .999 .0000 1 .996 .000 .996 .140 7.061 
  Marital c 1.607 .569 7.986 1 .005 .237 4.987 1.636 15.198 
          
Diagnosis -.242 .518 .217 1 .641 .000 .786 .285 2.168 
          
Pack years .009 .009 1.002 1 .317 .000 1.009 .992 1.026 
          
Time to first 
cigarette in the 
morning 
-.358 .562 .405 1 .524 .000 .699 .232 2.105 
          
ETOH .085 .042 4.162 1 .041 .143 1.088 1.003 1.180 
          
POMS Depr -.059 .034 2.089 1 .148 -.029 .952 .890 1.018 
          
POMS Ang .0680 .045 2.281 1 .131 .051 1.070 .980 1.169 
          
SPSI Total .0128 .093 .019 1 .891 .000 1.013 .844 1.215 
          
Constant -1.850 1.929 .920 1 .338     
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This model is only moderately predictive of smoking status (R2 = 22.9%). Although 
the model correctly classifies 78% of the cases (see Table 19), this is only slightly higher than 
the base rate classification of 72% (i.e., if nothing was known about the patient, he or she 
would be classified into the larger category of former smokers).  
 
 
 
Table 19. Classification table for model 
Observed Predicted  Percentage Correct 
 Former Smoker Current Smoker  
Former Smoker 70 3 95.89 
    
Current Smoker 19 11 36.67 
    
Overall Percentage   78.64 
    
Note. The cut value is .500 
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Multicollinearity 
 
 Independent variables were investigated for multicollinearity. The only two predictor 
variables which were found to highly correlate were POMS depression and POMS anger (r 
(n-1) = .89). This correlation was expected, and neither variable was removed from the 
analysis because both variables are directly related to the hypotheses.    
 
Residual Analysis 
 
 A residual analysis was conducted on the logistic model in order to identify potential 
outliers or unusual data points (i.e., cases) in this sample. Using several measures, including 
Cook’s distance, Leverage point, standardized residual (Z-score), and DFBETA, one case 
was high on more than one indicator, and was found to have significant influence on the 
regression equation. Briefly, the standardized residual identifies outliers that are not 
represented by the regression equation; an “observation is termed a leverage point if it has 
substantial impact on the regression results due to its differences from other observations on 
one or more of the independent variables (Hair, Anderson, Tatham, & Black, 1995, p. 152); 
DFBETA is a “measure of the change in a regression coefficient when an observation is 
omitted from the regression analysis” (Hair et al., 1995, p. 151), and Cook’s distance is “a 
measure of the influence of a single case (observation) based on the total changes in all other 
residuals when the case is deleted from the estimation process” (Hair et al., 1995, p. 151). 
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This case had a standardized residual greater than 2.58, a leverage value out of range, a 
small DFBETA, Cook’s distance greater than 1, and high leverage point. When this case 
was reviewed, variable by variable, the case was an outlier on two important measures, the 
POMS depression and the POMS anger. When this case was removed from the logistic 
regression analysis, the results of the analysis changed.  
 
Logistic Regression with Outlier Removed 
 
 The results of the logistic regression when the outlier was removed are presented in 
Table 20.  
In the first step, demographic variables were entered. Similar to the initial analysis, 
only marital status was significant and entered into the equation. Marital status significantly 
contributed to the equation, and accounted for 8.9% of the variance in smoking status. 
Demographic variables, as a whole, did not predict smoking status.  
In the second step, diagnosis was entered. Similar to the initial analysis, diagnosis did 
not significantly add to the prediction of smoking status above and beyond demographic 
variables, and the overall model remained nonsignificant. Diagnosis did not raise the amount 
of variance accounted for in smoking status.  
In the third step, smoking variables were entered. Pack years and time to first 
cigarette in the morning (a measure of nicotine dependence) were entered into the equation. 
Similar to the initial model, these variables did not significantly add to the prediction of 
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smoking status, and the overall model remained nonsignificant. The smoking history variables 
raised the amount of variance accounted for to 10.8%. 
In the fourth step, the alcohol variable was entered. Alcohol significantly contributed 
to the equation and increased the variance accounted for to 18.9%. 
In the fifth step, both mood variables were entered. Taken together, depression and 
anger were not significant. The overall model remained significant, with 25.4% of the 
variance was accounted for.  
In the sixth and final step, problem-solving was entered. This variable was not 
significant. The overall model remained significant, and the total variance accounted for 
increased only slightly, to 25.7%.  
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Table 20. Variables entered in the stepwise logistic regression analysis for smoking status 
with outlier removed 
 
Variable Step c2   df Sig. Model c2 Df Sig. Nakelkerke R2 
Demographics 6.528 2 .0382    .089 
        
Diagnosis .019 1 .8902 6.547 3 .0878 .089 
        
Smoking 
history 
1.442 2 .4862 7.990 5 .1568 .108 
        
Alcohol 6.442 1 .0111 14.431 6 .0252 .189 
        
Mood 5.410 2 .0669 19.841 8 .0110 .254 
        
Problem 
solving 
.314 1 .5752 20.155 9 .0170 .257 
        
* p < .05 
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Next, independent variables that were specifically predictive of smoking status were 
examined. A list of variables included in the final equation is presented in Table 21. In the 
final equation, marital status, alcohol use, and depression were significant.  
 
 
 
Table 21. Variables in the equation 
Variable B S.E. Wald Df Sig. R Exp(B) 95.0% C.I. for 
Exp(B) 
 
        Lower Upper 
Marital 4 a   9.0010 2 .0111* .2215    
  Marital4 (1) b -.1161 1.0190 .0130 1 .9093 .0000 .8904 .1208 6.5614 
  Marital4 (2) c 1.7045 .5869 8.4347 1 .0037 .2512 5.4985 1.7405 17.3699 
          
Diagnosis -.4229 .5325 .6305 1 .4272 .0000 .6552 .2307 1.8606 
          
Pack years .0080 .0089 .8060 1 .3693 .0000 1.0080 .9906 1.0258 
          
Nicotine  
dependence d 
-.1249 .5867 .0453 1 .8314 .0000 .8826 .2795 2.7873 
          
ETOH .0919 .0431 4.5481 1 .0330* .1581 1.0963 1.0075 1.1929 
          
POMS Depr -.0831 .0419 3.9274 1 .0475* -.1375 .9203 .8477 .9991 
          
POMS Ang .0996 .0500 3.9645 1 .5774 .1388 1.1047 1.0016 1.2185 
          
SPSI Total .0544 .0976 .3104 1 .2502 .0000 1.0559 .8720 1.2786 
          
Constant -2.2929 1.9940 1.3224 1      
          
a  married or living with significant other. b  single. c  separated, divorced, or widowed. d 
measured by the question “how soon after you wake/woke up do/did you smoke your first 
cigarette?” 
* p < .05 
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While this model is only moderately predictive of smoking status (R2 = 25.7%), it is 
still useful as a method to classify patients into smoking status groups. The classification table 
(see Table 22) for the final model shows an overall correct classification of 80% of the 
cases. This is only slightly higher than the base-rate classification of 72% (i.e., if nothing was 
known about a patient, he or she would be classified into the larger category of former 
smokers). Moreover, 13 current smokers were correctly classified using the model, and 16 
current smokers were mis-classified as former smokers, producing a sensitivity rate of only 
44.83% to detect current smokers.  
 
 
 
Table 22. Classification table for final model 
Observed Predicted  Percentage 
Correct 
 Former Smoker Current Smoker  
Former Smoker 69 4 94.52 
    
Current Smoker 16 13 44.83 
    
Overall Percentage   80.39 
    
Note. The cut value is .500 
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Analysis of Response Operating Characteristics 
 
 Response operating characteristics (ROC) analysis is often used to improve 
classification. In the above model, the final classification rate is 80.4%, with slightly less than 
chance classification of current smokers (44.8%). As Table 22 reveals, 16 out of 29 
(55.2%) current smokers are misclassified as former smokers. This model assumes equal 
odds at baseline for being a current versus former smoker. However, since we know that at 
baseline the odds are more likely to be a  former smoker, the ROC analysis allows us to 
change the cut value accordingly and improve the sensitivity (correctly identifying current 
smokers; 44.8%) and specificity (correctly ruling out current smokers, or identifying former 
smokers; 94.5%). To change the cut point, a ROC analysis is conducted.   
 The first step in the ROC analysis is to examine the ROC curve (see Figure 1) and 
its coordinates, looking for a line where sensitivity and specificity are both high. The straight 
line represents a model in which the variables have no relationship to the outcome. Each 
point on the curved line represents a possible cut point. Horizontal lines along the curve 
represent cut points in which we can keep the sensitivity the same but improve specificity, 
and vertical lines represent cut points where we can keep specificity the same and improve 
sensitivity. One way to describe the curve is to present the area under the curve. An area 
under the curve of .5 would means that there is no ability to predict outcome whereas an 
area of 1.0 represents a model with perfect prediction. Thus, the farther away the curve is 
from the straight line, the stronger the model. The area under the curve for this model is 74.4.  
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Figure 1. Curve for response operating characteristics 
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The second step involves determining a cut-point by examining the table of possible 
cut-points that are represented by the curve. A list of some of the possible cut-points, along 
with their corresponding sensitivity and specificity, is presented in Table 23. A ROC analysis 
which increases the sensitivity of the model would yield a more clinically meaningful and 
useful model. A cut point which increases the sensitivity of the model without sacrificing too 
much specificity would be a cut point equal to .2803. This cut point yields a sensitivity of 
69% and a specificity of 71.2%. A ROC analysis using a cut point of .2803 rather than .500 
yields a new classification table (see Table 24). While the overall classification of the model 
reduces from 80% to 70%, sensitivity has significantly increased. In other words, the model 
allows us to correctly identify more current smokers and misclassify fewer current smokers.  
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Table 23. Coordinates of the ROC curve 
Cut point Sensitivity 1 – Specificity 
.0457 1.000 .973 
   
.0908 .966 .877 
   
.1359 .793 .671 
   
.1928 .793 .425 
   
.2146 .690 .425 
   
.2642 .690 .301 
   
.2803 .690 .288 
   
.5026 .448 .055 
   
.5446 .414 .000 
   
.8757 .034 .000 
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Table 24. Classification table for final model based on ROC analysis 
Observed Predicted  Percentage Correct 
 Former Smoker Current Smoker  
Former Smoker 52 21 71.23 
    
Current Smoker 9 20 68.97 
    
Overall Percentage   70.59 
    
Note. The cut value is .2803 
   149 
Secondary Analysis 
 
 As discussed earlier, one of the initial research questions included examining the role 
of medical severity in predicting smoking status within the COPD population as well as in the 
head and neck cancer population. In order to increase the power of the statistical analysis, 
the two medical populations were combined to increase the sample size. However, because 
severity ratings for these two populations differ, this predictor variable was eliminated from 
the statistical analysis. Therefore, a secondary, post-hoc-like analysis was conducted in 
order to examine the relationship between disease severity and smoking status within each 
group. In the head and neck cancer group, smoking status was not related to stage of cancer 
at initial diagnosis (c2(4) = 4.718; p = .317). Frequencies of current smokers and former 
smokers according to TNM stage in the head and neck cancer group is presented in Table 
25. In the COPD group, there was a significant difference between the current smokers and 
the former smokers across diagnostic groups (c2(2) = 9.579; p = .008). Frequencies of 
current smokers and former smokers according to medical severity in the COPD group are 
presented in Table 26. 
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Table 25. Frequencies of current smokers and former smokers in the head and neck cancer 
group according to TNM stage at initial diagnosis 
 
TNM Stage Current smokers Former smokers 
I 4 7 
   
II 4 6 
   
III 1 11 
   
IV 4 9 
   
 
 
 
 
Table 26. Frequencies of current smokers and former smokers in the COPD group 
according to FEV1%   
 
FEV1% predicted Current smokers Former smokers 
50-70 10 8 
   
35-49 6 14 
   
<35 1 15 
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CHAPTER 14: POWER ANALYSIS 
 
 Statistical power is defined as “the probability of correctly rejecting the null 
hypothesis when it should be rejected” (Hair et al., 1995, p. 10). Statistical power is a 
function of three variables: effect size, alpha, and sample size. Effect size is a theoretical 
construct, and is an “estimate of the degree to which the phenomenon being studied (e.g., 
correlation or difference in means) exists in the population” (Hair et al., 1995, p. 1). Alpha, 
also known as Type I error, is the “probability of rejecting the null hypothesis when the null 
hypothesis is actually true” (Hair et al., 1995, p. 10). In other words, alpha is a false positive. 
“Conventional guidelines suggest alpha levels of .05 or .01” (Hair et al., 1995, p. 11). As 
alpha decreases (i.e., becomes more conservative), power also decreases. Sample size is 
integral to statistical power because as the sample size decreases, the power to detect 
significant differences also decreases. A sample that is too small may miss significant findings, 
whereas when a sample is extremely large, the analysis can be oversensitive, finding any 
differences between groups to be significant.  
 In this study, a total of 103 participants were accrued whose data was analyzed. As 
discussed in the Rationale section, to date, there is minimal research investigating the 
psychosocial variables related to smoking behavior in these two medical populations. 
Therefore, this study, and the logistic regression analysis, are exploratory in nature. In order 
to build the logistic regression model, relationships between each independent variable and 
the outcome variable were investigated through bivariate correlations and t-tests. In order to 
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determine the power of the statistical analysis, a medium effect size was selected, since there 
is a dearth of literature from which to suggest otherwise. As is convention, alpha was set at 
.05. Assuming a medium effect size and an alpha equal to .05, this study needed 50 subjects 
per group to yield a 70% power for t-tests, and 30 subjects per group to yield a 90% power 
for bivariate correlations (Cohen, 1977). Therefore, there was sufficient power to detect 
relationships between each independent variable and the outcome variable, smoking status.   
 There is not enough information from prior studies to run a meaningful power analysis 
for a logistic regression for an exploratory study such as this one. By convention, a total of at 
least 100 participants is recommended for studies where multivariate techniques are used, as 
is approximately 20-40 subjects per independent variable in a regression analysis. Thus, 
given that nine independent variables were included in the final model, the lack of statistically 
significant findings may be due to a lack of power to detect differences.  This lack of power 
is a result of the relatively small sample size for the multivariate model, and may also be 
related to a smaller effect size than estimated in the power analysis. 
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CHAPTER 15: DISCUSSION 
 
The strength of this study lies in its examination of psychosocial predictors of 
smoking behavior in people diagnosed with either head and neck cancer or COPD. To date, 
there is very little research investigating the relationship between mood (specifically, 
depression and anger) and smoking behavior and problem-solving skills and smoking 
behavior, in these two medical populations. The goal of the present study was to examine 
whether depression, anger and problem-solving skills predict smoking status in a group of 
patients diagnosed with either head and neck cancer or COPD.  
In this study, 68.5% (37/54) of individuals with COPD and 73.5% (36/49) of 
individuals with head and neck cancer were classified as former smokers, and the difference 
in the quit rates between the two medical populations was nonsignificant. Contrary to 
expectation, diagnosis did not predict smoking behavior in these two medical populations. 
Epidemiologic research has reported that approximately 30% of individuals with COPD 
(Anthonisen et al., 1994; Green, 1995) and approximately 70% of individuals with head and 
neck cancer (Ostroff et al., 1995; Spitz et al., 1990) quit smoking upon a diagnosis. 
Therefore, while the cessation rates for the head and neck cancer group are consistent with 
previous findings, the cessation rate of the COPD group is substantially higher.  
There are several reasons why this study may have yielded a higher cessation rate in 
the COPD population than other studies of the COPD population. First, many of the COPD 
patients who participated in this study attend the Temple University Hospital Lung Center. 
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This center conducts a variety of treatment outcome studies with people with COPD, 
including lung volume reduction surgery and lung transplantation. Individuals with severe 
COPD are required to discontinue smoking tobacco in order to qualify for these treatments. 
Therefore, not only may these individuals have more motivation to quit, but they may also 
receive more advice and assistance from their pulmonary physician. Second, although 
confidentiality of the patient’s smoking status was emphasized, individuals who continue to 
smoke may still feel compelled to under-report their current smoking habits or misreport their 
current smoking status. Because biologic assays were not taken, there is no means by which 
to confirm the validity of the participants’ responses. Therefore, there may be a high rate of 
false negatives (e.g., current smokers who claim to have quit). Third, the sample size of this 
study is relatively small compared to large population studies, and therefore, may be too 
small to reflect epidemiological cessation rates. Fourth, a point prevalence measure of 
smoking status may not accurately reflect smoking status because of the limitations of this 
type of measurement. More specifically, smoking cigarettes is an ever-changing behavior. 
Often, individuals attempt to quit many times before being successful abstainers over the 
long-term. In fact, “most people who are attempting to quit smoking change their status more 
often than once a year” (Murray et al., 1998, p. 1324). Therefore, it is possible that patients 
have accurately reported their smoking status if they have temporarily stopped smoking 
cigarettes. Redefining the classification for diagnosis could potentially alter the results of the 
study. For instance, in this study, current smokers included only individuals who smoked 
cigarettes within the past 7 days. Redefining current smokers to include anyone who smoked 
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within the past month could yield different findings. This is unlikely, however, given the 
follow-up results. A follow-up interview over the telephone found that of the individuals 
reached for follow-up, 100% of participants remained in the same smoking status category 
as when they were recruited into the study. Finally, the higher cessation rates of this COPD 
population as compared to previous literature may be a reflection of selection bias. Current 
smokers may be more likely to decline participation in the study for fear that their physician 
will learn of their smoking behavior.  
Research investigating the relationship between demographic variables and smoking 
behavior in the general, COPD, and cancer populations has been mixed. The typical 
demographic variables that have been previously investigated include age, gender, marital 
status, and income. In this study, income was eliminated from the analysis due to insufficient 
data (i.e., many participants refused to report their income). Overall, in this sample, 
demographic variables, taken together, did not predict whether an individual continues to 
smoke or quits smoking upon a diagnosis. The only demographic variable found to be 
significantly predictive of smoking status was marital status.  Because research on 
demographic variables has resulted in varied results in the past, the results of this study 
neither confirm nor disconfirm previous findings. Given the age of the population ranged from 
41-80, with a mean age of 60, it would be highly unlikely for age to predict smoking status, 
as previous studies demonstrating an age difference have included samples with a much 
larger age range. The fact that marital status was found predictive of smoking status confirms 
previous studies investigating the role of social support. However, many of these studies have 
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focused on the relationship between smoking behavior and number of other smokers in the 
household (Matheny & Weatherman, 1998; McIntyre-Kingsolver, 1986). However, in this 
study, marital status and number of other smokers in the household was not correlated. 
Furthermore, the median number of other smokers in the household was zero.  
This study found that neither pack years nor nicotine dependence improved 
prediction of smoking status. This finding was unexpected, as several studies have found that 
amount smoked (Gritz, 1993; Salive, 1992; Spitz, 1990) and nicotine dependence (Cohen, 
1989; Duncan, 1992) are associated with smoking behavior. There are several reasons why 
this study may have resulted in different findings. First, although some authors suggest that 
“time to first cigarette” is a valid measure of nicotine dependence (Gritz, 1993; Hall et al., 
1985; Velicer, 1992), this may not be the case. Nicotine dependence may be a more 
complex construct. Second, asking former smokers how soon they smoked their first 
cigarette upon waking in the morning relies on the participant’s memory. Retrospective data 
can be intentionally, or unintentionally, false. A third alternative to the lack of findings is that 
there are a variety of other smoking history variables which may be predictive, but were not 
examined in this study. Several of the smoking history variables which were not included in 
the logistic regression analysis include number of previous quit attempts, duration of previous 
quit attempts, and number of other smokers in the household. Although these questions were 
asked of the participants, the questions were not specific enough, and therefore, did not 
accurately reflect the construct the researcher was attempting to measure. For instance, 
when reviewing the data, it was unclear whether the number of previous quit attempts 
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included the current quit attempt. Likewise, current number of other smokers in the 
household was assessed rather than number of additional smokers in the household at the 
time the participant (if former smoker) had quit smoking. Therefore, it is possible that the 
smoking history variables which were not examined may in fact be significant predictors.  
In this study, alcohol use was predictive of smoking status. While this is consistent 
with the literature, the relevance of this variable is questionable. More specifically, current 
alcohol use was assessed rather than alcohol use at the time of diagnosis or at the time of 
cessation (for former smokers). This reduces the relevance of the interpretation of this 
variable for several reasons. First, individuals who quit tobacco often quit alcohol use at the 
same time. Therefore, it makes sense that former smokers will report decreased alcohol use 
as compared to current smokers. Moreover, studies show that for individuals who have both 
habits, individuals are more likely to give up alcohol before smoking (Deleyiannis et al., 
1996).  
Depression improved prediction of smoking status in this study. This finding is 
consistent with previous research of smoking behavior in the general population. An 
overwhelming amount of research suggests that depression is highly correlated with smoking 
behavior (Coogan, 1998; Glassman et al., 1990; Wang, 1994), that depression is associated 
with smoking cessation (Anda et al., 1990; Ginsberg, 1995; Glassman, 1993; Hall et al., 
1993; Rabois & Haaga, 1997), and that depression predicts relapse (Doherty et al., 1995; 
Shiffman, 1986; Shiffman et al., 1997; Swan, 1996). A strength of the present study is that it 
specifically examines the relationship between mood and smoking behavior in two medical 
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groups in which smoking behavior is directly linked to diagnosis, treatment outcome, 
morbidity, and mortality. There are few previous studies investigating the relationship 
between depression and smoking behavior in the head and neck cancer or COPD 
population. Therefore, the finding in this study that depression predicts smoking status in this 
combined group provides interesting preliminary results. Despite the relevance of this 
information, there are several limitations to the interpretation of this finding. First, depression 
was not assessed at the time of diagnosis, nor for former smokers, at the time of cessation. 
In other words, “fluctuations in mood more proximal to high-risk situations were not 
assessed” (Hall et al., 1994, p. 145). Depressive symptoms can change over time. 
Therefore, whether a participant is or is not depressed at the time of participation in this 
study does not indicate whether the individual was depressed, or would have reported 
symptoms of depression, at the time of diagnosis or at the time of cessation. For instance, 
depression could theoretically increase at time of diagnosis, and then increase or decrease 
over time depending on quality of life changes, treatment outcome, and a variety of other 
variables that were not assessed.  
Anger was not found to predict smoking status in this study. Initial studies have found 
an association between anger and smoking behavior in the general population (Doherty et al., 
1995; Ginsberg et al., 1995; Speilberg et al., 1998; Tate et al., 1996; Tsuda et al., 1996). 
Similar to depression, anger is a dynamic construct. Anger was assessed at the time of the 
participant’s participation in the study, rather than at the time the participant (if former 
smoker) quit smoking cigarettes. Current symptoms of anger do not necessarily reflect the 
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participant’s experience of anger at the time of cessation. This is particularly relevant because 
in the short-term, abstinence leads to increased symptoms of anger (Doherty et al., 1995; 
Ginsberg et al., 1995; Tate et al., 1996; Tsuda et al., 1996).  
Finally, problem-solving skills were not found to predict smoking status. This finding 
is contrary to previous research suggesting that former smokers report better coping skills 
than current smokers (Horowitz, 1985; Matheny & Weatherman, 1998; Wewers, 1988). 
There are several reasons why this study yielded different findings. First, the problem-solving 
construct (SPSI-R) used in this study may be testing different constructs than previous 
studies. This is the first time problem solving, as defined by the SPSI-R, has been examined 
with smoking behavior.   
Second, problem-solving skills were assessed at the time of participation, not at the 
time the individual (i.e., former smoker) quit smoking. Although it is unlikely that an 
individual’s problem-solving skills would change over time without an intervention (i.e., 
problem-solving skills training), the influence of an individual’s successful quit attempt on their 
problem-solving skills (in particular, problem orientation), cannot be ruled out.  
Third, the effect size for problem solving may be smaller than initially perceived. If 
so, a much larger sample may be required in order to detect a significant relationship 
between problem-solving and smoking behavior.  
Fourth, perhaps it is not an individual’s overall problem-solving ability which is 
associated with smoking status, but rather, one of the component problem-solving skills. For 
instance, previous research on coping skills in the smoking literature suggests that individuals 
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who demonstrated less avoidance behavior were more successful abstainers (Horowitz, 
1985). Therefore, perhaps one of the components of problem solving (e.g., subscales of the 
SPSI) is predictive of smoking status. Specifically, problem solving can help to increase 
one’s sense of self-efficacy and also help individuals to better define their problems (e.g. 
recognize cues; determine which situations are triggers), and brainstorm different ways to not 
only reach one’s goals, but to also overcome obstacles to prevent relapse. However, 
exploratory follow-up analyses of the SPSI subscales demonstrated low correlations 
between the subscales and smoking status. Therefore, it is unlikely that these variables would 
be significant predictors in the logistic regression analysis. 
Fifth, problem-solving skills may not be a predictor or smoking status, but rather, 
may moderate the relationship between mood (e.g., depression, anger) and smoking status. 
Much of the previous literature demonstrates the moderating role of problem solving on 
stress-related depression (Nezu, 1985, 1986, 1987; Nezu et al., 1986; Nezu & Ronan, 
1985).  
Finally, it may be that problem-solving ability is not correlated with smoking behavior 
in this sample, or in these medical populations. Several other theories of health behavior 
(e.g., Health Belief Model, Transtheoretical Model of Change, Theory of Self-Efficacy) were 
highlighted earlier. Although these theories were not specifically tested in this study, it is 
possible that these variables play a stronger role in smoking behavior and smoking cessation, 
and therefore, cannot be disregarded.  
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CHAPTER 16: LIMITATIONS 
 
 In addition to the limitations highlighted in the Discussion section, there are several 
additional limitations to this study, related to internal and external validity, measurement 
problems, and problems with statistical analysis.  
 First, this study is a cross sectional design, prohibiting a causal interpretation of the 
data. We cannot infer that depression predicts future smoking behavior, as depression and 
smoking status were assessed at the same point in time. Furthermore, this study cannot rule 
out the possibility that smoking behavior (i.e., smoking cessation) does not have a causal 
effect on the predictor variables. For instance, individuals who successfully quit smoking may 
subsequently fare better from their treatment, and thus, experience a decrease in depression. 
Likewise, smoking may affect an individual’s orientation such that “failing to quit smoking 
strengthens a person’s belief that s/he cannot control her/his life” (Stronks et al., 1997).  
Second, this study lacks external validity because the generalizeability of the results is 
limited. The information gleaned about smoking behaviors from this study is limited to head 
and neck cancer and COPD. Predictors of smoking behavior cannot be generalized to other 
cancers or respiratory diseases. This is not much of a concern, as the interest of the research 
was specifically smoking behavior in these two particular medical populations.  
Third, for the former smokers, smoking behavior questions relied on retrospective 
memory. Retrospective data is more likely to be inaccurate. The reliability of their answers 
depends on the accuracy of their memory. Furthermore, the greater the time between the 
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former smoker’s quit date and the time of their participation in the study, the greater the 
likelihood of mis-reporting. Therefore, smoking variables which are  used in the statistical 
analyses, such as pack years, or the response to the question “how soon after you woke up 
would you smoke your first cigarette” may be inaccurate, and subsequently impact the 
results. Even if participants attempted to provide honest reports, there is no means by which 
to determine whether the responses of former smokers are inaccurate, and if inaccurate, the 
extent to which these participants underreported or over-reported their smoking behaviors 
and alcohol use.  
  Fourth, smoking behavior is a dynamic process. In this study, smoking status is a 
point prevalence measure. Therefore, the smoking rates may be inaccurate, and may 
underestimate the number of smokers. For instance, individuals who were classified as 
former smokers may have just quit in the past week and may relapse next week. However, 
time to relapse is quite variable, so that determining a time for follow-up assessment is 
difficult. Some researchers suggest that the most difficult time for smokers, when there are 
the strongest urges to smoke, is immediately after quitting. However, other researchers claim 
that a typical smoker starts up 3 months after quitting. In this study, smoking status was 
assessed twice: at initial entrance into the study, and a second time 3 months later. 
Individuals who remained abstinent were classified as former smokers.  
 Fifth, measurement of variables which posed a difficulty particular to the head and 
neck cancer group were those that inquired about withdrawal symptoms, such as craving, 
irritability, anxiety, increased eating and restlessness. Individuals with head and neck cancer 
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who do quit, often quit the day of their surgery. Therefore, they may experience the afore-
mentioned withdrawal symptoms, although not necessarily due to withdrawal from nicotine. 
Furthermore, these individuals are unlikely to report increased eating, as they are unable to 
eat solid food for many months post surgery.  
 Sixth, measurement of alcohol use in this study could be improved. Current alcohol 
use, but not alcohol history, was assessed. Many individuals quit alcohol use along with 
smoking cessation. Therefore, current alcohol use is not reflective of prior alcohol use. A 
more time-specific assessment might alter the results of the analysis.  
 Seventh, although classification of smoking status was chosen based on previous 
research, classification remains arbitrary. Many studies use a cut-off of 7 days, such that 
individuals who have smoked within the past 7 days are considered current smokers. A 
different cut-off point might yield different results. Also, this researcher considered smoking 
even a puff of a cigarette as smoking behavior. Some might argue that there is a difference 
between an individual who smoked one puff in the past 7 days and an individual who 
smoked one pack of cigarettes within the past 7 days. For instance, one might argue that the 
former is not nicotine dependent and the latter is, and that the psychosocial profile might 
differ since depression and nicotine dependence share some of the same biologic 
underpinnings. Therefore, a different classification system could yield different results.  
 In addition to measurement limitations and difficulties, there are several limitations 
related to the patient population. First, the pool of participants may be a reflection of 
selection bias. Current smokers may be more likely to decline participating in the study for 
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fear of their physician learning of their continued habit, or due to embarrassment at continuing 
to do a behavior that is considered socially unacceptable. Second, even participants who do 
complete the study may underreport their smoking history or current smoking status. In this 
study, underreporting of current smoking habits might not have affected the data since 
participants are being classified as either current smokers or former smokers. Underreporting 
only becomes a problem for the analysis if the participant actually claims to be a former 
smoker when he or she is, in fact, a current smoker. Although a biochemical assay would be 
desirable, self-report measures are the primary measures used for assessing smoking status 
in most investigations (Matheny and Weatherman, 1998; Ossip-Klein et al., 1986). 
Furthermore, the debate as to whether individuals underreport their smoking or whether their 
self-reports are accurate has not been resolved. Even if participants attempt to provide 
honest reports, there may be error, as highlighted above, due simply to retrospective bias. 
Persson and Norell (1989) found that  those who had decreased their consumption over 
time underestimated previous cigarette consumption, whereas those who did not change their 
consumption provided more accurate retrospective information.  
Data on depression, anger and problem-solving skills were also solely based on self-
reports. It may be helpful to confirm self-reported symptoms and increase the reliability of 
the findings by utilizing clinician ratings or reports by significant others.  
Finally, due to the small sample size and the change in research analysis, this study 
was unable to answer one of the initial research questions investigating the role of medical 
severity in predicting smoking status of two separate medical populations. Thus, one of the 
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hypothesized predictors was eliminated from the analysis. The analysis of the combined 
groups does not allow for interpretation of either group alone. Although the power was too 
low to conduct a statistical analysis of the medical groups separately, medical severity may 
be a significant predictor of smoking status, and therefore, cannot be ruled out as a potential 
predictor.  
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CHAPTER 17: FUTURE RESEARCH 
 
 Based on the results, and on the limitations, of this study, several recommendations 
can be made for future research. 
 Given the previous research that medical severity impacts smoking behavior, and 
given the results of this study suggesting that measures of pulmonary function are associated 
with smoking status, more information could be gleaned from two separate studies, one on 
smoking behavior in the COPD population, and one on smoking behavior in the head and 
neck cancer population. A much larger sample size would be required in order to detect 
differences in smoking behavior.  
 Research incorporating a longitudinal design is essential. This study incorporated a 
cross-sectional design to answer temporal questions. Therefore, the results can only suggest 
that current depression is associated with current smoking status. The results cannot make 
any inferences about a causal relationship. Therefore, a study in which individuals are 
assessed at the time of their diagnosis, and then followed over time, will better answer the 
research questions of this study.  
 Moreover, because smoking behavior is a dynamic process, and because individuals 
will attempt to quit smoking several times before they are successful over the long-term, a 
study which assesses smoking status over the course of years, rather than months, may 
better capture the dynamic nature of smoking behavior, and may also more correctly classify 
smokers.  
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 Several of the important predictor variables, as well as the main outcome  
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variable, in this study, were based solely on self-reports. Multiple assessments of mood, 
problem-solving skills, and smoking status, from different sources, would be more reliable.  
For instance, future research could incorporate a self-report measure of mood as well as a 
clinician rating, and smoking status could be confirmed by a biochemical validation measure.   
 The relationship between problem solving and smoking behavior warrants further 
investigation. The fact that problem-solving skills did not predict smoking status in this study 
does not rule out the possibility that problem-solving skills and smoking behavior are related 
in another way. Given the strong findings from previous research of the moderating role of 
problem solving on stress-related depression, a promising area of research is the examination 
of problem solving as a moderator of depression and smoking behavior. 
 Two additional psychosocial variables that would be important to investigate in future 
studies are anxiety and hostility. Some studies have found an association between anxiety 
and smoking behavior (Brown, Kahler, Zvolensky, Lejuez, & Ramsey, 2001; Gilbert, 
McClernon, Rabinovich, Plath, Masson, Anderson, et al., 2002), whereas other studies have 
not found anxiety-related differences (Takemura, Akanuma, Kikuchi, & Inaba, 1999; 
Zvolensky, Feldner, Eifert, & Brown, 2001). For instance, in a group of 60 smokers with a 
past history of Major Depressive Disorder, higher anxiety (as measured by the Anxiety 
Sensitivity Index) during smoking cessation was associated with an increased risk of relapse 
during the first seven days (Brown et al., 2001). Likewise, in an intervention study of 96 
female smokers, anxiety (as measured by the Beck Anxiety Inventory) increased during the 
initial quit attempt, and then returned to baseline levels after one week (Gilbert et al., 2002). 
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Given that anxiety is often reported as a symptom of withdrawal, and given some of the 
previous research, this variable might yield improtnat information regarding smoking 
behavior.   
In addition to anxiety, smoking behavior has been associated with hostility (Calhoun 
et al., 2001; Janner et al., 1999; Scherwitz & Rugulis, 1991; Whiteman et al., 1997; 
Williams & Williams). For instance, Janner et al. (1999) found nicotine reduced reports of 
anger (as reported in an ambulatory diary) in both smokers and nonsmokers with high 
hostility (as measured by the Cook-Medley Hostility subscale of the Multiphasic Personality 
Inventory [MMPI]), but not in those with low hostility. Additionally, they found that in a 
group of smokers and nonsmokers with high hostility on the nicotine patch, nicotine reduced 
reports of anger in both smokers and nonsmokers, suggesting that reports of anger were not 
simply a symptom of withdrawal (Janner et al., 1999).  The current study assessed this 
variable using the anger/hostility subscale of the POMS. The POMS assesses an individual’s 
mood over the past week, and therefore, reflects more of a state anger. In addition, some 
researchers suggest that there is a difference between anger and hostility such that hostility is 
a trait characterized by a cynical mistrust of others, a low threshold for anger, and the 
aggressive expression of anger (Barefoot, Peterson, Dahlstrom, Siegler, Anderson, & 
Williams, 1991), whereas anger is the mood component of the hostility trait. Therefore, a 
measure which better captures the hostility trait might yield important information. For 
instance, previous studies have used the Cook-Medley Hostility subscale of the MMPI ( 
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Calhoun et al., 2001; Scherwitz & Rugulies, 1991) and the Bedford-Foulds Personality 
Deviance Questionnaire (Whiteman et al., 1997) to measure hostility.  
Finally, a study which includes all patients, including those who never smoked, might 
yield valuable information. The current study accepted only those who were smoking 
cigarettes at the time of their diagnosis. Based on this criteria, 61 people were excluded from 
the study because they had never smoked cigarettes, and 83 people were excluded from the 
study because they had quit prior to their diagnosis. Future research could include these 
populations as well, as they might prove to be interesting comparisons groups. 
Understanding these two additional populations might further explain smoking behaviors in 
these medical populations.  
The results of this study have important implications for the role of clinical health 
psychology in smoking cessation. Although the smoking cessation rates for both the COPD 
population and the head and neck cancer population in this study were quite high 
(approximately 70%), a significant proportion of patients continue to smoke cigarettes 
despite their diagnosis. Helping these patients quit smoking has important implications for 
treatment outcome. More specifically, individuals who quit smoking respond to treatment 
better, experience slower disease progression, and have decreased mortality rates. 
Therefore it is important to identify patients at risk for continued smoking and target those 
individuals with treatment aimed at reducing barriers to smoking cessation.   
This study demonstrates an association between depression and smoking status such 
that those who report symptoms of depression are more likely to continue smoking after a 
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diagnosis of either head and neck cancer or COPD. It may be useful, therefore, to identify 
patients who are depressed, and to provide them with psychotherapeutic intervention in 
order to reduce their depressive symptoms and to subsequently improve the chance of a 
successful cessation.   
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CHAPTER 18: SUMMARY 
 
 The present study examined psychosocial predictors of smoking status in a group of 
individuals diagnosed with either head and neck cancer or COPD. Results demonstrated that 
marital status, alcohol use, and depression predict smoking status above and beyond 
demographic variables. Results also demonstrated that smoking history, anger, and problem-
solving skills did not predict smoking status in this population. 
 Sixty-eight percent of individuals with COPD and 75% of individuals with head and 
neck cancer quit smoking since their initial diagnosis. Medical severity appeared to be 
associated with smoking status in the COPD population, but not in those diagnosed with 
head and neck cancer.  
 The fact that depression increased prediction of smoking status suggests that 
interventions targeted to treat depression may help individuals successfully quit smoking. 
Such treatments may, subsequently, reduce morbidity and mortality due to head and neck 
cancer and to COPD.  
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APPENDIX A: Demographic Form 
 
 
 
Smoking, Distress, and Problem Solving 
Clinic:  Hayden  Hahnemann Pulmonary  MCP Pulmonary 
  Temple head and Neck   Temple Pulmonary 
Doctor: _______________________ 
 
I.  Demographic Information 
 
Subject Number: ________________  Date: ___________________ 
 
Name: _______________________________________________________________ 
 
Address: ______________________________________________________________ 
  
_____________________________________________________________________ 
 
 
_______________________________________________________________________________
____ 
 
Telephone Number:  Home (________) _______-______________   
   Work  (________)_______ - ______________ 
 Best time and place to contact you: Time: __________ Place:   Home  
  Work 
 Okay to leave a message?    Yes    No 
Gender:  M       F 
 
Age: ________________ Date of Birth: ______________  
 
Ethnicity: 
 African American   Asian  Caucasian  
 Hispanic     Other: Please specify: _________ 
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Marital Status:  
 Single  Living with Significant Other    If so, for how long: __________ 
 Married   If so, for how long: __________  Separated Month/Yr: ________ 
 Divorced     Month/Yr: ________   Widowed Month/Yr: ________ 
Number of Years of Education: _____            Highest Diploma/Degree: ________ 
Current Occupation: ________________________________ 
If retired: 1) What was your occupation? _____________  2) Year you retired _____ 
Current Total Family Income: _________________________ 
 
II. Illness Variables 
 
What is your current diagnosis? 
_____________________________________________________________________ 
 
In what month and year were you first diagnosed? 
_____________________________________________________________________ 
 
What is your current treatment? 
_____________________________________________________________________ 
 
What treatment have you had in the past? 
_____________________________________________________________________ 
 
Do you have any other medical conditions? If so, please list ALL other medical conditions 
and medications. 
III.  Smoking Variables  
Please Note: Your honesty regarding these questions is very important to us and 
the research. Your answers to these questions will not be revealed to your 
physicians and other individuals on your health care team. 
 
If you are a current smoker, please complete the questions in Part A.  
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 If you have smoked at least one puff of a cigarette in the past 7 days, then  
please begin at Part A. 
If you are a former smokers, please complete questions in Part B. 
If you have not smoked even one cigarette in the last 7 days, please begin at  
Part B. 
 
Part A (Current Smoker) 
 
How old were you when you smoked your first cigarette? _______________________ 
 
How old were you when you first started regular daily cigarette smoking? __________ 
 
At the time you were first diagnosed, how many cigarettes, on average, did you smoke per 
day? ______________________________________________________________ 
 
On average, how many cigarettes are you currently smoking per day? _____________ 
 
Over the past six months, how many cigarettes, on average, did you smoke per day? 
_____________________________________________________________________ 
 
When your smoking is/was the heaviest, how many cigarettes do you smoke per day? 
_____________________________________________________________________ 
 
On average of the entire time you have smoked, how many cigarettes did you/have you 
smoke per day? 
_____________________________________________________________________ 
 
Do you inhale?  Always  Sometimes  Never 
 
Please check the appropriate boxes: 
      Never       Past Only        Currently 
Smoke a pipe?                   
Smoke cigars?                   
Chew snuff?                   
Chew tobacco?                  
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When do you smoke the heaviest (check one box only): 
 Mornings  Afternoons   Evenings  Throughout the day 
 
 
 
 
 
How soon after you wake up do you smoke your first cigarette? 
____ immediately 
____ within 30 minutes 
____ between 30 minutes and one hour 
____ beyond one hour 
 
Which cigarette would be the most difficult to give up? 
 First cigarette in the morning 
 After meals 
 During or after stressful situations 
 During social occasions 
 
In what situations do you smoke? 
 In public 
 At work 
 At home 
 In the presence of certain relatives 
 Do you have children?  In the presence of them  
 At meetings 
 Inside the home of non-smokers 
 Do you have a car? In your car when non-smokers are with me 
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 In other peoples cars 
 In restaurants 
 Other. Please specify __________________________________________ 
 
 
Have you ever tried to cut down or limit your smoking?  Yes   No    
How many times? How many times have you attempted to stop smoking? __________ 
How many times have you stopped smoking for at least one day? ________________ 
 
 
What is the longest time you have ever stopped smoking? _______________________ 
 How long was this?  Less than a day 
     At least one day but less than a week 
     At lease one week but less than a month 
     At least one month but less than one year 
     One year or more 
 
What methods did you use to quit smoking? (e.g. “cold turkey,” patch, gum, Zyban; support 
group): ________________________________________________________ 
 
 
What symptoms did you experience when you stopped smoking in the past? (Please check 
all that apply): 
 Craving    Anxiety    Restlessness 
 Decreased heart rate  Increased eating   Difficulty concentrating 
 Irritability    Other: _______________ 
 
Do you believe that quitting smoking would be beneficial to your health?  
 Yes   No   Not sure 
 
Who lives in your household? _____________________________________________ 
 
How many of these individuals are current smokers and what is their relationship to you? 
________________________________________________________________ 
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How many days per week, on average, do you drink alcoholic beverages? __________ 
 
On the days that you drink alcohol, how many drinks, on average, do you have? _____ 
(One drink = 8 ounces of beer (or) 4 ounces of wine (or) 1.5 ounces of liquor) 
 
 
 
 
Part B. (Non Smoker) 
How old were you when you smoked your first cigarette? _______________________ 
 
How old were you when you first started regular daily cigarette 
smoking?_____________________________________________________________ 
 
At the time you were first diagnosed, how many cigarettes, on average, did you smoke per 
day? ______________________________________________________________ 
 
On average, how many cigarettes did you smoke per day immediately before you quit? 
_____________________________________________________________________ 
 
When your smoking was the heaviest, how many cigarettes did you smoke per day? 
_____________________________________________________________________ 
 
On average of the entire time you have smoked, how many cigarettes did you smoke per 
day? 
___________________________________________________________________ 
 
Did you inhale?  Always  Sometimes  Never 
 
Please check the appropriate boxes: 
      Never       Past Only        Currently 
Smoke a pipe?                   
Smoke cigars?                   
Chew snuff?                   
Chew tobacco?                  
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When did you smoke the heaviest (check one box only): 
 Mornings  Afternoons   Evenings  
 
When was the last time you smoked a cigarette (month and year)? ________________ 
 
 
 
 
When you were a smoker, how soon after you woke up did you smoke your first cigarette? 
____ immediately 
____ within 30 minutes 
____ between 30 minutes and one hour 
____ beyond one hour 
 
Which cigarette was the most difficult to give up? 
 First cigarette in the morning 
 After meals 
 During or after stressful situations 
 During social occasions 
 
In what situations did you smoke? 
 In public 
 At work 
 At home 
 Do you have children? In the presence of them  
 Inside the home of non-smokers 
 Do you have a car? In your car when non-smokers were with you 
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 In other peoples cars 
 In restaurants 
 Other. Please specify __________________________________________ 
 
 
 
 
 
Prior to your final, successful quit attempt, had you ever attempted to quit smoking? 
 Yes  No  How many times? ________ 
 
Of those times, how many times had you stopped smoking for at least one day? _____ 
 
What is the longest time you have ever stopped smoking? _______________________ 
 How long was this?  Less than a day 
     At least one day but less than a week 
     At lease one week but less than a month 
     At least one month but less than one year 
     One year or more 
 
What methods have you used in the (past or currently) to stop smoking? (e.g. “cold turkey,” 
patch, gum, Zyban; support group): _________________________________ 
 
What symptoms did you experience when you stopped smoking? (Please check all that 
apply): 
 Craving    Anxiety    Restlessness 
 Decreased heart rate  Increased eating   Difficulty concentrating 
 Irritability    Other: _______________ 
For assessor:  
Mark this box if difficult to assess because quit upon diagnosis and surgery:  
 
Do you believe that quitting smoking was beneficial to your health?  
 Yes   No   Not sure 
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Who lives in your household? _____________________________________________ 
 
How many of these individuals are current smokers and what is their relationship to you? 
_________________________________________________________________ 
How many days per week, on average, do you drink alcoholic beverages? __________ 
On the days that you drink alcohol, how many drinks, on average, do you have? _____ 
(One drink = 8 ounces of beer (or) 4 ounces of wine (or) 1.5 ounces of liquor) 
 
 
 
 
APPENDIX B: Social Problem-Solving Inventory – Revised 
 
 
 
Sample Test Items of the SPSI Scales 
 
Positive Problem Orientation 
#7 When my first efforts to solve a problem fail, I know if I persist and do not  
give up too easily, I will be able to eventually find a good solution.  
 
 
Negative Problem Orientation 
# 13 When I am faced with a difficult problem, I doubt that I will be able to solve it  
on my own no matter how hard I try. 
 
 
Rational Problem Solving 
#24 When making decisions, I consider both the immediate consequences and  
long-term consequences of each option. 
 
#44 When I have a problem to solve, I examine what factors or circumstances in  
my environment might be contributing to the problem.  
 
 
Impulsivity/Carelessness 
#34 When I have a decision to make, I do not take the time to consider the pros  
and cons of each option.  
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Avoidance Style 
#23 I prefer to avoid thinking about the problems in my life instead of trying to  
solve them. 
 
 
 
 
 
 
 
Copyright © 1996, Multi-Health Systems, Inc. All rights reserved. In the USA, P.O. Box 
950, North Tonawanda, NY  14120-0950, 1-800-456-3003. In Canada, 3770 Victoria 
Park Ave., Toronto, ON  M2H 3M6, 1-800-268-6011. Internationally, +1-416-492-
2627. Fax, +1-416-492-3343. Reproduced with permission. 
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APPENDIX C: Profile of Mood States 
 
 
 
Sample Test Items  
 
Items from the Depression/Dejection Scale 
 
#5 Unhappy 
 
#32 Discouraged 
 
#48 Helpless 
 
 
Items from the Anger/Hostility Scale 
 
#3 Angry 
 
#24 Spiteful 
 
#33 Resentful 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © 1971, Douglas M. McNair, Ph.D., Joan Lorr, Ph.D., Leo F. Droppleman, 
Ph.D., under exclusive license to Multi-Health Systems Inc. All rights reserved. In USA, 
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APPENDIX D: Patient Diagnostic Form 
Patient Diagnostic Information 
( to be obtained from the medical chart) 
 
Subject Number: _____________  Name: ___________________________ 
 
Clinic:  Hayden  Hahnemann Pulmonary   MCP Pulmonary 
  Temple Head and Neck    Temple Pulmonary  
 
Doctor:  Date: 
 
Diagnosis: COPD    Head and Neck Cancer 
  _____ Emphysema  _____ Oral cavity 
  _____ Chronic bronchitis _____ Paranasal sinus and nasal cavity 
  _____ COPD   _____ Salivary glands 
      _____ Oropharynx 
      _____ Nasopharynx 
      _____ Hypopharynx 
      _____ Larynx 
      _____ Metastatic squamous cell  
carcinoma 
      _____ Other: ______________________ 
 
Date of Initial Diagnosis (Month/Year): ________________ 
 
Disease Severity (Please check below):  
COPD         Head and Neck 
Cancer 
FVC (current/most recent): _____(_____) DATE:      /      / Stage (current) : 
_____  
         DATE:      /      / 
FEV1 (current/most recent): _____(_____)      
         Stage (at initial 
diagnosis): _____
  
FEV1/FVC (current/most recent): _____    DATE:      /      /
    
_________________________________ 
FVC (at initial diagnosis/earliest in chart): _____(_____) DATE:      /      / 
 
FEV1 (at initial diagnosis/earliest in chart) _____(_____) 
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FEV1/FVC (at initial diagnosis/earliest in chart) _____ 
Treatment: 
Current Medications (Please list):__________________________________________ 
_____________________________________________________________________
_____________________________________________________________________ 
Surgery (Date of most recent surgery M/DD/YY):_____________________________ 
Radiation:   Yes   No  Chemotherapy:  Yes   No 
Other (Please list additional treatment): 
_____________________________________________________________________ 
_____________________________________________________________________ 
 
Previous Treatment: 
_____________________________________________________________________ 
_____________________________________________________________________ 
 
Other Medical  Conditions: 
_____________________________________________________________________ 
_____________________________________________________________________ 
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APPENDIX E: Informed Consent 
 
MCP Hahnemann University  
Consent to Participate 
In a Research Study 
 
1.  Subject Name: ________________________________ 
  
  
2.  Title of Research: Predictors of Smoking Behavior in People with Head and Neck  
         Cancer and Chronic Obstructive Pulmonary Disease  
  
3.  Purpose of Research: 
 
 You are being asked to participate in a research study. The purpose of this study is 
to assess how various problem-solving styles are related to a person’s psychological 
reactions to either head and neck cancer or chronic obstructive pulmonary disease, and their 
smoking behavior. It is expected that 150 individuals will be enrolled in the study. 
 
 
4.  Procedures and Duration: 
  
 You understand that you will be asked to do the following: 
  
(a)  To provide information about yourself, such as your age, race, and medical 
treatment. Your name will not be on any materials retained in the study and this 
personal information will only be known to the research team. 
  
(b)  To allow us, the research team, to communicate with your doctor regarding your 
medical diagnosis. 
  
(c)  To fill out several brief questionnaires asking how you typically solve problems in 
living, how you are currently feeling, about current problems that you have due to 
either cancer or COPD, and questions about your past and current smoking 
behaviors. You understand that information about your smoking, both past 
and current, will NOT be revealed to your doctor. The questionnaires are 
expected to take approximately 20-30 minutes, and you are asked to complete 
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them in the physician’s office. You will be provided a private room in which to 
complete these questionnaires. You will be asked to complete these 
questionnaires only one time, during today’s visit. 
  
  
(d)  You will be contacted in three months and asked to complete a telephone 
interview regarding your smoking status and smoking behavior since your 
participation in this study. You understand that the telephone interview is 
expected to take approximately 5 minutes. 
 
5.  Risks and Discomforts: You have been told that the risks and/or discomforts of being 
in this study include: 
 
(a)  You may worry about who may have personal information about me. Since 
information about you is private, when the researchers talks about the 
results of this project, all information will be put together with everyone 
else’s. Only the professionals involved in this study will see any of the 
answers. However, your physician and the care coordinator, who are a 
part of the research team, will not have access to your personal smoking 
history.  
  
(b)  Filling out the questionnaires may increase your negative feelings by making you 
think about your current problems. If these feelings or thoughts make you feel 
worse, you can discuss them with any member of the project. They will try 
to understand these feelings and be of help to you. 
 
 
6.  Benefits: You understand the following benefits may occur as a result of your 
participation in this study: 
  
(a)  You understand that you may not directly experience any benefits. 
(b)  Your participation may help future people with head and neck cancer and 
COPD by helping researchers know more about the importance of problem-
solving styles in coping with medical illness. This information can lead to the 
development of important educational and counseling programs. 
  
  
7.  Reasons for Removal from Study: 
 
 You may be required to stop the study before the end for any of the following 
reasons: 
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(a)  If required by a change in medical condition; 
  
(b)  If all or part of the study is discontinued for any reason by the sponsor or 
government agencies; or 
  
(c)  If others in this study experience harmful reactions. 
8.  Voluntary Participation 
 
 You understand that being in this study is voluntary. Your health care will not be 
affected in any way if you decline to be in, or later withdraw from, this study. 
 
 
9.  In Case of Injury 
 
 You have been told that if you have any questions or believe you have been injured 
in any way by being in this research project, you should contact Dr. Christine M. Nezu at 
(215)762-3677. If you have an adverse reaction as a result of this study, you should contact 
the MCP Hahnemann University Research Administration Office at (215)762-3453.  
 
10. Consent to Use Research Results and Confidentiality of Records: 
 
 All data obtained in this study will be kept confidential. In any publication or 
presentation of research results, your identity will be kept confidential, but there is a 
possibility that records which identify you may be inspected by authorized individuals and 
agencies such as the Food and Drug Administration, the Institutional review Board (IRB), or 
employees conducting peer review activities. I consent to such inspections and to the 
copying of excerpts from my records, if required by any of these representatives. 
 
 You medical records will be handled as are the records of all patients with similar 
medical condition entering MCP Hahnemann University Hospitals for clinical treatment. 
 
 
11. Other Considerations  
  
 If new information becomes known that will affect you or might change your decision 
to be in this study, you will be informed by the investigator. If you have any questions at any 
time about this study or your rights as a research participant, I may contact the Office of 
Research Administration at (215)762-3453. 
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12. Participant Certification: 
 
  I hereby certify that I do not fit within any of the following categories: 
 
· known history of mental illness diagnoses including bipolar disorder, psychosis, 
and/or mental retardation 
· under 25 years of age or over 80 years of age 
12. Consent 
 
 ·    I have been informed of the reasons for this study. 
· I have had the study explained to me. 
· I have had all of my questions answered. 
· I have carefully read this consent form, have initialed each page, and have 
received a signed copy. 
· I give consent voluntarily. 
 
 
 
________________________________  
Participant Name (please print)   
 
 
________________________________  __________________ 
Participant’s Signature    Date 
 
 
 ________________________________  __________________ 
 Investigator/Individual Obtaining Consent *  Date 
 
 
________________________________  __________________ 
Witness to Signature     Date 
 
List of Individuals Authorized to Obtain Consent* 
 
* Name    Telephone Number 
 Kim P. Baron, Ph.D.  (215) 762-7625 
   Christine M. Nezu, Ph.D. (215) 762-3677 
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APPENDIX F: Informed Consent 
 
Temple University Hospital 
Consent to Participate 
In a Research Study 
 
Predictors of Smoking Behavior in People with Head and Neck Cancer and  
Chronic Obstructive Pulmonary Disease 
Principle Investigator: Edward Volkman, M.D. 
Co-Investigators: Kim Baron, M.A. 
         Daniel J. Kelley, M.D. 
         John Travaline, M.D.  
Participant Name : ____________________________ ID# ___________ 
IRB Protocol # __________ 
 
PURPOSE OF THE STUDY 
I am being asked to participate in a research study. The purpose of this study is to assess 
how various problem-solving styles are related to a person’s psychological reactions to 
either head and neck cancer or chronic obstructive pulmonary disease, and their smoking 
behavior. It is expected that 150 individuals will be enrolled in the study. 
 
DESCRIPTION OF THE PROJECT 
I understand that I will be asked to do the following: 
(a)  to provide information about myself, such as my age, race, and medical 
treatment. My name will not be on any materials retained in the study and this 
personal information will only be known to the research team.  
(b)  to allow the research team to communicate with my doctor regarding my medical 
diagnosis. 
(c)  to fill out several brief questionnaires asking about how I typically solve problems 
in living, how I am currently feeling, about current problems I have due to either 
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cancer or COPD, and questions about my past and current smoking behaviors. I 
understand that information about my smoking, both past and current, 
will NOT be revealed to my doctor. The questionnaires are expected to take 
approximately 20 - 30 minutes, and I am asked to complete them in the 
physician’s office. I will be provided with a private room in which to complete 
these questionnaires. I will be asked to complete these questionnaires only one 
time, during today’s visit.  
(d)  I will be contacted in three months and asked to complete a telephone interview 
regarding my smoking status and smoking behavior since my participation in the 
study. I understand that the telephone interview is expected to take 
approximately 5 minutes.  
 
CONFIDENTIALITY STATEMENT 
All documents and information pertaining to this research study will be kept confidential in 
accordance with all applicable federal, state and local laws and regulations. I understand that 
medical records and data generated by the study may be reviewed by Temple University’s 
Institutional Review Board, the study sponsor, and the United States Food and Drug 
Administration (FDA) to assure proper conduct of the study and compliance with federal 
regulations. I understand that the results of this study may be published. If any data are 
published, I will not be identified by name. 
 
VOLUNTARY PARTICIPATION STATEMENT 
I understand that my participation in this study is entirely voluntary, and that refusal to 
participate will involved no penalty or loss of benefits to me. I may discontinue my 
participation at any time without penalty or loss of benefits.  
 
COMPENSATION STATEMENT 
I understand that I will receive no compensation for this study.  
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INSTITUTIONAL CONTACT 
If I have any questions about my rights as a research subject, I may contact the Institutional 
Review Board Manager, Ruth S. Smith at (215) 707-3249. 
If I have any questions about research-related injuries, I may contact Dr. Edward Volkman 
at (215) 707 - 5343. 
 
STANDARD INJURY STATEMENT 
I understand that if I sustain an injury as a result of participation in this study, only physician’s 
fees and medical expenses not covered by my medical and hospital coverage or other third 
party coverage will be paid at no cost to me. I understand that financial compensation for 
such injuries is not available. I understand that I have not waived any of the legal rights which 
I would otherwise have as a participant in an Investigational study. 
 
COSTS STATEMENT 
I understand that the tests required by the study will be provided at no cost to me. 
 
TERMINATION STATEMENT 
The investigator or the sponsor may terminate my participation in the study without my 
consent. 
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FINAL STATEMENT AND SIGNATURE 
This study has been explained to me, I have read the consent form and I agree to participate. 
I have been given a copy of this consent form.  
 
_____________________________   ____________________ 
Participant      Date 
 
_____________________________   ____________________ 
Investigator / Co-Investigator    Date 
 
______________________________  ____________________ 
Witness      Date 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   218 
 
 
   219 
APPENDIX G: Three-Month Follow-Up 
 
Predictors of Smoking Behavior in People with Head and Neck Cancer  
and Chronic Obstructive Pulmonary Disease 
 
Telephone Interview 
3 Month Follow-Up 
I. General Information 
 
Subject Number: ________________    
 
Name: __________________________________   
 
Date if Initial Participation: _____________  
 
Clinic:  Hayden  Hahn.  Pulmonary  MCP Pulmonary  
 Temple Head and Neck     Temple Pulmonary Doctor: _________ 
 
Date of Follow-Up Interview: ___________ 
 
Telephone Number:  Home (________) _______-______________   
   Work  (________)_______ - ______________ 
 Best time and place to contact you: Time: __________ Place:   Home  
Work 
 Okay to leave a message?  Yes   No 
 
Smoking Status at Initial Interview:  Smoker  Ex-smoker 
(From Initial Contact, Record: Amount Smoked: _________     (or) Date Quit: _____ ) 
 
II. Illness Variables 
 
What is your current diagnosis? ___________________________________________ 
 
What is your current treatment? ___________________________________________ 
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III.  Smoking Variables Remind participant about confidentiality. 
A.  Have you smoked at least one puff of a cigarette in the past 7 days?      
      Yes No 
 
Have you smoked at least one puff of a cigarette in the past 3 months (since your 
initial participation in the study? Yes No 
 
If yes to either: 
On average, how many cigarettes are you currently smoking per day? _____________ 
 
Over the past three months, how many cigarettes, on average, did you smoke per day? 
_____________________________________________________________________ 
 
Over the past 3 months, when your smoking is the heaviest, how many cigarettes do you 
smoke per day? _______ 
 
Do you inhale?  Always  Sometimes  Never 
 
Over the past 3 months, when you did smoke, when do you smoke the heaviest (check one 
box only):      Mornings   Afternoons   Evenings 
 
Over the past 3 months, on the days that you did smoke, how soon after you wake/woke up 
do/did you smoke your first cigarette? 
____ immediately 
____ within 30 minutes 
____ between 30 minutes and one hour 
____ beyond one hour 
 
Which cigarette is/would be/was the most difficult to give up? 
 First cigarette in the morning 
 After meals 
 During or after stressful situations 
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 During social occasions 
 
In what situations do you smoke? 
 In public 
 At work 
 At home 
 In the presence of certain relatives 
 In the presence of my children 
 At meetings 
 Inside the home of non-smokers 
 In my car when non-smokers are with me 
 In other peoples cars 
 In restaurants 
 Other. Please specify __________________________________________ 
 
B. Over the past 3 months, did you try to cut down or limit your smoking?  
 Yes      No 
If Yes: 
How many times have you attempted to stop smoking? _________________________ 
 
During the last 3 months, how many times have you stopped smoking for at least one day?  
________________________________________________________________ 
 
During the last three months, what is the longest time you had stopped smoking?  
 
   Less than a day 
   At least one day but less than a week 
   At lease one week but less than a month 
   At least one month but less than two months 
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   At least two months but less than three months 
 
What methods, if any, did you use to stop smoking (e.g., cold turkey; nicorette gum; nicotine 
patch; support group; Zyban, etc.)? __________________________________ 
What symptoms did you experience when you stopped smoking? (Please check all that 
apply): 
 Craving    Anxiety    Restlessness 
 Decreased heart rate  Increased eating   Difficulty concentrating 
 Irritability    Other: _______________ 
 
 
 
PLEASE THANK THE PERSON FOR THEIR PARTICIPATION IN THE 
STUDY. 
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